Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
July/August, 2014 • Vol. 6, Issue 4 www.vet-advantage.com Promoting Excellence in Animal Health Sales Tiger by the Tail Zack Mills has a passion for veterinary medicine Inside: Patterson National Sales Meeting Success, Unplugged The Senior Pet Heartworm Diagnosis » p.10 » p.23 » p.56 » p.64 It’s a soft chew. Kills both fleas and ticks. It’s prescription only. Now a pprov to kill m ed ore ticks! NexGardTM (afoxolaner) is the protection you asked for, and patients will beg for. NexGard is FDA-approved to kill fleas, prevent flea infestations, and kill Black-Legged (deer) ticks, Lone Star ticks and American Dog ticks. NexGard is available only with a veterinarian’s prescription, and features anti-diversion technology monitored by Pinkerton® Consulting & Investigations. NexGard and FRONTLINE VET LABS are trademarks of Merial. ®PINKERTON is a registered trademark of Pinkerton Service Corporation. ©2014 Merial Limited, Duluth, GA. All rights reserved. NEX14TTRADEAD (06/14). TM IMPORTANT SAFETY INFORMATION: For use in dogs only. The most common adverse reaction is vomiting. Other adverse reactions reported are dry/flaky skin, diarrhea, lethargy, and anorexia. The safe use of NexGard in pregnant, breeding, or lactating dogs has not been evaluated. Use with caution in dogs with a history of seizures. July/August 2014 www.vet-advantage.com 46 page »» Publisher’s letter: Chris Kelly Is the Pet Owners Act Really Fair? pg6 »» Industry insights: Kirk Augustine Your Summer/Fall Forecast for Sales pg8 »» d istribution Patterson Veterinary National Sales Meeting Committed to Possibilities pg10 pg14 »» Sa les: Big Words Lead to Big Confusion Brian Sullivan pg16 Sales Call Challenges Pat Malone »» Sales: ATS Voice Mail vs. Text Messaging pg20 pg24 »» Finance: Fritz Wood, CPA, CFP Who Does What? »» r oad tales »» Trends pg32 FIV, Lyme disease up, but many signs of improvement appear in Banfield State of Pet Health 2014 Report, with its focus on infectious diseases The Persistent Threat of Rabies pg22 Success, Unplugged pg34 Laura Thill Summertime finds more pets outdoors, making it a good opportunity for your customers to remind pet owners to stay current with their pets’ rabies vaccines. Understanding Diabetes »» p erspective: Adam Augustine Get more accomplished with a healthy dose of detachment Help veterinary practices become the local pet-care authority in their communities Infectious Disease Trends are Mixed Cut Through the Clutter The steps toward solving two of the biggest obstacles reps face with customers Local Authority Effective use of veterinary healthcare team talent pg28 »» Inside Sales: Dawn Singleton-Olson Find and use the information that will be most valuable to your customers »» M arketing: Pam Foster pg38 Laura Thill An understanding of diabetes – including the symptoms and challenges it presents – can help sales rep better service their veterinary customers. pg42 pg23 Veterinary Advantage magazine (ISSN 1948-0288) is published bi-monthly, PO Box 862151, Marietta , GA 30062. Copyright 2014 All rights reserved. Subscriptions: $49.00 per year for individuals; issues are sent free of charge to dealer representatives. If you would like to subscribe or notify us of address changes, please contact us at the above numbers or address. POSTMASTER: Send address changes to Veterinary Advantage, PO Box 862151, Marietta, GA 30062. Please note: The acceptance of advertising or products mentioned by contributing authors does not constitute endorsement by the publisher. Publisher cannot accept responsibility for the correctness of an opinion expressed by contributing authors. Periodicals Postage Paid at Marietta, GA and at additional mailing offices. www.vet-advantage.com • Veterinary advantage «« July/August 2014 3 July/August 2014 Editor Mark Thill [email protected] www.vet-advantage.com Managing Editor Graham Garrison [email protected] Senior Editor Laura Thill [email protected] Contributing Editor Jennifer Ryan [email protected] Art Director Brent Cashman 81 page [email protected] Vice President of Sales & Marketing Rick Boggess [email protected] »» cover story: Tiger tails Tiger by the Tail Graham Garrison Zack Mills has a passion for veterinary medicine pg46 »» Trends Preventive healthcare, an understanding of the unique needs of older pets, and owners’ eagerness to care for their aging animals have contributed to longer lives for companion animals pg56 Heartworm diagnosed by 75 percent of veterinarians Preventives identified as key to stemming incidence Managing Expectations Practice managers discuss the future of veterinary medicine pg64 pg66 pg70 »» Sa les meeting pg74 Jennifer Ryan pg78 A passion followed Karen McGarrah uses the skills – and passion – she learned as a healthcare supply chain executive to help rescue horses pg81 News pg85 »» Product Announcementspg89 »» Editor’s note: Mark Thill July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Sales & Marketing Coordinator Paige Kelly Circulation Laura Gantert [email protected] Photography by Dan Carmody, Studio 7 Corporate Headquarters 3628 Blakeford Club Dr. Marietta, GA 30062 866-388-8212 phone 866-615-9232 fax 2014 editorial board »» C OMMUNITY Senior pets demand our attention [email protected] [email protected] »» E quine Equine veterinarians are increasingly using stem-cell therapy to help repair bone, ligament and tendon injuries Vice President Industry Relations Lorne Elder President & Publisher Chris Kelly Anesthesia Equipment Veterinarians are looking to provide safe anesthesia at a reasonable cost. By understanding the needs of their clinics, sales reps can help them do so. Executive Vice President of Business Development Kirk A. Augustine [email protected] Words that Work The best messages about preventive care are simple and to-the-point, says Karyn Gavzer [email protected] [email protected] »» pa rtners for healthy pets 4 [email protected] Account Executive Doreen Carpenter The Senior Pet Cell by Cell Recovery Senior Account Executive Kim Long pg98 Kim Allen, Henry Schein Animal Health Spencer Breithaupt, M WI Veterinary Supply Scott Handler, DVM, Patterson Veterinary Jeannie Jeffery, Henry Schein Animal Health Jackie King, AVDA Karen Miller, Midwest Veterinary Supply Clay Cass, Merritt Veterinary Supplies John Ryan, MWI Veterinary Supply Michael Stone, Henry Schein Animal Health Mark Ziller, Animal Health International »» Publisher’s Letter Is the Pet Owners Act Really Fair? Most people believe our system of government is not serving Chris Kelly its constituents well. That includes people from both political parties and all walks of life. While much of what goes on in Washington, D.C. is aggravating, the new Fairness to Pet Owners Act (H.R. 4023) rates very high on the aggravation scale. Like its predecessor H.R. 1406, it would require a veterinarian to provide a client with a written prescription for pet medications, regardless of whether it was requested by the client. The veterinarian would also be prohibited from charging for the prescription or asking a client to sign a liability waiver related to writing the prescription. It’s likely that even if H.R. 4023 is defeated, like its predecessor, it will continue to be brought up time and again in Congress. That’s because, at least in my opinion, the big box stores, who are anxious to increase their market share in pet prescriptions, have successfully lobbied and/or contributed to a Congressman who then goes to work on their behalf. The Congressman, in the spirit of “fairness” then brings up a bill that moves money from the veterinary hospital to the retailers supporting him, with the veterinarian required to work on behalf of the retailers. I know this is standard protocol in D.C., but it is hitting close to home once again, thus the aggravation. If this was truly an issue of limiting consumer choice and flexibility, I would probably favor a bill of this nature. I don’t believe this is a problem though. Consumers understand they have choices, and are reminded of that every time they turn on the TV or shop in a big box retailer. In addition, most states have laws protecting consumer choice when it comes to pet prescriptions. The big question is how do we win this battle? There are many valid arguments against this bill, from the burden placed on veterinarians to whether choice truly is being limited, but the one I believe resonates most effectively has to do with safety. Veterinarians are uniquely qualified to fill prescriptions because they can offer guidance and education around the use of the products, which most human retail pharmacies are not qualified to do. This helps ensure that pets are properly treated, which is hard to argue against, regardless of your position. On a related note, in an attempt to help veterinarians properly price these products, we have launched a new Price Index App which is now available in the Apple App Store. It focuses on flea, tick, heartworm and NSAID products and pulls pricing from a large number of retail sources. The information is presented as a pricing range, showing the high, low and median prices. It also includes a calculator to determine margin or margin dollars, historical pricing, as well as retail tips. If hospitals are currently doing their own pricing research, the Price Index will save them a significant amount of time and money. The cost is $25 and includes future upgrades. For more information please visit www.vet-advantage.com. Veterinarians are uniquely qualified to fill prescriptions because they can offer guidance and education around the use of the products, which most human retail pharmacies are not qualified to do. 6 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com DECHRA OPHTHALMIC O I N T M E N T S A R E BA C K Now your customers can treat canine and feline patients with the trusted ophthalmic products, VETROPOLYCIN® (bacitracin-neomycin-polymyxin) Veterinary Ophthalmic Ointment and VETROPOLYCIN® HC (bacitracin-neomycinpolymyxin-hydrocortisone acetate 1%) Veterinary Ophthalmic Ointment, that are FDA-CVM approved for use in dogs and cats. The choice is clear. Contact your Dechra Representative for more information. 24 Hour Technical Support available from trained Veterinary Professionals. LIMITED TIME OFFER | 866-933-2472 BUY 9, GET 3 FREE Some restrictions apply. As with all drugs, side effects may occur. In field studies, the most common side effects reported were ocular itching, burning, or inflammation in animals sensitive to the product. Prolonged use may result in the overgrowth of nonsusceptible organisms including fungi. VETROPOLYCIN ONLY— Do not use as a pre-surgical ocular lubricant. VETROPOLYCIN HC ONLY— This product is not for use in animals with corneal ulcers, fungal infections, or viral infections. Patients should be monitored for signs of corticosteroid overdose. The safe use of this product has not been evaluated in pregnant animals. Refer to the prescribing information for VETROPOLYCIN and VETROPOLYCIN HC for complete details or visit www.dechra-us.com. Dechra Veterinary Products, 7015 College Blvd., Suite 525, Overland Park, Kansas 66211, 866-933-2472 »» Industry Insights Your Summer/Fall Forecast for Sales Summer can make selling a bit challenging. Doctors are on vacation, hospital managers are juggling duties and often short-staffed. Purchasers or buyers are not sure what the upcoming days or months will bring. Certain geographies are reeling from drought or floods. However, uncertainty is often the distributor rep’s best friend, because you could know more about the practices’ purchasing needs than they do. You have a complete look at their historical purchases, and field reps can frequently see (literally) the products that practices are not buying from your organization. In a previous issue, I shared practice profile information, including the reality that average clinic reorders hover around +/- $500. This is an indication of an unsophisticated supply chain or channel. Distribution reps that seek to help their customers forecast and ensure key products remain on-hand By Kirk Augustine will be successful. Consider how you might take action: Consider this: The average hospital reacts to inventory • Teach customers how to use your company’s history outages (“0” quantity on hand) instead of acting to restock tools in the web application. based upon a minimum quantity on hand. • Facilitate a discussion during a lunch meeting with your A recent article in Supply Chain Digest underscores key accounts to help them manage inventory as a team. this. Although focused on issues in more traditional supply • Utilize manufacturer promotions or offers to secure chain management, the results also apply to our animal customers level pricing for a time period (be sure to health industry. remind them to manage their margin calculations in the practice management system). Among the Leading Barriers to Improved Supply Chain • Become the liaison to create an outside, inside, and clinic Success* were: buyer collaborative team to service key customers more • Forecast accuracy and • Lack of internal crosseffectively. (Too often, ISRs and OSRs are not aligned). demand variability functional collaboration • Utilize purchase history to establish a forecast, reorder • Lack of visibility across points (ROP), and economic order quantities (EOQ). • Cost volatility the supply chain The most collaborative reps that help customers optimize • Lack of external crosstheir business opportunities are those who will be at work in our • Supply chain complexity functional collaboration industry five years from now. It takes just a little extra effort, a bit more strategic thinking, and solid pre-planning to realize the re* http://www.scdigest.com/ASSETS/NEWSVIEWS/ sults from working in this way; but the rewards are boundless. 11-06-30-1.php?cid=4689 Forecasting Steps with a Customer 1st – Remember, inventory should never stand still. 2nd – Acquire annual purchases by SKU in total units. 3rd – Assemble this listing in descending unit quantities. 4th – Work first with the SKUs where the annual quantity is > 144 units (12/month) 5th – Divide the annual quantity by 18. This establishes a reorder point (ROP), which leaves three weeks of inventory on hand pending buyer actions and time to recognize a shortage, reorder, receive, and restock. 8 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com 6th – Then suggest using the same formula (annual quantity÷18) rounded to the nearest case quantity as the economic order quantity (EOQ). 7th – Make sure you advocate your distributor company as the primary supplier for these SKUs in the practice management system. 8th – Make this collaboration a part of future calls and track hospital progress by looking at the logical results indicated by increasing dollars per order and lines per order. • • • • • • W e a r e p e o p l e p r o t e c t i o n.® Learn how eco-friendly practices minimize our global impact at www.GlovethePlanet.com »» Distribution Patterson Veterinary National Sales Meeting Committed to Possibilities Patterson Veterinary, a division of the Patterson Companies, held its national sales meeting at the Omni Fort Worth Hotel in Fort Worth, Texas on May 12-15. More than 275 attendees from Patterson Veterinary and 100 of its vendor partners were in attendance. The theme of the meeting was Committed to Possibilities and focused on the changes Patterson is making as a company to differentiate itself in the eyes of the customer, as well as celebrating the successes of 10 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com the past year. The meeting included breakout sessions, interactive forums where new ideas were shared, manufacturer presentations and presentations by well-known national speakers. The meeting kicked off with a presentation by George Henriques, president of Patterson Veterinary. “Our theme for this year’s meeting, Committed to Possibilities, sets the stage for envisioning, discussing and preparing for some of the opportunities we plan to embrace in fiscal 2015,” said Henriques. “We have many factors in our favor, including a 6 percent increase in pet ownership and indications that people are spending significantly more money on their pets, making the independent practitioner our bread and butter.” Henriques also detailed the expansion of Patterson’s markets, key strategic partnerships, and differentiators that continue to improve Patterson’s competitive position in the marketplace. Jeff Baker, Patterson Veterinary’s Vice President of Sales, followed Henriques and commented on Patterson’s commitment to change. “As a company, we have the right strategy, the right team and we’re going in the right direction,” said Baker. “In addition, our commitment to change will allow the company to remain competitive by improving our IT infrastructure and streamlining “That’s just my [SUPRESSED IMMUNE SYSTEM. ELEVATED HEART RATE. ABNORMAL RESPIRATORY RATE. GI UPSET. HORMONE CHANGES. ] stress coming out.” INAPPETANCE . Start Zylkene. a new dialogue about behavior then start new Because your patients aren’t just stressed out. They’re stressed within. Your clients don’t realize behavior problems aren’t just stress-related, they’re health-related too. You’re the life line for answers and new Zylkene is your first line: • The only veterinary nutraceutical with alpha-casozepine, a safe and natural ingredient derived from casein, a milk protein with calming properties • Clinically proven for behavioral problem management without drowsiness or sedation • Indicated for situational stress or chronic anxiety in dogs or cats • Palatable, once-daily formulation in three sizes Learn more at vetoquinolusa.com/zylkene or call 800-267-5707. Relax, you’ve got Zylkene is a registered trademark of Vétoquinol. ©2014 Vétoquinol 7/2014 ® »» Distribution the way we do things.” Baker also urged Patterson team members to personally commit to change, noting even small changes can lead to big success. Baker concluded, saying, “The reason we are a great company is because you make up the company. You own it – it’s your business. Thank you for all you do.” Scott Anderson, Chairman and CEO of the Patterson Companies, also addressed the group and discussed the company’s vision to connect expertise to inspired ideas, products and services to create a memorable difference in the lives of their customers. “Patterson Companies is making investments in IT that will give us the necessary edge to be leaders in the industry,” he said. “These investments, combined with our specialized sales force, decentralized structure, full-service support and key strategic partnerships, give us a competitive advantage.” The Awards Ceremony celebrated the accomplishments of the past year, and also included a special tribute to Dale Spann, Vice President of Marketing and Operations, who is retiring after a 38-year career with Patterson Veterinary. The tribute included pictures and comments of gratitude to Spann by Patterson Team Members, as well as a moving thank you from Spann, who thanked his colleagues for an unforgettable journey. Also receiving special recognition as the top branches of the year were the Southern Branch, the North Central Branch and the Southwest North Branch. “There are many great opportunities on the horizon,” said Henriques in closing. “We are positioning ourselves for growth and are giving you more tools to be more efficient and effective. We have what it takes and we are committed to the possibilities.” Renowned Speakers The meeting featured presentations by a number of wellknown speakers, including futurist Jim Carroll, musician Mike Rayburn and Andy Roark, DVM, MS. Jim Carroll’s presentation, Positioning Ourselves for the World of 21st Century Veterinary Care, talked about the pace of change and the need for innovation. “Everything is becoming connected as things are speeding up,” said Carroll. He added it’s no longer a world in which the big will beat the small, but a world where the fast will beat the slow. “And it’s not just the customers who are changing,” said Carroll. “Future veterinarians are different too. The next generation thrives on change. They are tech savvy, collaborative, entrepreneurial, wired, and change oriented.” He added it is innovation which will allow companies to serve these customers with the resources they want and need. Mike Rayburn, a talented musician who combines his music with an entertaining and inspiring presentation, asked the audience to ask themselves, “what if?” and urged them to move outside of their current comfort 12 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com zones. “Look at perceived problems as an opportunity, and use your creativity to turn a problem into a solution,” said Rayburn. He also stressed the importance of setting goals, writing them down and committing to them. “After you do this, events that seem like coincidences begin to happen.” Dr. Andy Roark’s presentation, Leading Those Who Don’t Want to be Led, was filled with his trademark humor and keen insights into the veterinary profession. “Veterinarians aren’t business people, and they need someone to lead them,” said Roark. “You can be that person.” He recommended four activities that he believed would lead a sales rep to be successful in building partnerships with customers. First, embrace change. “We aren’t going to continue growing and moving toward the future doing what we did yesterday,” said Roark. Second, invest in the long term and always have the best interests of the practice at heart. Third, speak the language and use messages that resonate with your audience. Last, never give up. “If you help educate and enlighten customers, they will take ownership.” EASOTIC® Otic Suspension (hydrocortisone aceponate, miconazole nitrate, gentamicin sulfate) Anti-inflammatory, antifungal, and antibacterial For Otic Use in Dogs Only CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian. BRIEF SUMMARY: Please consult package insert for complete product information. INDICATIONS EASOTIC® Suspension is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius). CONTRAINDICATIONS Do not use in dogs with known tympanic membrane perforation. EASOTIC® Suspension is contraindicated in dogs with known or suspected hypersensitivity to corticosteroids, imidazole antifungals, or aminoglycoside antibiotics. WARNINGS Human Warnings: Not for use in humans. Keep this and all drugs out of reach of children. Humans with known or suspected hypersensitivity to hydrocortisone, aminoglycoside antibiotics, or azole antifungals should not handle this product. Animal Warnings: As a class, aminoglycoside antibiotics are associated with ototoxicity, vestibular dysfunction and renal toxicity. The use of EASOTIC® Suspension in a dog with a damaged tympanic membrane can result in damage to the structures of the ear associated with hearing and balance or in transmission of the infection to the middle or inner ear. Immediately discontinue use of EASOTIC® Suspension if hearing loss or signs of vestibular dysfunction are observed during treatment (see ADVERSE REACTIONS). PRECAUTIONS Do not administer orally. Concurrent administration of potentially ototoxic drugs should be avoided. Use with caution in dogs with impaired hepatic or renal function (see ANIMAL SAFETY). Long-term use of topical otic corticosteroids has been associated with adrenocortical suppression and iatrogenic hyperadrenocorticism in dogs (see ANIMAL SAFETY). The safe use of EASOTIC® Suspension in dogs used for breeding purposes, during pregnancy, or in lactating bitches, has not been evaluated. ADVERSE REACTIONS In a field study conducted in the United States, there were no adverse reactions reported in 145 dogs administered EASOTIC® Suspension. In foreign market experience, reports of hearing loss and application site erythema have been received. In most reported cases, the hearing loss and erythema were transient and resolved with discontinuation of EASOTIC® Suspension. To report suspected adverse drug events, or for technical assistance contact Virbac at 800-338-3659. ANIMAL SAFETY Aural administration of EASOTIC® Suspension to 12 week old Beagle dogs at 1, 3, and 5 times the recommended dose (1mL/ear/day) for 15 days (three times the treatment length) was associated with alterations of the hypothalamicpituitary-adrenal axis as evidenced by the ACTH stimulation results. Other findings considered to be related to treatment include the development of aural hyperemia; the presence of renal tubular crystals and possibly renal tubular basophilia and atrophy; elevated liver weights; the development of otitis externa and media; and elevations in alanine aminotransferase, alkaline phosphatase, total protein, albumin, and cholesterol levels. STORAGE INFORMATION: Store at temperatures between 20º C-25º C (68º F-77º F), with excursions permitted between 15º C-30º C (59º F-86º F). HOW SUPPLIED: EASOTIC® Suspension is supplied in a polyethylene canister, with a soft applicator canula. Distributed by: Virbac AH, Inc., Fort Worth, TX 76137 USA NADA 141-330, Approved by FDA. © 2013 Virbac Corporation All Rights Reserved. Rev 8/2011 12 34 5 DAYS OF EASY A unique, new-generation steroid makes otitis externa simpler to treat. The hydrocortisone aceponate in EASOTIC® (hydrocortisone aceponate, miconazole nitrate, gentamicin sulfate) Otic Suspension for Dogs enables a quick, 5-day treatment regimen with low risk of systemic side effects.1 Combine that with an innovative applicator and proven antimicrobial and antifungal agents, and you get a one-of-a-kind treatment for otitis externa. 1 pump • 5 days • No sweat Talk to veterinarians about this simple, effective treatment today. Visit www.virbacvet.com to learn more. Indications: EASOTIC Otic Suspension for Dogs is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius). Important safety information: EASOTIC Otic Suspension for Dogs is contraindicated in dogs with known or suspected hypersensitivity to corticosteroids, imidazole antifungals, or aminoglycoside antibiotics. Do not use in dogs with known tympanic membrane perforation. The safe use of EASOTIC Otic Suspension for Dogs in dogs used for breeding purposes, during pregnancy, or in lactating bitches has not been evaluated. See brief summary for additional product information. Reference: 1. Guaguere E, Bensignor E, Carlotti DN, et al. Clinical practice guidelines on the best use of topical glucocorticoids in canine dermatology. Prat Med Chir Anim Comp. 2011;46:S1–S20. © 2014 Virbac Corporation. All Rights Reserved. EASOTIC is a registered trademark of Virbac S.A. 3/14 14340 »» Inside Sales By Dawn Singleton-Olson Cut Through the Clutter Find and use the information that will be most valuable to your customers “Life is really simple, but we insist on making it complicated.” Confucius may have spoken those words more than 2,000 years ago, but they have never been truer than they are today. We have become a culture of information overload. Technology allows us to receive more than five times as much information every day as we did 20 years ago. Globally, consumers will own more than 6 billion mobile phones by the end of this year; about 2 billion of those will be smartphones. Since 1980, a typical credit card contract has jumped from a page and a half to 31 pages long! A big part of our job in animal health sales is to stay informed about hundreds of new and current products, promotions and specials and pass that 14 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com information on to our clients. How do we cut through all the clutter and reach customers who are bombarded with as much, or more, information as we are on a daily basis? Empathize, distill and clarify In their book “Simple – Conquering the Crisis of Complexity” authors Alan Siegel and Irene Etzkorn advocate a three-part formula for simplifying almost anything. They stress the need to empathize, distill, and then clarify to save your customers time, build their trust, and be a valued asset to their business. I once worked for a company who – as numerous customers expressed – made it very hard for them to do business with us. A lengthy, complicated credit application caused many prospects to give up before there was even a chance to turn them into customers. Online ordering was a chore with a poorly-designed website and frustrating item search. Even small orders shipped from several warehouses created stacks of packing slips and multiple invoices to be paid. Imagine if creating a positive customer experience had been at the forefront when each of those processes was put into place. Ideally, everything a company creates that touches a customer – from its products or services, to its website, correspondence or invoices – should reflect a commitment to considering the customer’s point of view. Simplicity means shortening the distance between you and your customer. Empathizing involves understanding your customer’s needs and taking the time and effort to customize and simplify the information you give them. When you make a sales call – on the phone or in person – are you just repeating facts and figures about a new product or promotion, or are you taking the time to understand and focus on the benefits for that specific customer? One of the best ways to improve any customer experience is to focus on the essence of what people want or need in a particular situation. Distilling information When you understand your client’s needs, you can help them make informed decisions by cutting out the clutter. An article in this issue of VetAdvantage discusses senior pets and the key issues and products for geriatric animals. Joint health is one obvious concern for older animals, and there are dozens of joint treatments and supplements available. It would be impossible and inefficient to carry them all. Too many options can be overwhelming, so “distilling” all that product information and providing solutions that consider their needs will help your clients determine the best product mix to provide for their customers and help save them time and money. What message are you sending to your customers? Too much information is a prime source of complexity, not clarity. When they are inundated with information, people are apt to lose sight of what’s important and just stop paying attention. Some sales managers tend to emphasize quantity over quality and require their sales teams to make ‘X’ number of sales calls in a given day or week, in order to achieve a specific call volume. Calling simply for the sake of calling to hit a goal erodes your credibility and wastes your customer’s time, so make every contact count. Whether you’re communicating by phone or in writing, take time to organize and prioritize before you dial a number or send an email. Keeping track of numerous manufacturer promotions or rebates can be time-consuming and confusing, so you can be a huge asset to your customers by providing them with this information. Preparing a clear, concise spreadsheet showing their purchase history, total dollars to date and how much more they may need to spend – along with the end date of the promotion and when you’ll check in before it wraps up – sets you apart from your competitors as a true partner to your customers. Marketing departments are notorious for designing product brochures with dark colors and fine print that don’t fax well. If faxes are a preferred communication for your clients, provide them with an easy-to-read detailer, Simplicity means shortening the distance between you and your customer emphasizing the features you know will be important to them. Bullet points, large type size, bold fonts for emphasis and plenty of white space will ensure that your fax will be read. And don’t forget to include your contact information! A couple of hundred years after Confucius made his comments about how complicated we make our lives, another famous philosopher developed a classic model for simple communication that has stood the test of time. Aristotle’s theory of persuasion combining logos (logic and common sense in all of your messaging), pathos (empathizing with and relating to your customers) and ethos (maintaining integrity and honesty in all your client interactions) is still a solid model in this era of information overload. Remember this 2,000-year old advice: Keep things simple, and your value to your customers will continue to grow. Dawn Singleton-Olson has over 25 years of experience in the animal health industry, including distributor sales, manufacturing, practice management, and as a zoo supervisor. She is a volunteer, fundraiser and board trustee for several humane organizations and the Omaha (NE) Police Mounted Patrol. www.vet-advantage.com • Veterinary advantage «« July/August 2014 15 »» Sales Big Words Lead to Big Confusion If your sales presentation sounds like it came from a corporate brochure, change it! Language on the sales “street” is often different than the language created for brochures and marketing materials. Those are created to help you in your conversations with customers – not to be the conversation itself. Customer interactions By Brian Sullivan Sales Coach and Business Consultant Brian Sullivan, CSP is the author of the book, 20 Days to the TOP – How the PRECISE Selling Formula Will Make You Your Company’s Top Sales Performer in 20 Days or Less. Follow him on twitter @preciseselling. Daily tips that will keep you focused on getting to the top! Be yourself. Act like you are talking to a friend. Don’t recite your presentation from the PowerPoint that’s behind you or just spew out your company mission statement. Your job on the outside is to translate the message created on the inside. In fact, you exist in sales because you are good at taking an often complex message and getting to bottom-line benefits. Here are some examples of “overspeaking” I recently heard uttered to customers from the mouths of misguided salespeople: Your job on the outside is to translate the message created on the inside 16 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com • “Our product increases efficiencies.” (What on earth does that mean?) • Better translation: “I can save you an hour each day.” • “You will maximize your workflow utilization” (Hey Buddy, try utilizing the English language next time) • Better translation: “You can get more done without adding more employees.” • “Other clients have seen significant outcome enhancement.” (The outcome of that statement is that the customer wants you out the door) • Better translation: “I have three clients just like you that saved 15 percent in expenses, increased profit by 10 percent and reduced their insurance rates by 17 percent.” So this week, while delivering your sales presentation, keep it real. Think about what you would need to hear as a prospect to get you excited by focusing on the plainspoken benefits. You will arrive at those benefits by answering this question at least three times. HDTHMP-How Does That Help My Prospect? When you can no longer answer that question, you will have arrived at the real reason the prospect needs your product or service. And by delivering your value in its simplest form, your prospect will come to the simple conclusion that they cannot live without you. Labradoodle Putney Cefpodoxime Proxetil The perfect combination of Labrador and Poodle The perfect combination of quality and affordability FDA Approved for Veterinary Use: Putney Cefpodoxime Proxetil Putney Cefpodoxime Proxetil is a generic Simplicef ® at a more affordable price. • Our FDA-approved veterinary generic is available in 100 mg tablets (scored) and 200 mg tablets in 100 count bottles. When prescribing Cefpodoxime Proxetil tablets for your patients, choose quality and affordability. Choose Putney. Committed to quality. Delivering affordability. www.putneyvet.com Find Putney distributors at www.putneyvet.com/howtobuy.com or call us at 866-683-0660 SIMPLICEF® is a registered trademark of PAH P&U LLC. ® PUTNEY and the Putney “P” logo are registered trademarks and service marks of Putney, Inc. ©2014 Putney, Inc. All rights reserved. 0523-1000-13 »» Sponsored by IDEXX: Building Your Lab Business Improving education, efficiency and care: High-tech disease screening wows clients Pet-side disease screening has often been a mystery to clients. They usually see their pets taken away to the lab area and then returned to the exam room for a final conversation about next steps. What’s been missing is the WOW FACTOR: the ability to show test results in a compelling way during the conversation, opening the door to improved client education and better care. This all changed when IDEXX introduced a new screening tool in early 2014: the SNAP Pro™ Mobile Device. It’s revolutionizing the way practices use the SNAP® tests they’ve relied on for years. With its high-tech display of screening results, the SNAP Pro device gives practices a new way to impress clients in the exam room – with meaningful answers that really hit home. Dr. Adam Hechko, owner of North Royalton Animal Hospital in Ohio, explained. “Before, we’d run SNAP® tests and tell clients the results. They wouldn’t see the test or the process. But we discovered that our clients love technology – they become more engaged when they see the SNAP Pro results. Our clients really get into it, often saying, ‘Wow, this is cool!’ And, because the SNAP Pro is portable, it’s easier to discuss prevention with every client. During the appointment, if we’re negative, we’re celebrating and reinforcing the good care while bringing up steps to keep the pet negative. If it’s positive, we’re talking about why it’s positive and what to do about it.” Plus, the SNAP Pro is more efficient. All we do is fill in the blood for any SNAP test, and our SNAP Pro does the rest. My team can move on to the next thing while I relay the importance of each result to my client!” How to discuss the many benefits of SNAP Pro testing with your customers When visiting a practice, ask about the approach their team follows for pet-side disease screening and discussing prevention with clients. • Check-off (qualify): Establish your direction by asking, “Doctor, are your clients truly engaged when you talk about disease screening and prevention with them?” • Confidence: If YES, confirm and support benefits. If NO, assert the benefits with confidence. “I’m sure you can deepen the prevention conversation with a hightech tool that wows your clients.” • Invitation to neutral: “Let’s look at the ways the SNAP Pro Mobile Device gives you more opportunities to impress clients, get their attention and have an impactful conversation about care… while also saving steps for your team.” • Seek alignment/ understanding as the dialogue continues: “Can you help me understand … • “How do you currently discuss pet-side screening results and prevention with clients?” • “When you run SNAP tests, do you still have the team run them in the lab area and then give you the results? • “What if a portable, high-tech solution could save time and help you deliver your prevention message in a more compelling way, getting more clients to comply?” With its high-tech display of screening results, the SNAP Pro device gives practices a new way to impress clients in the exam room – with meaningful answers that really hit home. When you show your customers the many advantages of using SNAP Pro in their practices, you’ll be making a difference in the practice workflow… but even more important – you can improve disease prevention compliance and the overall health of patients. To learn more, visit idexx.com/smallanimal/inhouse/snap/snap-pro-instrument.html 18 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com SNAP test results just got a whole new look ® With the new SNAP Pro™ Mobile Device, your customers can streamline SNAP® protocols and automatically capture SNAP test invoice charges to improve practice revenue. See scratch card in this issue for a SNAP Pro™ Mobile Device offer for your best customer. © 2014 IDEXX Laboratories, Inc. All rights reserved. • 104722-00 All ®/ TM marks are owned by IDEXX Laboratories, Inc. or its affiliates in the United States and/or other countries. The IDEXX Privacy Policy is available at idexx.com. »» Sales Sales Call Challenges The steps toward solving two of the biggest obstacles reps face with customers I recently attended a conference with a diverse group of distributor reps. During an informal session after dinner the subject of sales call challenges was raised and discussed. I thought it might be helpful to share our thoughts on a couple of those issues that seemed to present the greatest challenge to the group. “How do I get past the gatekeeper?” By Patrick T. Malone Patrick T Malone is a Leadership Expert and Senior Partner at The PAR Group, an international training and development firm based in Atlanta, Ga. He is the coauthor of the business book Cracking the Code to Leadership and may be reached at [email protected] The mindset that a gatekeeper is someone to “get past” is the root of some of the problem here. I believe there are various levels of decisionmakers within a practice, and each deserves the same level of respect that would be accorded to the owner. Gatekeepers decide whether or not to grant access. These are generally the staff at the front desk. My sense is most reps talk about what they believe is important to the decisionmaker without really knowing for sure that it is important. 20 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com An influencer cannot decide “yes,” but they can suggest “no.” Even worse, they can sabotage the implementation in order to prove their suggested “no” was the appropriate response. These can be practice managers, technicians and/or associate veterinarians. The owner is usually the ultimate decision-maker. The experienced successful reps in the group talked about finding out what was important to the individual decision-makers and then mentioning that benefit in order to gain a positive decision. But that is not so easy. After all, what is important to the front desk personnel is likely different than what is important to the practice manager or the tech or the associate vet. All of that is likely different than what is important to the owner. The answer involves some work to determine the values of all the decisionmakers involved in making your sales call a success. The question remains: Is it worth the time and effort it takes to obtain all this information? The distributor reps that know what each decisionmaker values are those who are the primary suppliers to those practices. So if you want to be primary, stop trying to “get past” the gatekeeper and start ask more questions to determine what every decision-maker values. “How do I differentiate myself and my company from others calling on the practice?” My sense is most reps talk about what they believe is important to the decision-maker without really knowing for sure that it is important. Not every practice owner wants to grow their business. Some may what to maximize its sale value. Others may want to lighten their workload or maximize their bottom line. Once again the experienced successful reps talked about building their territories to become the primary supplier by understanding the specific values of every decision maker. When they were on the outside looking in, the first question they asked was, “What do you like about your current distributor?” The answers to that question begin to paint that practice’s value picture. The next question was “Is there anything you would like to have, that you are not getting out of your current relationship?” The answer adds targets of opportunity to the value portrait. The final question “Are there any points of contention in your current relationship that you would like to change?” The answer here will describe the current pain points, and that is important because change only occurs when the pain of doing nothing exceeds the perceived pain associated with the change. The answers to all three questions provide the successful distributor rep with the information necessary to construct a strategy to build a long and loyal relationship with her/his clients. Start by addressing the pain points and finding out what the potential consequences are if those areas of contention are not fixed. Once the consequences reach the point of being intolerable, your solutions will seem like a snap. If there are no pain points, select the targets of opportunity to provide something they would like to have. In either case you will have an entry to prove you and your firm can provide everything they like and more. Over time you will have more and more of the business. Certainly these two challenges only scratch the surface of the various challenges a distributor sales rep faces on a daily basis. So if you have a specific challenge you are struggling with, send us the information. We’ll select the most popular challenges for inclusion in future columns. THINK Bovie® is a registered trademark of Bovie Medical Corporation The Aaron® 1250-VS provides veterinary offices and clinics with the ultimate Electrosurgery and Smoke Evacuation combination to perform safe and effective surgical procedures, while keeping your pets and pals safe from smoke plumes. Contact your Bovie Manufacturer rep to learn more! Bovie Medical Corporation • 5115 Ulmerton Road • Clearwater, FL 33760 U.S. Phone 1-800-537-2790 • 727-384-2323 Fax 1-800-323-1640 • 727-347-9144 www.boviemed.com • [email protected] www.vet-advantage.com • Veterinary advantage vetadvantage_MAG_insert_July_Sept.indd 1 «« July/August 2014 21 6/27/14 2:59 PM »» Sales Voice Mail vs. Text Messaging Over the last few years I’ve been told voice mail is outdated and text messaging is the way to go. Both are tools to maintain contact with your customers, and both have advantages and disadvantages for sales professionals. Regarding texting, one business owner put it this way: “I’d rather get almost any other type of message than voice mail.” Does this individual represent to norm? The short answer is – it depends. Most of what I’m reading claims people who are tech savvy may not even listen to voice mail and recommend sending a text message to follow up if the call goes unanswered. For some people checking voice mail is more of a nuisance than a convenience, and voice mails go unchecked unless it’s a call from an unknown number. What this means to me is you have taken the time to assess your customer and understand their preferred method for communications not requiring a conversation. Research shows 8-in-10 Americans now own cellphones and three quarters (and growing) of them are using text messaging. Additionally, some research indicates as many as onethird of adults prefer to receive a text to talking on the phone. The same research shows a business contact is more likely to be an SMS power user if aged 18-29 (87.7 messages per month) or have an income of less than $30,000 (58.7 messages per month). Why do people prefer texting? • Text messages force the person to be brief; they need to carefully consider the message due to character constraints. • A text message can be read faster than listening to a voice mail. Additionally, the research suggests the more important the message, the more important it is to follow up with some kind of explanation of the missed call. For example, if an answer is needed immediately, sending a short text explaining the nature of the call is warranted. Don’t assume the person receiving the call is going to call you. Texting, “Call me back” is already implied (the missed call) but this text doesn’t provide any information and doesn’t invite immediate action from the business contact. If texting a business contact, stick to text messaging whenever the message is short and would be better communicated in text rather than a conversation. For example, calling to say, “I am on my way” or confirming an appointment is not worth a conversation or a voice mail. So when should you leave a voice mail? • If your message is long and would require more than one text to explain. E.g., the order is incomplete or the product is out of stock. • If you have several questions to ask or you need clarification on an action. • Also, never assume the number you are calling is a cellphone. If there is a single phone number on the business card assume it may be an office phone. • Also, if you’ve left a voice mail and you know the person rarely checks voice mail you may want to leave a text saying you’ve left a voice mail message. For more information on training in this area or other sales training curriculum, visit: www.ats-solutions.net or contact Mike Biggins at [email protected] Are you new to the Animal Health industry? Are you new to the Animal Health industry? Are you looking for a way to “accelerate” your new employees along the learning curve for the Animal Health Industry? Then you are a candidate for the next session of “Introduction to the Animal Health Industry” Open enrollment courses are offered at ATS’s Kansas City Training Facility. • September 23-24, 2014 22 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com To enroll contact: ATS animal health training solutions ATTN: Leah Byers 12200 NW Ambassador Drive, Suite 601 Kansas City, MO 64163 Phone: 816-569-3154 Perspective «« By Adam Augustine Success, Unplugged Get more accomplished with a healthy dose of detachment I recently read a personal management article in a popular business magazine in which a life coach extolled the virtues of occasionally “losing it” for the purpose of stress management. His advice: Stop in a parking lot, roll up the windows, and scream bloody murder while pounding away at your steering wheel. He claimed it would make you feel better. A strong dose of heroine would also make you feel better, but that doesn’t make either of those things a good idea. We know from nearly a century of research that venting, also known as catharsis, has detrimental cognitive, emotional and physiological effects. So, ignore the life coach’s ill advice and do something that will actually help you manage your hormone levels, emotions, and felt stress … unplug. Research from my laboratory (Augustine & Hemenover 2008, 2013; Augustine & Larsen, 2014) has consistently shown that distraction is one of the easiest and most effective means of emotion regulation across all levels of self-regulation ability. Even if you are horrible at managing intrusive stress and emotions, anyone can jump on a treadmill or pick up a good book. Unplugging doesn’t mean that an annual trip to the lake will recharge you for another year of mistreating your body and mind. It is something that must occur multiple times a day. The first step to a proactive distraction program is simple. Turn off the phone. The vibrating call to action that follows you around has the effect of never letting you disengage from work, or the personal upkeep notifications from social media and email that quickly feel like work. Set aside two or three hours in the evening where you refuse the disruption; let the nightstand take the rattling. If you must, turn the infernal contraption off. During that time, attend to anything but action items, spreadsheets, and obligations: a conversation with your spouse, the latest episode of Game of Thrones, or, for a double dose of physical and cognitive health, a heavy set of weights or a yoga mat. “But how will I succeed if I am not at the beck-and-call of my superiors?” A relaxed mind is also an agile mind – a million pin-pricks can kill, just as a hundred thoughts can disable. Benjamin Franklin often remarked that his best ideas were born in a bathtub, and for good reason. Research has consistently demonstrated that innovation comes easier when we are not directly focused on the task at hand. When the noise is quieted by a healthy dose of enjoyment and distraction, you Unplugging doesn’t mean that an annual trip to the lake will recharge you for another year of mistreating your body and mind. will quickly find that ideas spring from nowhere and focus is easier to attain when it is required. So, at least once a day, throw the Apple in the garbage. I would imagine that for most of you, it has already spoiled anyway. Your mind, just like your body, cannot heal without rest. Adam Augustine, Ph.D., is a statistician and psychologist with over 20 scientific publications. He works as a consultant in the veterinary supply industry, and as a manager of marketing, customer, and big data analytic projects in the hunting and shooting sports industry. He may be contacted at [email protected] www.vet-advantage.com • Veterinary advantage «« July/August 2014 23 »» Marketing Local Authority Help veterinary practices become the local pet-care authority in their communities If you’re looking for new ways to serve as a value consultant to your customers, here’s an idea: Help veterinary practices become the local pet-care authority in their communities. By Pam Foster Pam Foster is Managing Editor, Community Content & Media for the NAVC (North American Veterinary Community) and the Marketing Faculty Advisor on its CE website VetFolio.com. Pam is a Certified SEO Copywriter and the co-author of Wildly Profitable Marketing for the Pet Industry. She specializes in helping practices and other veterinary organizations thrive through strategic marketing content, online and offline. In every community, local pet parents need advice. They need to know what to do about flea prevention, crate training a puppy, introducing an adopted cat to the family, choosing the right pet food, how to trim nails (and how often), what to do about their dogs’ thunderstorm fears and much, much more. Sure, dog and cat owners can read generic websites to find answers, but research shows that pet July/August 2014 Marketing Test No. 4: “Who is the local authority for pet care?” Your customers are constantly thinking about the latest marketing “mustdo’s.” But one of the easiest and most effective marketing approaches is overlooked. Public relations – and reaching out to local media – can be incredibly powerful. It can establish your customer as the “local authority” the area’s pet owners trust for care. Local TV, print and online news editors are eager to find community authorities on a wide range of pet subjects. owners trust their local veterinarians more than any other source for reliable pet-care information. Not only that, but the local media is always looking for human-interest stories – including animal-related stories – to bring in viewers and valued advertising dollars. Local TV, print and online news editors are eager to find community authorities on a wide range of pet subjects. Find out how veterinary practices can make a huge local splash 24 as the local pet-care authority (and then show them how to do it with our cheat sheet). »» Veterinary adVantage • www.vet-advantage.com The problem is, most practices don’t include PR in their marketing efforts. As you prepare for practice calls, ask the following question during your visit. This cheat sheet can help you explain why you’re asking the question, and how the answers can help the practice. Consider this cheat sheet to be a tool for enhancing the value you offer your customers, and even their loyalty to you. It’s a win for everyone. In the next issue, we’ll cover Marketing Test No. 5: The “Email Savvy” practice. Does Your Veterinary Practice Pass the Local Authority Test? Use this quick, easy test to see if you’re doing all you can to be the local resource for pet-related questions and important pet care tips. our practice website Y includes LOCAL articles and/or blog posts. If your website includes pethealth content, well done! However, make sure your content is LOCAL. Here’s what I mean. When pet owners search in Google to find “pet nutrition advice in [your town],” Google won’t show your pet nutrition article unless you put your town or region name in it, such as, “Pet Nutrition Tips for Pets in [Your Town].” This image happens to have the city in the hospital name. If that’s not the case for you, add the city name to your article title. Also add an invitation or incentive to schedule a screening. This approach works well with all kinds of pet-care topics. ou’re building relationships Y with local news media. Which local-interest topics can you help the media cover when it comes to pets? For instance, if you’re in a region of the United States where hurricanes are an annual concern, send out a one-page press release to local media: “Preparing to Bring Your Pet Along During a Hurricane Evacuation in [Your Town].” The media may present your tips on TV, in the local newspaper and on their websites, and perhaps even interview you. ou’re building strong Y alliances in your community. As you know, local referrals are very strong sources of new business for your practice, and we don’t mean just among your clients. Think of all the local businesses that could be referral sources: dog trainers, rescue shelters, pet bakeries, Chamber of Commerce members, etc. Are you connecting with all these opportunities so they refer your practice? As you offer your community more pet-health information, your practice will gain momentum as the local go-to expert on anything related to pets, bringing more revenue your way. www.vet-advantage.com • Veterinary advantage «« July/August 2014 25 »» Sponsored by Merck: Sourced by Merck Animal Health A leap forward in flea and tick protection Easier dosing, long-lasting efficacy helps solve the challenge of compliance Even the most willing owners may forget to diligently administer their pet’s monthly flea and tick control programs, notes Joel Sailor, D.V.M., owner of the Town & Country Veterinary Clinic in Starke, Fla. Fleas and ticks just won’t cut pets a break – fleas will reinfest a dog the moment a protection gap occurs after a monthly treatment is missed or is inconsistently applied. “It’s not so much a willingness to comply, but it’s remembering,” Dr. Sailor says. “We have clients with the best intentions, but we’re all human. If it’s a topical product, maybe the owner missed an application because they wanted to wait until after visitors left. Pills are the same way.” One mistake can lead to a home reinfested with fleas or potentially lead to a preventable tick-borne disease like Lyme disease. 1 chew = 12 weeks of protection1* BRAVECTO™ (fluralaner), approved by FDA in May, is the first oral chew to deliver up to 12 weeks of flea and tick protection in a single dose.1* “Easier dosing helps solve the challenge of compliance,” says Kathleen Heaney, D.V.M., director of technical services for the companion animal business unit at Merck Animal Health. “The great thing about BRAVECTO is that it helps reduce gaps in protection that can be seen with monthly products,” Dr. Heaney says. “It delivers robust protection, even at the end of the 12 week treatment period to give pet owners not just fast, but long-lasting and consistent flea protection.”1 When Dr. Sailor began participating in a BRAVECTO field trial prior to the launch of the product, he was excited about offering his clients a product with long-lasting efficacy against both fleas and ticks.1 He also found it started killing rapidly. BRAVECTO kills fleas within two hours1 and killed 100 percent of fleas within 12 hours of administration.2 “I think we still hold the record for the dog with the most fleas – 2,000,” Dr. Sailor says. “That population went down to basically nothing, and we were impressed with the speed of kill and how long the product lasted.” Plus, BRAVECTO offers an opportunity to offer a prescription product only through his veterinary clinic. It gives him the chance to discuss flea and tick management within the practice. “We can increase or renew interest in flea control in those clients that are getting it at the grocery store or other over-thecounter outlets,” Dr. Sailor says. “Plus, there are an awful lot of clients that aren’t doing preventive care at all. Innovation brings interest. People want to know when there’s something new and cool available. It’s going to be one of those products that will draw clients to it.” *BRAVECTO kills fleas, prevents flea infestations, and kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks. BRAVECTO also kills lone star ticks for 8 weeks. IMPORTANT SAFETY INFORMATION: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto has not been shown to be effective for 12-weeks’ duration in puppies less than 6 months of age. Bravecto is not effective against lone star ticks beyond 8 weeks after dosing. Please see the BRAVECTO advertisement for full prescribing information. 1 Bravecto [prescribing information]. Summit, NJ: Merck Animal Health; 2014. 2 Freedom of Information Summary, NADA 141-426. Approved May 15, 2014. BRAVECTOTM is a trademark of Merck Animal Health, Summit N.J., USA 26 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com INTRODUCING… FLEA AND TICK MANAGEMENT JUST TOOK A GREAT LEAP FORWARD— 12-WEEK PROTECTION,* ONE ORAL CHEW1 This is now. That was then. * Order BRAVECTO today—contact your Merck Animal Health sales representative or distributor partner. *Bravecto kills fleas, prevents flea infestations, and kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks. Bravecto also kills lone star ticks for 8 weeks. IMPORTANT SAFETY INFORMATION: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto has not been shown to be effective for 12-weeks’ duration in puppies less than 6 months of age. Bravecto is not effective against lone star ticks beyond 8 weeks after dosing. Please see Brief Summary on following page. Reference: 1. Bravecto [prescribing information]. Summit, NJ: Merck Animal Health; 2014. Available by veterinary prescription only. Copyright © 2014 Intervet Inc., a subsidiary of Merck & Co., Inc. All rights reserved. Intervet Inc. d/b/a/ Merck Animal Health, Summit, NJ 07901. US/BRV/0514/0026 www.BravectoVets.com »» Finance Who Does What? Effective use of veterinary healthcare team talent In too many clinics today, compensation for all members of the veterinary healthcare team is inadequate. Why, on average, do dentists enjoy personal incomes more than double their veterinary counterparts? Why are starting salaries for optometrists nearly twice that for veterinarians? Why do dental hygienists make more than many veterinarians? The good news is that most clinics can address and resolve these problems. There are great opportunities to improve veterinary practice productivity. How is revenue or income produced in a veterinary clinic? (Note: By Fritz Wood, CPA, CFP For purposes of this discussion, revenue and income are synonymous with other commonly used terms such as “gross” or “gross income”). Revenue is generated when pet owners give up something of value – typically money – in order to receive something of perceived equal or greater value – in this case, veterinary services and products. The greatest opportunity for veterinary income or productivity is to grow revenue – or the top line. There is typically far less opportunity to enhance practice health through cost cutting. Rare is the practice that cost cuts its way to prosperity. Unusual is the veterinary practice where expenses are wildly out of control. Because growing the top line – or gross income – is the key to higher hospital productivity and income, let’s dissect hospital revenue further. Two types of gross income I broadly classify gross income into two categories: (1.) Active income, and (2.) Passive income. Active income is income that can only be generated with the doctor’s direct, full-time involvement. Examples of veterinary services that require the doctor’s direct, full-time involvement include: • Examining the pet • Diagnosing • Prescribing and initiating treatment • Surgical procedures • Certain client consultation activities Passive income is income that can be produced without the doctor’s direct, full-time involvement. Passive income is critically important to overall practice profitability and productivity. 28 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Examples of veterinary hospital services that generate passive income include: • Routine dental cleanings • Radiographic procedures • Lab work (fecal tests, heartworm tests, urine tests, CBC’s, and biochemical profiles) • Nail trims • Ear cleaning • Anal sac expression • Suture removal • Bandage changes • Anesthesia induction • Boarding • Grooming • Pet adoption programs • Behavioral programs • Weight management programs • Etc. It’s important to note that although the doctor may have some involvement in the delivery of these services, the veterinarian need not be involved on a direct, full-time basis. The doctor might be in an exam room or the surgical suite (generating active income) while these services are delivered. For example, assume the doctor orders a radiograph. Team members are capable of taking radiographs – which constitutes the bulk of the time and effort involved in that procedure. The veterinarian could then read and interpret the radiographs. Both processes are vital to an accurate diagnosis – that is, good images to read and competent interpretation of those images. In this scenario, each party is assuming an appropriate role. Team members are performing tasks for which they have adequate training and experience (taking the radiograph), while the doctor is performing tasks for which he or she is rightly trained (ordering and interpreting the radiograph). Examples of veterinary products that generate passive income include: • Heartworm prevention products • Flea and tick control and prevention products • Nutritional products • Refilling other prescriptions • Shampoos and other skin and coat products • Other pet supplies Look around your clinics and you’ll see myriad veterinary services and products that produce passive income. Is passive income important? Passive income is critically important to the success of a practice. Why? Because in a veterinary practice, the veterinarian’s time is the constraining factor – or the most limited, finite, and scarce resource. A doctor has only 24 hours each day to generate active income. As a result, there exists a “cap,” or physical limitation in terms of how much active income a veterinarian can generate. As other professionals have found, that cap may be quite low. Therefore, dramatic increases in hospital income are a function of how well the practice is positioned to generate passive income. The principle of having people undertake tasks or activities for which they are adequately trained and experienced is called delegation. Delegation is required in order to generate passive income. That is, if a doctor is unable or unwilling to delegate to others, only active income can be produced. A veterinarian can and should delegate to members of the veterinary healthcare team everything not specifically required of the doctor. Then, veterinarians can begin to command the level of income they deserve and competitively compensate other members of the healthcare team. Recall your last visit to the dentist for routine care. How much time did you spend with the hygienist? How much time did you spend with the dentist? Most likely, the great majority of your time was spent with the hygienist. The hygienist probably examined your mouth, cleaned your teeth, applied fluoride, and perhaps took radiographs. Next, the dentist examined your mouth and read the radiographs. Again, each member of the dental healthcare team assumed an appropriate role – each doing what he or she was specifically trained to do. Similarly, recall your last visit to the optometrist for routine eye care. Which tasks or activities were delivered by the optician or optical assistant? Which were reserved for the optometrist? The economic or financial consequences of delegation are staggering. Imagine how many more patients a dentist or optometrist can see each day by appropriately delegating to team members. If the dentist performed tasks typically assumed by the hygienist, could he or she see even half as many patients? If the optometrist “fitted” each set of eyeglasses and performed all the eye tests, could he or she see even half as many patients? In both cases, the answer is “no.” These professionals have found that by effectively delegating to members of their healthcare team, they can focus on the more complex – and the more remunerative – tasks and activities. Although veterinary medicine, dentistry, and optometry have been specifically mentioned, the principle of delegation is relevant to all professional service businesses. What tasks or activities in your customers’ practices are currently performed by a veterinarian, which could be delegated to members of the veterinary healthcare team? Encourage your customers to “brainstorm” lists of things that could (should) be performed by non-veterinary personnel. Veterinarians are often surprised by the confidence, competence, and talent of their support staff. Also, team members usually enjoy the opportunity to use their skills and abilities to contribute to pet health and well-being. Effective use of veterinary healthcare team talent cannot be overemphasized. In general, veterinary income and income of veterinary healthcare team members is woefully inadequate. Dramatic increases in hospital income are a function of how well the practice is positioned to generate passive income. Encourage your customers to “brainstorm” lists of things that could (should) be performed by non-veterinary personnel. www.vet-advantage.com • Veterinary advantage «« July/August 2014 29 CAPSTAR ® (nitenpyram) IS THE TRUSTED CHOICE FOR IN-CLINIC USE 1 CAPSTAR (nitenpyram) can be the cornerstone of maintaining a healthy clinic environment and making sure patients that come in flea-free leave that way. In addition, establishing a flea-free facility admissions protocol can generate up to $12,000 a year in new revenue.* CAPSTAR is the #1 on-site flea product for both dogs and cats among clinics that stock CAPSTAR. 1 Almost 40 % of clinics that stock CAPSTAR treat all dogs and cats entering the clinic for surgery or boarding.1 S PE E D O F F L E A K I L L Starts working within 30 minutes. Greater than 90 % effectiveness against adult fleas within 4 hours for dogs and within 6 hours for cats. SAFET Y Safe for daily use. Safe for puppies and kittens 4 weeks of age and older, weighing 2 lbs. or more. Safe for use in breeding or pregnant dogs and cats. (Refer to label.) Can be used in conjunction with other flea products, parasiticides and medications. (Refer to label.) CONVENIENCE Oral formulation. Can be given with or without food. VA LU E Available in bulk packages for in-clinic administration. Priced to provide high-margin revenue stream for high-volume, in-clinic usage. Provides great value-added service clients appreciate when boarding or grooming pets. *Individual clinic results may vary. Data on file. Novartis Animal Health US, Inc. – NAH.JE.001 1 CAPSTAR (nitenpyram) CLINICS GENERATE REVENUE WITH A FLEA-FREE FACILITY PROTOCOL ® It’s not uncommon for a pet entering a clinic to have fleas. How much could your clinic generate by implementing a flea-free protocol? A conservative estimate of increased profit for a clinic that sees 2,000 dogs and 1,200 cats a year is more than $12,000. H ER E ’S H O W IT W O R KS: 3,200 2,000 dogs and 1,200 cats per year x $3.10 Average cost of a CAPSTAR tablet = $9,920.00 Cost per year to clinic 3,200 x $7.00 2,000 dogs and 1,200 cats per year Average daily flea-free facility fee (1 CAPSTAR tablet every 24 hours) = $22,400.00 $22,400.00 – $9,920.00 Annual clinic revenue generated from protocol Clinic revenue Clinic cost $12,480.00 CLINIC PROFIT THE PROTOCOL FOR A FLEA-FREE CLINIC STEP 1 Administer CAPSTAR upon admission of all patients staying more than a couple of hours (dogs and cats coming for boarding, surgery, grooming, and/or an annual wellness exam). STEP 2 Administer CAPSTAR upon discharge for all patients staying more than 24 hours. STEP 3 Incorporate a flea-free fee into your standard clinic fee or itemize as “routine flea-free clinic maintenance.” © 2014 Novartis Animal Health US, Inc. CAPSTAR is a registered trademark of Novartis AG. US/CAP/14/0845 ROAD TALES »»Role models? Parents are just as likely to engage in driving distractions, such as cell-phone use, as drivers from the general population, according to a recent University of Michigan study published in Academics Pediatrics. The study finds that 90 percent of parent drivers said they have engaged in at least one of the 10 distractions examined in the study while their child was a passenger and the vehicle was moving, according to lead author Michelle L. Macy, M.D., M.S., an emergency medicine physician at the University of Michigan’s C.S. Mott Children’s Hospital. The study, conducted in two Michigan emergency departments, shows • Get the used parts from the repairs. If the garage will not give them to you, send a written request and keep a copy. • Have the car checked by an expert. While it’s possible to get a free estimate from a repair shop, drivers may be better off paying an expert to evaluate the need for repairs. • Negotiate. Armed with evidence, drivers may be able to call and ask the first repair shop to redo the work, or discuss a refund. If the repair shop agrees to redo its work, insist on a written agreement detailing what they’ll do and how long it will take. Talk to the mechanic who’ll actually work on the car to be sure you both understand what needs to be done. Giving the repair shop a chance to make amends is usually easier to negotiate than getting a refund. • Write a demand letter. If still not satisfied, drivers should write a formal demand letter that is short, polite and written with the expectation that a judge will read it. • Consider filing in court. If necessary, drivers can file papers at a small claims or other appropriate court, depending on their jurisdiction and the amount in dispute. These will typically be filed with the court clerk’s office in the county where the garage is located. If the state or locality has a motor vehicle repair law that the repair shop did not follow, drivers should consider asserting a claim or defense based on the violation. • Prepare for court. Research the situation by reading car manuals, talking to an objective mechanic, etc., in order to be able to explain to a judge why the original repairs were substandard. • Appear in court. If appearing in court, it’s necessary to be organized, with documented, written warranties, photographs and used parts if they help make the case. Bring any witnesses to court, or if that’s not possible, ask the witness to write a letter explaining what he or she heard. While it’s possible to get a free estimate from a repair shop, drivers may be better off paying an expert to evaluate the need for repairs. that about two-thirds of respondents (570 parents of 1-to-12-year-old children who arrived in the emergency departments of the two hospitals) say they have talked on cellular phones while driving their child, and one-third say they have texted while driving their child. Each year, more than 130,000 children younger than 13 are treated in U.S. emergency departments after motor-vehicle collision-related injuries, according to Macy, who says she is also concerned about whether parents are modeling the right behaviors in front of children who will eventually learn to drive. »»Get it fixed ARAG ®, a legal insurance company, recommends the following for drivers who believe their car was not properly repaired: 32 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com »» Trends Infectious Disease Trends are Mixed FIV, Lyme disease up, but many signs of improvement appear in Banfield State of Pet Health 2014 Report, with its focus on infectious diseases Feline immunodeficiency virus (FIV) infection has risen 48 percent since 2009, while the proportion of dogs infected with the bacterium that causes Lyme disease has risen 21 percent, according to Banfield Pet Hospital® in its State of Pet Health™ 2014 Report. The report, compiled by Banfield’s internal research team, Banfield Applied Research and Knowledge (BARK), analyzed data collected in 2013 from nearly 2.3 million dogs and 470,000 cats cared for in Banfield’s more than 850 hospitals in 43 states. This year’s report focuses on infectious diseases, that is, diseases caused by organisms, such as bacteria, commonly transmitted during mating, through bite wounds associated with cat fights or from an infected mother to her kittens. FIV infection leads to permanent and progressive infection in affected cats, eventually attacking the immune system and increasing the cat’s risk for other serious infections. However, not all cats who become infected with FIV will become ill, and with care taken to avoid other infections along with frequent veterinary visits, many infected cats can go on to lead long lives. FIV infection is typically diagnosed by a veterinarian using a blood test. “We don’t really understand what’s behind [the rise in FIV],” says Sandi Lefebvre, DVM, PhD, an epidemiologist and senior research manager at Banfield Pet Hospital. “Unfortunately, although a vaccine is available, its ability to prevent FIV infection in the average house cat is not fully understood. The best way of preventing infection is by keeping the cat indoors and making sure other cats in the household aren’t infected.” Cats who do go outdoors should be tested every year, she adds. Lyme disease viruses, fungi and parasites. Many of these diseases can be avoided by good preventive care, according to the company. FIV The report shows that in 2013, approximately one of every 300 cats seen in Banfield hospitals was found to be infected with feline immunodeficiency virus, with the highest prevalence identified in Oklahoma, Iowa and Arkansas. Banfield’s research shows male cats are three times as likely to be infected as female cats. Like HIV, FIV is a slow-acting virus spread through intimate contact with infected individuals. The virus is 34 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com In 2013, approximately one in every 130 dogs visiting Banfield hospitals was infected with the bacterium (Borrelia burgdorferi) that causes Lyme disease. It is spread through the bite of an infected deer tick. Since 2009 there has been a 21 percent increase in the prevalence of infection among dogs, corresponding to an increase in tick infestation over the same period. The report reinforced that the Northeastern states are a hot spot for Lyme disease. The highest prevalence of infection is in New Hampshire, where one in every 15 dogs seen was infected, followed by Massachusetts and Rhode Island. By contrast, only one in 1,000 dogs or less was infected in the Pacific Northwest. Furthermore, the infection was twice as common in large breed dogs as in toy/small breed dogs. “We think the increase in Lyme disease is caused by an increase in the tick population and white-tailed deer population,” says Lefebvre. “As more humans encroach in the deers’ natural environment, the chance of a deer going into an urban area, where pets hang out, is greater.” Though the Northeast has the highest incidence of Lyme disease, any dog that goes outside – anywhere in the country – is at risk, she adds. But Lyme disease is easily preventable. “A dog cannot catch Lyme disease if ticks don’t bite it, and it’s so easy to prevent them from doing so with flea/tick preventives.” Other infectious diseases The prevalence of upper respiratory infection in cats has increased by 18 percent in the past five years – from eight cases for every 100 cats in 2009, to almost 10 cases per 100 in 2013, according to the 2014 Banfield report. “This is really disappointing, because there are vaccines to help prevent these illnesses among cats,” says Lefebvre. The data would suggest that after the kitten series of vaccinations, cat owners are failing to keep up to date as their pets age. Banfield also has data on diseases such as canine influenza, leptospirosis, canine distemper and toxoplasmosis, for which the prevalence of infection on a national scale has not been quantified. Such diseases are either rare or emerging and therefore still fairly uncommon, or they cause signs of illness that are not specific to any one disease and/or for which testing for them is not routinely performed, according to the company. For example, canine influenza is so new that dogs do not have the antibodies to fight the infection naturally. The disease is caused by a fairly new strain of the influenza virus that affects the respiratory system and is typically spread through the air, or through interaction with an infected dog or contaminated objects. Leptospirosis is an example of a disease that dogs are not routinely tested for, but that continues to be a serious health threat to dogs and people alike, according to Banfield. The disease, caused by infection of the internal organs, can be contracted through exposure to urine from infected animals such as dogs, livestock and wildlife. Though it exists all over the world, leptospirosis is commonly found in tropical climates, where the risk is even higher after a hurricane, flood or heavy rain. Backyard dangers Banfield Pet Hospital’s State of Pet Health™ 2014 Report suggests that the threat of infectious disease is often closer to home than pet owners realize. Seemingly innocent and regular activities for pets – such as drinking out of or swimming in a pond, sharing a toy or chasing wildlife – may result in serious illness if a pet is not properly vaccinated and protected with anti-parasite medications. For example, dogs can contract leptospirosis by drinking, swimming or wading in contaminated water, or by sniffing or licking contaminated urine. Similarly, cats can come into contact with the parasite that causes toxoplasmosis by eating raw meat from infected animals, such as mice, or by eating items contaminated with the feces of infected cats. A veterinarian can provide additional information for pet owners to protect their pets against the spread of disease, as well as recommend vaccines that may be best for the individual pet based on the pet’s lifestyle and geographic location, the company says. Encouraging notes Despite the statistics on the rising incidence of FIV infection and Lyme disease, the 2014 report offers cause for encouragement, says Lefebvre. The incidence of several diseases decreased or stayed roughly the same last year, she says. Examples include kennel cough, parvovirus and Giardia in dogs; and feline leukemia virus and ear mite infestation in cats. “Pet owners are doing some things right,” she says. But they can do more. Simply keeping an eye on their pet, ensuring he or she doesn’t eat feces or fight with other pets, and making sure they get their vaccines and anti-parasitic treatments, can stave off many infectious diseases, she points out. “We want to ensure that pet owners [follow preventive measures], not only for their own pets, but to protect other pets from becoming infected,” she says. “So get your pets vaccinated, and clean up after them when they go outside.” Editor’s note: To see the entire State of Pet Health™ 2014 Report, visit www.stateofpethealth.com. www.vet-advantage.com • Veterinary advantage «« July/August 2014 35 »» Trends Breed Icon* Banfield sees 1 cat per every 5 dogs Breed Overview Dogs and cats can be prone to certain diseases based on their breed. For dogs, breed size can also put them at an increased risk for certain diseases. As such, breed and breed size have become important in veterinary medicine to understand the diseases or conditions to which a dog may be predisposed. Cat – average weight: 10 lbs Common Breeds 51% of dogs seen at Banfield Domestic Shorthair Domestic Medium Hair Domestic Longhair 27% Chihuahua Scottish Terrier Shih Tzu Yorkshire Terrier of dogs seen at Banfield Common Diagnoses Dental tartar Patellar luxation (kneecap pops out of place) Retained baby teeth Common Names Bella Max Coco Buddy Medium – weight: 20-50 lbs Common Breeds Beagle Boxer Cocker Spaniel Schnauzer 21% Common Names Kitty Bella Tiger Toy/Small – weight: <20 lbs Common Breeds of dogs seen at Banfield Common Diagnoses Feline respiratory virus Kidney disease Tapeworms Common Diagnoses Common Names Conjunctivitis (eye infection) Bella Cystitis (bladder inflammation) Max Underbite Buddy Daisy Large – weight: 50-90 lbs Common Breeds German Shepherd Golden Retriever Labrador Retriever Rottweiler Common Diagnoses Common Names Gastroenteritis (GI upset) Bella Otitis externa (ear infection) Max Overweight Buddy Bailey Giant – weight: >90 lbs Common Breeds 2% of dogs seen at Banfield Great Dane Great Pyrenees Mastiff St. Bernard Common Diagnoses Arthritis Lameness Skin tumor Common Names Bella Zeus Duke Max * The percentages for dogs add up to 101% (not 100%) due to rounding 6 36 July/August 2014 Chart Credit: Banfield Pet Hospital’s State of Pet Health 2014 Report. »» Veterinary adVantage • www.vet-advantage.com Jorgensen Laboratories, Inc. A family owned business, owned by veterinarians for veterinarians, since 1965 PawFlex Bandages are a true innovation in wound care. PawFlex super stretch material flexes in all joint degrees and angles plus moves gently and smoothly with your patient. In sizes for the tiniest of patients to the giant breeds. - Non-adhesive means absolutely NO FUR pulling or skin ripping. This makes the bandage comfortable and easy to change. - Non-slip application assures minimal slippage....even on the most active dogs. - Non-adherent wound pad - each bandage has a non-adherent absorbant pad integrated into the bandage itself as a primary bandage layer. - Can be adjusted or re-adjusted. Can check on wound healing and still keep the same bandage....just lift and release. ECO - friendly biodegradable burial pods Be a part of the new standard in pet aftercare services. Provides a better end of life experience. All Paw Pods® can be personalized at home. Personalize at home. Sympathy Card - For use with either cremation ashes or whole body burial. - Made from 100% bamboo and rice husk »» Trends By Laura Thill The Persistent Threat of Rabies Summertime finds more pets outdoors, making it a good opportunity for your customers to remind pet owners to stay current with their pets’ rabies vaccines. Although awareness of rabies continues to grow, the threat still exists. Veterinarians have done a nice job of containing rabies with regard to domestic pets, says Robert Menardi, DVM, director, veterinary technical services, Merial. Nevertheless, “we’ll never get rid of the wildlife reservoirs,” he says. “And, complacency cannot be accepted, because there are still thousands of wildlife cases documented. Any time animals are more likely to be exposed to wildlife, there is a greater risk of rabies.” 38 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Veterinarians are very thorough when it comes to communicating to clients the importance of vaccinating pets against rabies, he continues. “Many veterinarians continue to use the rabies vaccine appointment as a means of getting clients in the front door.” What is the role of the distributor sales rep? “Sales reps don’t need to remind their veterinarian customers about the importance of rabies vaccines,” says Menardi. “The most important thing they can do is to know the products they carry and understand how they stand apart from other products.” “In any discussion [with the customer], it comes down to managing relative risks,” he continues. “The disease is prevalent across the country in the wildlife population, and it’s 100 percent fatal to pets. So, there’s no question that veterinarians need the vaccine on hand. The question may be as to the type of vaccine they need. For instance, we have learned that modified live vaccines can cause a rabies-like illness in vaccinated animals, so they are no longer allowed. So, killed vaccines have since served us well. And, in the last 15 years, the first recombinant vaccine was introduced to address the risk of injectionsite inflammation in cats.” Vaccination is important not only clinically, but from a regulatory standpoint Covidien Animal Health Clinically proven products; from Spay to Z. Absorbable suture FDA approved, human hospital accepted • Over 100 years of suture manufacturing expertise • Unique materials made for improved outcomes • Higher strength1, with easy handling Competitive price with brand quality • From manufacturer straight to distribution, no middle-man • Higher margin products • Direct account support from the manufacturer Maxon™ Monofilament Synthetic Absorbable • 67% stronger out of the package than competition1 Biosyn™ Monofilament Synthetic Absorbable • Stronger through the critical wound healing time1 Polysorb ™ Braided Synthetic Absorbable • Significantly stronger knot security than competition2 1 2 Learn the benefits, feel the difference, see the savings. www.covidien.com/animalhealth Data on file, Covidien Ltd. Faulkner, et al, University of Virginia School of Medicine, Biomechanical Performance of a Braided Absorbable Suture, 1996. “In any discussion [with the customer], it comes down to managing relative risks. The disease is prevalent across the country in the wildlife population, and it’s 100 percent fatal to pets. So, there’s no question that veterinarians need the vaccine on hand. The question may be as to the type of vaccine they need.” – Robert Menardi, DVM, director, veterinary technical services, Merial as well, notes Menardi. “The rabies vaccine is the only vaccine regulated by state, county and municipal laws, although it varies by location,” he says. Sales reps can check with local public health officials and state veterinary medical associations to be clear, he adds. If anything, rabies vaccines have done such a good job of helping to diminish the disease, some pet owners might mistakenly believe the disease has disappeared. “The rabies vaccine is one of the biggest vaccine success stories,” says Menardi. “In the last century, we have been able to reduce rabies in animals and people to the point where many have forgotten it exists.” Fortunately, though, it’s always on veterinarians’ radars, he adds. Have the discussion When discussing rabies vaccines with their veterinarian customers, sales reps can remind them to: • Communicate information about current state and local requirements for rabies vaccination compliance in writing with clients. • Educate clients on the risk – and consequences – unvaccinated pets face when exposed to rabies. • Clarify the importance of keeping pets current with their rabies vaccination. When a dog or cat is even one day overdue for its rabies vaccine, it is considered unvaccinated. www.vet-advantage.com • Veterinary advantage «« July/August 2014 39 »» Trends Rabies: Testing and diagnosis When it comes to rabies in the United States, raccoons and skunks are the most highly reported rabid wildlife species, followed by foxes and coyotes. Small animals, such as squirrels, rats, mice, hamsters, guinea pigs, gerbils, chipmunks, rabbits and hares, are rarely discovered to be infected with rabies, according to the CDC. Generally, there are two types of rabies exposures: bite and non-bite. A bite refers to the penetration of the skin by teeth. A non-bite includes the contamination of open wounds, abrasions, mucous membranes or scratches. Rabies is only transmitted through saliva and brain/nervous system tissue. Rabies is transmitted when the virus is introduced into a bite wound, open cuts in the skin or onto mucous membranes, such as the mouth or eyes. When the virus is introduced by a bite into a dog, cat or ferret, it travels within the animal’s nerves from the site of the bite to the brain. During this time – the incubation period, which may last between three weeks to two or three months in dogs and two to six weeks in cats – the animal does not appear ill. Because the rabies virus has not yet reached the animal’s saliva, it will not pass along the virus if it bites another animal or human. However, studies have shown that rabies can be excreted in an infected animal’s saliva for up to 10 days before the illness is apparent, according to the CDC. Once the virus reaches the animal’s brain and multiplies, it causes inflammation of the brain before moving from the brain to the salivary glands and saliva. Infected animals generally show signs of illness once the virus has multiplied in its brain (usually between three and five days). In dogs, the early signs of rabies include a change in the dog’s tone of bark, chewing at the bite site, fever, loss of appetite or small changes in the animal’s behavior. These signs 40 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com may last for two or three days, followed by aggressive behavior that lasts for two to four days. During this time, rabid dogs may viciously attack a moving object, person or animal, show strange food (and/or non-food) cravings, constantly growl and bark, behave erratically, disoriented or restless, or have seizures or lack muscle coordination. In the last two to four days of illness, the rabid dog may appear to be choking, have difficulty swallowing, leading to drooling and foaming of saliva, or have paralysis of the jaw. Paralysis spreads to other parts of the body and the animal enters a coma and dies. With cats, the first stage of illness involves anxiety and sometimes a fever. They likely will lick the site of the bite. After a couple of days, cats often become restless and vicious. They become disoriented, have seizures and develop paralysis, which generally affects the throat and facial area. They have trouble swallowing, become increasingly weak and die of respiratory failure. There are several methods used to test euthanized animals for rabies, according to the CDC. These include: • A histologic exam. • Immunochemistry. • Electron microscopy. • Amplification methods. • Direct fluorescent antibody (dFA). The CDC considers the direct fluorescent antibody test, which has been used in the United States for about 50 years, to be highly sensitive and specific and, as such, the gold standard diagnostic method for rabies. Animals infected with the rabies virus have rabies virus proteins – or antigens – present in their tissues. Unlike many viruses, which are present in the blood, rabies is present in nervous tissue, making brain tissue the ideal place to test. MISSING SOMETHING? . More complete.* For ferrets† HEARTWORMS MICROFILARIA Dogs only FLEAS ROUNDWORMS HOOKWORMS WHIPWORMS Dogs only SARCOPTIC MANGE Dogs only EAR MITES Cats only FLEAS HEARTWORMS See the difference at bayerdvm.com/multi *Based on label indications: spectrum of species, parasites (dog) and life stages (dog and cat). † Advantage Multi® for Cats (imidacloprid + moxidectin) (0.4 mL) is indicated for ferrets that weigh at least 2 lbs. CAUTION: Federal (U.S.A.) law restricts Advantage Multi® for Dogs (imidacloprid + moxidectin) to use by or on the order of a licensed veterinarian. WARNING: DO NOT ADMINISTER THIS PRODUCT ORALLY. For the first 30 minutes after application ensure that dogs cannot lick the product from application sites on themselves or other treated animals. Children should not come in contact with the application sites for two (2) hours after application. (See Contraindications, Warnings, Human Warnings, and Adverse Reactions, for more information.) CONTRAINDICATIONS: Do not use this product on cats. CAUTION: Federal (U.S.A.) law restricts Advantage Multi® for Cats to use by or on the order of a licensed veterinarian. WARNINGS: Do not use on sick or debilitated cats or ferrets. Do not use on underweight cats. (see ADVERSE REACTIONS). Do not use on cats less than 9 weeks of age or less than 2 lbs body weight. Do not use on ferrets less than 2 lbs body weight. PRECAUTIONS: Avoid oral ingestion. HUMAN WARNINGS: Children should not come in contact with the application site for 30 minutes after application. ©2014 Bayer HealthCare LLC, Animal Health Division, Shawnee Mission, Kansas 66201 Bayer, the Bayer Cross and Advantage Multi are registered trademarks of Bayer. AM14535 »» Trends By Laura Thill Understanding Diabetes An understanding of diabetes – including the symptoms and challenges it presents – can help sales rep better service their veterinary customers. As pets age, they face several health issues, including diabetes. They typically show symptoms at around 7 years and up, according to Peter Hanson, DVM, PhD, director of research & development and medical affairs, Abbott Animal Health. Particularly as older pets become increasingly sedate and often overweight, they are at higher risk of developing the disease. Distributor sales reps can play an important role in ensuring their veterinary customers are supplied with solutions for diagnosing and treating their diabetic patients, as well as tools for educating their clients. 42 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Humans share a lot of things with their pets. NOW AT A REDUCED PRICE Blood glucose meters shouldn’t be one of them. Portable blood glucose meters designed for blood glucose monitoring in humans are not validated for veterinary use on pets. AlphaTRAK is specifically calibrated and validated for dogs and cats for accurate readings. Now with a reduced price, accuracy is affordable for your practice and your patients. With a recommended Starter Kit price of just $70 to pet owners, there is no better time than now to upgrade to AlphaTRAK. © 2014 Abbott Laboratories. AlphaTRAK is a trademark of Abbott Group of companies in various jurisdictions. AT2-2058 For more information call 866-257-8807 or visit www.AlphaTRAKmeter.com »» Trends About the disease Veterinarians generally agree that obesity is a leading factor in the increase of diabetes in dogs and cats, according to Hanson. (Tremayne J., Education Key in Diabetes Maintenance, Vet Practice News, Nov 2009 (RPRT-010)) However, pet owners are not always aware that their pet is obese, he says. “In a recent study, 47 percent of veterinarians felt that their canine patients were obese, while only 17 percent of dog owners agreed,” he says. (Bound G., When Man’s Best Friend Is Obese, WSJ, Feb 2011) There are two types of diabetes: type 1 and type 2. Type 1 diabetes occurs from a shortage of insulin, while type 2 diabetes results from impaired insulin production or an incorrect response to the insulin. “Dogs most often get type 1 there is a greater likelihood that changes in diet can reverse the insulin resistance, and cats enter remission if diagnosed early and aggressive intervention is started,” he adds. Common signs of diabetes include: • Excessive drinking. • Excessive urination. • Increased appetite. “Often, there is weight loss, even with the increased appetite,” says Hanson. “If the disease has been present for a while, cataracts of the eyes may occur in dogs. In cats, diabetic neuropathy may present. In either species, diabetic ketoacidosis can be a life-threatening complication of untreated diabetes.” “Human meters underestimate blood glucose in dogs and cats because glucose is distributed differently in the blood and blood cells between species.” Accurate blood glucose monitoring – along with proper diet and insulin therapy – permit veterinarians to control their patients’ diabetes and reduce secondary complications, usually at a minimal cost to the pet owner. Screening and monitoring Screening and early detection of diabetes can help veterinarians prevent the disease from progressing to a severe state. Uncontrolled diabetes may result in cataracts, severe metabolic disorders, such as ketoacidosis, depression, inappetance, coma and sometimes death. And, as the disease progresses, it can be more costly to treat. – Peter Hanson, DVM, PhD, director of research & The most common screening development and medical affairs, Abbott Animal Health test is for blood glucose. “Cats may have elevated blood glucose if they are stressed,” says Hanson. “With dogs and cats, a single diabetes,” says Hanson. “In dogs, obesity may lead to longhigh blood glucose result may be followed with a repeat term pancreatitis, which in turn impairs islet cells and leads test after the animal has fasted. Persistent hyperglyceto diabetes. mia with levels >200 mg/dL in dogs and >250 mg/dL “Cats most often get type 2 diabetes,” he continues. in cats is consistent with diabetes. Persistent glucose in “Particularly in cats, obesity can lead to insulin resistance the urine is typically a confirmatory diagnostic for susand an overproduction of insulin. Prolonged overproducpected diabetes. Additionally, fructosamine can be run tion of insulin causes increased demand on the islet cells to evaluate the average blood glucose readings over the in the pancreas that produce insulin. Over time, this leads past few weeks. to damaged cells or cell death, which may result in a “Ideally diabetic dogs and cats should be monitored shortage of insulin.” daily, one to three times per day, to allow proper adjustOnce a dog is diabetic, it typically requires insulin for life. ment of insulin doses,” he says. “People with diabetes However, proper weight and diet can reduce the insulin recheck their blood glucose levels throughout the day to quired and improve glucose control, says Hanson. “In cats, 44 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com “It is important [for sales reps] to find out if there is a diabetes champion in the practice who understands the benefit of home monitoring and other management practices.” – Peter Hanson, DVM, PhD ensure they are maintaining proper glucose levels through diet and insulin therapy. Pets are the same. Their blood glucose levels rise and fall through the day based on diet, activity, insulin dose, and other factors. To ensure the right dose of insulin is being given requires regular monitoring of blood glucose. “Handheld blood glucose monitors that require only a drop of blood have made home monitoring easy,” Hanson continues. It is important to use a meter that is calibrated for use in dogs and cats, he says. “Human meters underestimate blood glucose in dogs and cats because glucose is distributed differently in the blood and blood cells between species.” Accurate blood glucose monitoring – along with proper diet and insulin therapy – permit veterinarians to control their patients’ diabetes and reduce secondary complications, usually at a minimal cost to the pet owner, he adds. Working with customers Distributor sales reps looking to initiate a discussion about diabetes with their customers might do so by asking several probing questions, such as the following: • “Doctor, how many patients do you see who are at risk for diabetes?” • “How do you screen these patients?” • “How do you address diabetes with your clients and educate them on the signs of the disease?” • “Does your staff utilize a designated technician who can initiate diabetes discussions with owners of recently diagnosed pets?” • “How do you manage a diabetic patient in the hospital?” • “What is your approach to glucose curves and interpretation?” • “Do you discuss home monitoring as an option with your clients?” While many veterinarians and their clients appreciate the convenience of home monitoring, some veterinarians may initially be uncomfortable with their clients’ role in regulating their pet’s blood glucose levels, says Hanson. However, a number of texts and protocols now exist to guide this, he says. “There may be concern that the client is not capable of getting a blood sample for home monitoring,” he says. And, some clients might be tempted to make decisions about adjusting insulin dose without first consulting with their veterinarian. “It is important [for sales reps] to find out if there is a diabetes champion in the practice who understands the benefit of home monitoring and other management practices,” he says. “This champion can instruct the client on diet, exercise and easy techniques to get a blood sample for home monitoring. Proper training is [also] key for the owner to understand the need to share blood glucose levels with the practice before adjusting insulin levels.” www.vet-advantage.com • Veterinary advantage «« July/August 2014 45 46 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Tiger Tail by the Zack Mills has a passion for veterinary medicine By Graham Garrison It was an itch that he just couldn’t leave alone. Despite a very successful run on the business side of the veterinary industry, including head of sales for Merial, Zack Mills still had his eye on where he first began – practicing veterinary medicine. “I always wanted to go back,” says Mills, DVM, owner of Duluth, Ga.-based Tiger Tails Animal Hospital. “I never planned to stay in industry full time. I was planning on staying about 5-10 years, but different opportunities kept coming up.” There and back again Mills began his career as a veterinarian in 1984. He started at a practice in Charleston, S.C., with the understanding that in five years he would buy out the owner. Within five months though, they ended up negotiating a deal, and Mills was the owner of a practice. Within ten years he had built the business up to two practices and four veterinarians. During this time, Mills got involved doing clinic trials for Rhone Merieux. The industry itself was something that intrigued Mills. “I enjoyed sales,” he says. “I was a born salesman. I actually worked my way through veterinary school as a salesman – purchasing an ice cream truck and selling ice cream novelties.” www.vet-advantage.com • Veterinary advantage «« July/August 2014 47 Tiger Tails Eventually, Mills decided to sell his practice and make the leap into industry. He was hired by Hills Pet Nutrition. He worked there as a territory manager, and then moved to Rhone Merieux as a senior manager of technical services, vaccine product manager and then director of veterinary services for Rhone Merieux. When the merger between Rhone Merieux and Merial happened, Mills considered going back into veterinary practice. However, he was convinced to stay on board, and transitioned into global marketing. Tom Zerzan, VP North America, soon came aboard at Merial Limited. He became Mills’ mentor and moved him to head veterinary medical affairs. The last six and a half years worked and what didn’t work for other practices. I could learn from others and apply my own ideas.” His involvement with the American Animal Hospital Association, as well as the Partners for Healthy Pets programs, gave him an up-close look at the challenges and problems veterinary hospitals were having. There were also the relationships he’d already built with distribution. Mills says the distributor reps he worked with made a huge difference in helping get Tiger Tails off the ground. “Jim Cleary at MWI introduced me to the people at IDEXX,” Mills says. “He told me ‘we have grown our business working together; now I want to help you grow Mills was at Merial, he was in what he called his “dream job” in the industry – head of sales. “I loved it and it was fun for me. I was responsible for not only the Merial sales force, but the relationship with the distributors.” Still, there was always the pull toward his first passion – veterinary medicine. “I loved industry, but also loved and missed practice,” he says. “My wife Susan and I knew if we didn’t get back in now, I’d never do it. Practicing veterinary medicine is something I can do for the next 30 years.” your business.’” The distributor reps introduced Mills to the people, products and equipment he would need to make a successful launch. Patterson Veterinary had a draftsmen visit the proposed site Mills was considering to purchase and lay out a rough draft of floor plans. Mills was able to use that in his business plan he took to the bank. “If I hadn’t had that opportunity with Patterson I’d have to do it myself,” Mills says. “That helped me start getting things approved.” His distributor reps were instrumental in getting the business up and running, and both of his reps were there supporting his open house. Today they are regular visitors at the office, coming in every week to two weeks to discuss products, training and promotions with Mills and his team. “They are partners,” Mills says. “They know my numbers and I trust them. That’s the kind of relationship you should be able to have. They should know where Lessons that carry over The lessons learned from his time in the industry proved critical in developing his business plan. “I had the opportunity to see hundreds of practices while I was head of sales and talk to a tremendous number of vets and see different ways of things being done,” he says. “I could see what 48 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com everything is, and continually come with new ideas. They see more practices than I see now, so they can help me keep up with what’s new.” Foundations Mills says it is easier in the long run to invest in creating the practice you want at the beginning, so he set out to do just that with the building specs, equipment they chose, and certifications they strove to meet. When choosing which equipment to invest in, Mills says he was sold on the idea of systems integration “and it has proven to work beautifully,” he says. “We were also right and we had all our protocols together, he says. “By forcing ourselves to do that, it allowed us to get all protocols in place to make sure we were doing everything right. By getting it right early, it ensured we were doing what we needed to be doing from the beginning. If you get into good habits, good habits will stay. If you get into bad habits, it’s very hard to change.” While the average client may not know what AAHA accreditation meant, if clients asked, Mills could tell them it meant they were doing things the right way. This also carried over into their decision to become a Cat-Friendly practice. The name, the people Mills wanted a story behind the name of their practice, and he had a good one in Tiger Tails. He attended Clemson University and was the school’s mascot at one point, “which in addition to being a great experience, it opened a few doors for me along the way.” fortunate to work a great deal on the purchase of our building so we could invest more into the build-out and equipment. We wanted a state-of-the-art practice, so we invested in cutting edge technology.” For the facilities, “look and feel” were important too. Consumers appreciate a friendly, efficient and clean ‘shopping’ experience, Mills says. “When we built the practice we wanted it to have the look and feel of a spa, yet evoke a playful, fun feeling. We’ve also embraced technology and state-of-the-art equipment. We like to be cutting edge in treatments and therapies we offer. Yet the basic premise of best quality medicine and customer care remains unchanged.” Mills set a target goal to become AAHA accredited within six months. Tiger Tails actually accomplished it in four months. “I wanted to make sure we were doing everything CALL TO SCHEDULE YOUR IN-CLINIC DEMONSTRATION www.vet-advantage.com • Veterinary advantage «« July/August 2014 49 Tiger Tails The Tiger Tails staff meets on a regular basis to discuss how they function and the right, consistent messaging to have in place for things such as flea/tick season, vaccinations, etc. Just as important as the building was the team. Mills says that during the interview process, it was important to find people that liked people, not just pets. “Anybody can say ‘I love animals.’ That’s great, but that’s not a reason I will hire you,” says Mills. “I want someone who loves animals, but loves working with people, because it’s a team. You’ve got to have ‘giveand-take’ on a team, and enjoy working with clients. It’s the clients who bring in the animals – the animals don’t come in by themselves. You can be the greatest vet in the world, but if you don’t have a great happy team to support you and communicate to the client you aren’t going to be successful.” The Tiger Tails staff meets on a regular basis to discuss how they function and the right, consistent messaging to have in place for things such as flea/tick season, vaccinations, etc. He says they also rely heavily on manufacturer reps to come in and train staff on the talking points. Retail Tiger Tails doesn’t shy away from being competitive in the retail space. You can see their retail strategy the moment 50 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com you walk into the practice – a neat, clean shelving system with products the Tiger Tails recommended to clients. Mills says Tiger Tails offers a 12-pack for heartworm preventatives, in either oral or combo applications, because that’s what they need. He also limits the number of products he keeps in inventory to keep his costs in line. “We work hard to educate clients on our retail products and are proactive in recommending them,” he says. “We coach our team on having a consistent message about the products so customers hear the same message whether they are speaking with the doctor, a tech or a customer service team member, and it pays off. Our compliance on 12 months of heartworm prevention is 70 percent. Living in the South, there’s no reason a pet shouldn’t be on heartworm prevention, as well as flea and tick control.” With pricing, Mills says people look to see how competitive a veterinary practice is based upon things like heartworm preventives and flea/tick. “If you’re charging $140 for a 12-month supply of HEARTGARD, and they look online and can get a 12-month supply for $100, they’ll look at it and . D E G N A ? o H o t , C D I E A S V N r A u o H y e g S n E a h c M TI Is it time to THEN. NOW. ®PREVICOX is a registered trademark of Merial. ©2014 Merial Limited, Duluth, GA. All rights reserved. PVX13PB2014TRADEAD (02/14). Important Safety Information: As a class, cyclooxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney or liver side effects. These are usually mild, but may be serious. Pet owners should discontinue therapy and contact their veterinarian immediately if side effects occur. Evaluation for pre-existing conditions and regular monitoring are recommended for pets on any medication, including PREVICOX® (firocoxib). Welcome to the now. Tiger Tails say – ‘If he’s overcharging me for this, what else is he overcharging me for?’ I tell clients that my prices are about what you’d see online. I’m not going to match the price you get online, because it’s not fair to my other customers. But I price my products at a fair markup and there are a number of benefits they enjoy buying directly from their veterinarian.” Veterinary medicine is Mills’ first love, but with his success and experience on the business side, his switch back into practicing has become a proving ground of sorts. “One of the reasons I wanted to do this was to prove to practitioners that you can still be very successful being a veterinarian,” Mills says. He’d heard the concerns: There are too many vets, too much debt, veterinarians can’t compete with Wal-Mart or retail chains, etc. “I want to prove that yes you can, and be very successful at it.” Social media The best way to promote a practice is still through word of mouth, says Zack Mills, DVM, owner of Tiger Tails Animal Hospital. Social media has just become a high-tech way to do it. Tiger Tails uses a mixture of social media, community events and traditional advertising to build client awareness. “We continue to do those things and whole heartedly embrace social media. However, our clients recommending our practice to their colleagues, family and friends is our most effective form of advertising.” The message is certainly resonating. Tiger Tails has almost 1,000 Likes on Facebook within 18 months of opening. “We don’t put a lot of medical information in there,” says Mills. Rather than in-depth medical content, Tiger Tails uses Facebook for things such as posting pictures of lost animals that people bring in to their clinic. “Almost every single time, the post is responded to and in a couple hours the owner is coming to pick up their pet,” Mills says. “Someone on Facebook saw the pet and realized it belonged to somebody else or they shared it with their network of friends.” 52 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Leslie Scarpa, Tigers Tail’s social media and event coordinator, says their Facebook page gets a lot of traffic from clients on vacation who want to see pictures of their dog that is being boarded. “The boarding and day care team is so good at putting pictures up,” says Scarpa. “Sometimes we’ll get a private message ‘please put a video up of our pet’ because a little boy is missing his dog.” Tiger Tails has a Shutterfly page, referenced on the boarding invoices, so clients know to go there for lots of pictures. Tiger Tails has also developed an app, which already has more than 1,100 downloads. “That’s well over a third of our client base,” says Scarpa. The app is popular for setting appointments for boarding and day care. Customers have the ability to purchase product through the app and request hospital appointments and prescription refills. Tiger Tails also has a YouTube page and is active on Twitter. The key to making social media work for your practice is having team members who embrace it and update it consistently, says Scarpa. RILEXINE® (cephalexin) Chewable Tablets for Dogs Antimicrobial for Oral Use in Dogs only CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. BRIEF SUMMARY: Please consult package insert for complete product information. INDICATION: For the treatment of secondary superficial bacterial pyoderma in dogs caused by susceptible strains of Staphylococcus pseudintermedius. CONTRAINDICATIONS: RILEXINE Chewable Tablets are contraindicated in dogs with a known allergy to cephalexin or to the ß-lactam (any of the penicillins or cephalosporins) group of antibiotics. WARNINGS: For use in dogs only. Not for use in humans. Keep this drug out of the reach of children. Antimicrobials, including penicillins and cephalosporins, can cause allergic reactions in sensitized individuals. Sensitized individuals handling such antimicrobials, including cephalexin, should avoid contact of the product with the skin and mucous membranes in order to minimize the risk of allergic reactions. PRECAUTIONS: Prescribing antibacterial drugs in the absence of a proven or strongly suspected bacterial infection is unlikely to provide benefit to treated animals and may increase the risk of the development of drug-resistant animal pathogens. The safe use of RILEXINE Chewable Tablets in dogs intended for breeding and in pregnant or lactating bitches has not been evaluated. Positive direct Coombs’ test results and false positive reactions for glucose in the urine have been reported during treatment with some cephalosporin antimicrobials. Cephalosporin antimicrobials may also cause falsely elevated urine protein determinations. Some antimicrobials, including cephalosporins, can cause lowered albumin values due to interference with certain testing methods. Occasionally, cephalosporins have been associated with myelotoxicity, thereby creating a toxic neutropenia1. Other hematological reactions observed with cephalosporin therapy include neutropenia, anemia, hypoprothrombinemia, thrombocytopenia, prolonged prothrombin time (PT) and partial thromboplastin time (PTT), platelet dysfunction, and transient increases in serum aminotransferases2. ADVERSE REACTIONS: The most common adverse reactions in dogs include diarrhea, vomiting, anorexia and lethargy. To report suspected adverse reactions call Virbac at 1-800-338-3659. ANIMAL SAFETY: RILEXINE Chewable Tablets were administered orally three times a day to 12-week-old healthy Beagles at 0 mg/kg (placebo), 22 mg/kg (1X), 66 mg/kg (3X), and 110 mg/kg (5X) for 12 weeks, and at 22 mg/kg twice a day for 12 weeks. The most common clinical findings included epiphora, salivation, vomiting and diarrhea among all the dose groups. Three dogs had decreased activity (1 in each from the 22 mg/kg twice a day, 22 mg/kg three times a day, and the 66 mg/kg three times a day groups). These observations were mild and sporadic. There were increases in alanine aminotransferase (ALT) in the 110 mg/kg three times a day group and in the 22 mg/kg twice a day group that increased in a dose-dependent pattern. There was an increase in sorbitol dehydrogenase (SDH) in the 110 mg/kg three times a day group compared to the controls. These changes were minimal and the values remained within expected historical control ranges. There were several decreases in total protein (in the 110 mg/kg three times a day group) and/or globulin (in the 22, 66, and 110 mg/kg three times a day groups) compared to the controls. These changes resulted in occasional increases in albumin/globulin ratios. Although a drug effect cannot be ruled-out, these changes were not clinically relevant. A mild prolongation in prothrombin time (PT) was observed in the 22 mg/kg three times a day group. This was not considered clinically relevant due to the small change that remained within the reference ranges. One dog in the 110 mg/kg three times a day group had moderate amounts of bilirubinuria at the Week 8 and Week 12 samplings. No clinical significance was noted. Cephalexin was not present in any Day 1 samples prior to dosing or in any control animals. After dosing, cephalexin was well absorbed into systemic circulation of the treated dogs. Within gender and dosage level, Week 8 mean trough concentrations were generally higher than the Week 4 and 12 mean trough concentrations (between a 0.9 and 3.6-fold difference). The geometric mean plasma cephalexin trough concentration following three times daily administration of the 110 mg/kg dose was 11.2 µg/mL compared to 2.6 µg/mL and 8.7 µg/ mL following 22 mg/kg and 66 mg/kg, respectively at Week 12. Geometric mean plasma cephalexin trough concentrations following administration of 22 mg/kg twice daily were 0.7, 1.3, and 1.0 µg/mL at Weeks 4, 8, and 12, respectively. STORAGE INFORMATION: Store at 20°C-25°C (68°F-77°F), with excursions permitted between 15°C-30°C (59°F-86°F). HOW SUPPLIED: RILEXINE (cephalexin) Chewable Tablets are supplied in 75 mg, 150 mg, 300 mg, and 600 mg tablets packaged in bottles of 100 and 500 tablets or boxes of 28 blister-packs, 7 tablets per blister pack. NADA 141-326, Approved by FDA. Distributed by: Virbac Animal Health, Inc. Fort Worth, TX 76137 USA Revision date: 08/2011 References: 1. Birchard SJ and Sherding RG. Saunders Manual of Small Animal Practice, 2nd edition. W.B. Saunders Co. 2000: p. 166. 2. Adams HR. Veterinary Pharmacology and Therapeutics, 8th edition, 2001, p. 825. © 2014 Virbac Corporation. All Rights Reserved. RILEXINE is a registered trademark of Virbac S.A. in the United States and Canada. TREATING DOGS WITH PYODERMA IS NO LONGER SUCH A BITTER HUMAN PILL TO SWALLOW. Show your clients the benefits of RILEXINE (cephalexin) Chewable Tablets for Dogs ® The first and only veterinary approved cephalexin makes treating pyoderma feel more like giving a treat. Human generic cephalexin may be your clients’ first-line choice for secondary superficial bacterial pyoderma, but it’s a bitter pill to swallow for their canine patients. RILEXINE Chewable Tablets for Dogs is the first and only FDA-approved cephalexin specifically designed for the veterinary market. This unique alternative combines proven palatability with the efficacy veterinarians have come to expect at a value similar to other veterinary-labeled antibiotics. Plus, it comes in 3 convenient tablet sizes that can be easily scored for more precise dosing. When your clients prescribe RILEXINE Chewable Tablets for Dogs, they generate additional revenue for their clinic and create more sales opportunities for you. Talk to veterinarians about the benefits of RILEXINE Chewable Tablets for Dogs so you both can start earning more revenue today! Visit www.virbacvet.com to learn more. Indication: For the treatment of secondary superficial bacterial pyoderma in dogs caused by susceptible strains of Staphylococcus pseudintermedius. Important Safety Information: RILEXINE Chewable Tablets for Dogs are not for use in dogs with a history of allergic reactions to penicillins or cephalosporins. Sensitized individuals should avoid contact of the product with the skin and mucous membranes. The most common adverse reactions in dogs include diarrhea, vomiting, anorexia, and lethargy. The safety of RILEXINE Chewable Tablets for Dogs in breeding, pregnant, and lactating bitches has not been evaluated. www.virbacvet.com © 2014 Virbac Corporation. All Rights Reserved. RILEXINE is a registered trademark of Virbac S.A. in the United States and Canada. 2/14 14336 Tiger Tails Summer Camp Tomorrow’s veterinarians and pet owners can start their education for proper pet care today. Tiger Tails Animal Hospital emphasizes this in a week-long summer camp for kids. The camp runs each day from 9 a.m. to 1 p.m. During the office lunch hours, the campers come through the practice and meet and talk with the assistants, veterinary technicians and veterinarians while viewing some really cool stuff in the hospital, says Leslie Scarpa, Tiger Tails’ social media and event coordinator. “We also have presenters coming in,” says Scarpa. “For example, on Monday we have Pawsitive Practice, blood (in this case vitamin water), and marbles in the bladder area to simulate bladder stones. On another day, the local K9 unit will have a presence. The SPCA will also stop by to discuss the difference between a no-kill shelter and shelter. “We’re also going to do something on the importance of spaying and neutering your pets,” says Scarpa. On Monday, the kids will have the opportunity to color a pair of cat drawings to coincide with a chart created to show the kids how fast a cat population can grow without spaying or neutering. Each day, according to the chart, more cats will be dropped off, and the campers will have to color each one. “So it will be a great visual to drive home how fast the population can grow.” After the camp ends, the students will bring in their pets on a Saturday, and get a chance to show their parents what they’ve learned by helping to perform a physical exam. Mills says last year’s Vet Camp and Saturday checkup were such a hit, most of the families became clients. Mills says the camp is a great opportunity to develop an interest in veterinary medicine, and if nothing else, an appreciation for taking care of – Zack Mills one’s pet. “This whole program is giving back to the profession,” Mills says. “You start educating kids, they get excited about veterinary medicine, and you might get more kids into veterinary medicine. More importantly too, even the ones who don’t get into veterinary medicine now know the importance of pet wellness. They can talk to their parents about it, and help ensure it happens.” During the first year, Tiger Tails had 16 campers. It had a full house of 25 for this year’s camp, which ran the first week of June. “You start educating kids, they get excited about veterinary medicine, and you might get more kids into veterinary medicine. More importantly too, even the ones who don’t get into veterinary medicine now know the importance of pet wellness.” which is a dog training company, and they will talk to the kids about bite prevention. Because the kids will be in the hospital setting with animals, we want them to know how to approach them.” They also bring in outside visitors. Merial visits and discusses the importance of heartworm preventives and preventive medicine overall. Merial is also providing stethoscopes for the kids to use on a toy dog that has been outfitted with a beating heart, a tube to draw 54 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Keep your Patients Warm ™ 3M Bair Hugger therapy forced-air warming ™ ™ Quiet and easy to use • Warming blankets available in a variety of designs and sizes • Provides safe, effective warming for your patients • Now available to 3M veterinary distributors. Find out more by contacting your local sales representative, or visit us at www.3M.com/animalcare. 3M, BAIR HUGGER and the BAIR HUGGER logo are trademarks of 3M Company, used under license in Canada. © 2014 3M. All rights reserved. 603720A 5/14 »» Trends The Senior Pet Preventive healthcare, an understanding of the unique needs of older pets, and owners’ eagerness to care for their aging animals have contributed to longer lives for companion animals Pets – like people – are living longer. And with the heightened awareness of the needs of senior pets comes a heightened awareness of products and equipment geared to this subset of the pet population. “Over the past 11 or 12 years since I graduated from Cornell University, I am seeing a trend toward longer life expectancies,” says Christopher Byers, DVM, DACVECC, DACVIM (SAIM), Midwest Veterinary Specialty Hospital, Omaha, Neb, and chair of the Marketing and Communications Committee of the American College of Veterinary Internal Medicine. “Cats today are expected to live near their 20s and often into their 20s, and miniature and toy breeds are expected to live to their mid- to high teens.” Says Kate Crumley, DVM, owner of Heartwood Animal Hospital in Youngsville, N.C., and president of the American Animal Hospital Association, “Pets certainly are living longer than they did 20 years ago, when I came out of school. It depends on breed and species, but gaining years on the pet’s life is pretty common. It’s expected these days.” Starts with TLC, but doesn’t end there The reasons are many. “A lot of it is TLC – from owners as well as veterinarians,” says Crumley. 56 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com That’s a reflection of the human-animal bond. “Animals are living closer to us, so we can see when they don’t feel right. And people care intensely about making the quality of their pets’ lives better. We do what we can to help our pets feel better and make them part of our lives. “There’s a lot of good, new nutrition information out there, and a lot of focus on nutrition,” she adds. “Also, the general population of pet owners is aging a bit, so people are sensitive to what’s ailing their pet. ‘What I am experiencing, are my pets experiencing that as well?’” Says Byers, “In the United States, we have an extremely dedicated base of what we call pet parents. They will go above and beyond what commonly happens in other parts of the world. Simply stated, the pet-owning American public is very proactive with animal health.” True, during hard economic times, such as the recent recession, priorities are rearranged, and pet care may suffer. “But now that we seemingly are on the upswing, with reports that the private sector has made modest improvements in economic growth, pet parents have more disposable income, for lack of a better term, for veterinary healthcare.” But economics is just one factor influencing pet longevity, says Byers. “The level of education for our primary care colleagues who are on the forefront of preventive healthcare medicine is phenomenal,” he says. “They are a very dedicated group of clinicians who are trying to monitor and head off medical problems at their infancy, before they become major medical issues. Geriatric programs and protocols to perform disease screenings at all ages, including the geriatric years, have gone a long way in helping us identify disease and start treatment earlier.” Veterinary specialty medicine plays a big role too. “It is something that pet parents are honestly starting to expect nowadays, and it is blooming,” he says. Pet owners have come to expect assistance from what Byers calls the “triad of care” – that is, a team comprising the pet parent, the primary care veterinarian and the veterinary specialist – to help them keep their pets healthier longer. While primary care veterinarians assume responsibility for screening and providing preventive care, the specialist provides advanced care when needed, he says. Specialists, including surgeons, oncologists, cardiologists, critical care specialists, eye specialists, etc., are exposed to data on many different disease processes, many of them unique to the geriatric pet population. “Working and partnering with primary care doctors for those patients who are really sick, a specialist can pull off the shelf the latest drug therapies or new procedures that aren’t commonly available,” he points out. Unique health needs Successful primary care practices have developed preventive healthcare programs targeted to their geriatric patients. “Geriatric programs and protocols to perform disease screenings at all ages, including the geriatric years, have gone a long way in helping us identify disease and start treatment earlier.” – Dr. Christopher Byers “When I worked as a technician in the mid-90s, if an old dog or cat came into the office with his or her family, honestly, they were often treated just like any other patient – with care and compassion, yes, but they weren’t considered a special patient population with unique healthcare needs,” says Byers. “Today, we recognize that geriatric patients do have unique health needs, and the sooner we identify them, the better they will likely be in both the short and long term.” Many primary care hospitals have developed protocols for geriatric care and have trained their nursing staffs and client services teams to educate pet owners and promote this specific aspect of preventive healthcare, he says. As a result, practices are educating pet owners about their senior pets’ oral health, osteoarthritis and heart disease. “In the name of trying to keep these older pets as comfortable as possible, we talk about various supplements and www.vet-advantage.com • Veterinary advantage «« July/August 2014 57 »» Trends dietary modifications, and simple athome exercises that geriatric pets can do at home with their families,” he says. “It not only improves the pet’s health, but it strengthens the bond between family and pet.” Veterinarians and their staffs are trained to look for different things among their senior pet patients, he continues. Excess thyroid hormone production – hyperthyroidism – is an example. “Screening for hyperthyroidism in young kittens may be a waste of resources; but failing to do so in the geriatric feline population is a mistake,” he says. “Similarly, failing to monitor older pets for chronic kidney disease or blood Key Points • Many veterinary practices have developed protocols for geriatric care and trained staff to promote this specific aspect of preventive care • “Signalment,” taking into consideration a pet’s age, breed and gender before initiating treatment can be a key to improving care for senior pets. • Pet owners can pre-empt some problems with proper nutrition for their senior pet. process progressed near to the end stage, or to a point where a specialist is needed.” Arthritis and mobility issues The influx of senior pets is changing care protocols. Prior to bringing their older pet in to Twin Cities Animal Rehabilitation and Sports Medicine Clinic, Burnsville, Minn., for example, clients are asked to fill out a mobility questionnaire, explains Julia Tomlinson, BVSc, MS, PhD, DACVS, CCRP, CVSMT, DACVSMR. That’s because arthritis and mobility issues are common among senior pets. “Older pets are sedentary and prone to obesity – “Today, we recognize that geriatric patients do have unique health needs, and the sooner we identify them, the better they will likely be in both the short and long term.” – Dr. Christopher Byers pressure abnormalities is a mistake.” But 10 or 15 years ago, these were things that were not routinely done. “Today, I could go to any of my referring doctors and ask them what they do for geriatric healthcare, and at some level, they have a protocol and a recommended plan. Not every parent will be able to heed those recommendations, or they may elect not to, but at least a surveillance program is in place. “As a profession, we have recognized that individual patient populations – whether you’re talking about geriatrics or pediatrics – have unique health concerns. If we take that geriatric population and focus a majority of our efforts on trying to identify issues before they become major, the pet’s health and quality of life will remain high – much longer than if we let it get to a point where a specific disease 58 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com and obesity can exacerbate the problem,” she says. In addition, muscles in the older pet can waste away, a phenomenon that, in human beings, is called “frailty syndrome.” In people as in pets, it leads to further problems with mobility, she says. Though general practitioners can – and do – equip their practices with modalities geared to the older pet, such as laser, they can offer their clients and senior pets a great service by educating them on therapeutic exercises for the home, says Tomlinson. “There are simple things to do with the frail pet at home,” she says. For example, the owner can gently bend his or her pet’s legs to loosen up the joints. “Things like that have a big effect” on the pet. At the annual or semi-annual wellness exam, the veterinarian should include some quick mobility testing, Because your waiting room is filled with variety... so is our glove line. From the makers of Sensi-Touch® Your day can turn into a real zoo. Choose from a variety of premium surgical and exam gloves that provide tactile sensitivity, long-wearing comfort, allergy protection and fit your unique needs. Extra protection, powder-free latex, latex-free, chemotherapy approved and more, our product line is as versatile as you are. To see all of our species of gloves, visit www.ansellhealthcare.com For samples, visit www.ansellinfo.com/VA13 ® and ™ are trademarks owned by Ansell Limited or one of its affiliates. Original Perry® Style 42® Micro-Touch® Nitrile GAMMEX® Non-Latex Sensitive Latex, Powdered Surgical Gloves Synthetic, Nitrile, Powder-Free Exam Gloves Non-Latex Surgical Gloves 2014 Ansell Limited. All Rights Reserved. © such as watching the pet get up. They should prepare questions such as, “Can your pet still stand up during eating their whole meal?” It should come as little surprise to veterinarians or cat owners that cats exhibit symptoms differently than dogs, continues Tomlinson. “Cats are masters at hiding pain,” she says. “They can go a lot longer and hide a lot more issues that are only recognized later on.” Signalment Kate Crumley believes that “signalment” – that is, taking into consideration a pet’s age, breed and gender before initiating treatment – can be key to improving care for the senior pet. “That’s one of the first things they teach you in veterinary school. “If it’s a puppy, you look for puppy problems. If it’s a senior pet, there are many more possible problems, and you have to ask the client many more history questions.” Feeling the lymph nodes, looking for lumps elsewhere in the body, listening a little longer to the heart and lungs, asking questions about stiffness – it’s all part of the senior pet wellness visit, says Crumley. Blood work is more comprehensive as well. “We’re looking for thyroid issues, electrolyte problems – risk factors that get greater as the pet gets older. “The biggest thing for me is to watch for potential kidney disease. It used to be, we picked it up only after they were in failure. But now, we can identify the warning signs and postpone [its onset].” “The general population of pet owners is aging a bit, so people are sensitive to what’s ailing their pet. ‘What I am experiencing, are my pets experiencing that as well?’” www.vet-advantage.com • Veterinary advantage – Dr. Kate Crumley «« July/August 2014 59 »» Trends Healthy aging Healthy aging for pets involves many components, but one of the most critical is weight control, says Julia Tomlinson, BVSc, MS, PhD, DACVS, CCRP, CVSMT, DACVSMR, Twin Cities Animal Rehabilitation and Sports Medicine Clinic, Burnsville, Minn., who speaks about healthy aging to professional groups. The older pet typically gets less exercise than his or her younger counterparts, and hence needs fewer calories. Furthermore, contrary to what many believe, older pets, with their aging muscles, need more – not less – protein than when they were younger. Outfitting the practice Proper nutrition is another important aspect of healthy aging, says Tomlinson. “We try to pre-empt problems [with activities and products] that support joints and keep muscles strong.” Glucosamine chondroitin and fish oil are two examples. Simple mobility aids – such as harnesses that the pet can wear all day – can help older pets get around, even up and down stairs. “Some owners whose pets have trouble getting up stairs choose to keep them downstairs all the time. But giving them that little bit of aid – a harness – allows their pet to be more mobile, which helps muscle mass.” “If it’s a puppy, you look for puppy problems. If it’s a senior pet, there are many more possible problems, and you have to ask the client many more history questions.” with arthritis, and you have a pet who wants to get up and go, Accommodating older pets means outfitbut whose back end won’t. The ting the veterinary practice accordingly. muscles weaken. So you have the Because of its patients’ special combination of bones, muscles and needs, Twin Cities Animal Rehanerves all getting older and weaker. bilitation and Sports Medicine Clinic “And these guys look embarfeatures high-traction flooring and rassed,” she says, speaking of soft padded treatment mats, and some of her older canine patients uses oils and psychoacoustically whose feet have slipped out from designed music to calm and relax under them. (“The kitties tend to pets during treatments and exams. hunker down and look at you and Its staff offers a wide range of thernot move, rather than embarrass apeutic modalities, including hydrothemselves,” she adds.) Owners therapy, laser and ultrasound theracan do the older pets a favor by py, manual therapies, acupuncture, fixing them up with a bottoms-up electrical stimulation and more. – Dr. Kate Crumley leash, that is, one that offers supThough these treatments are availport to the rear legs, she says. able for patients of all ages, they are Hygiene is important too, particularly when older particularly critical for the older pet, who may not be able pets are involved, says Crumley. They may be incontito tolerate pain medications as well as their younger counnent, which challenges the hospital staff to keep surterparts, says Tomlinson. roundings clean. “Sometimes it’s fecal incontinence, “We have a lot more mats, to provide traction,” says which can be very embarrassing for the dog.” Safety Crumley. Older, arthritic pets aren’t as mobile as their is another concern for older pets. “We need to make younger counterparts. Their joints hurt, and they may sure we isolate the young, rambunctious, wild ‘chilneed something to help them stand up. “The other dren’ from the seniors, so they don’t get knocked over thing is, their nervous system ages; they’re not nearly or annoyed.” as agile and nimble on their feet. You put that together 60 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com U-40 insu lin syringes available for diabe te mellitus s in both do gs and cats Practices may have to augment their inventory with new equipment and/or supplies to accommodate procedures for the senior pet. “When I came out of school, it was pretty rare to see blood pressure measurements taken; now it is very common,” says Crumley. In fact, it’s something for which the American Animal Hospital Association has standards. Furthermore, surgery is an option for older pets, something that wasn’t always true in years past. But it’s an option that some owners delay as long as possible. A former pet might have had a bad experience with anesthesia years ago, or maybe a friend or neighbor shared an anesthesiarelated horror story. Such fears are ungrounded today. “I have a couple dozen different anesthesia protocols,” which can be tailored to the individual pet, her age, and her medical condition, says Crumley. “So, just because the pet has heart disease or kidney disease doesn’t mean she has to spend the rest of her life with a toothache.” Some teeth can get so bad, the pet’s jaw breaks. That could be because the owner is unaware of how much pain his or her pet is in, or because they want to avoid anesthesia and surgery. Surgery isn’t the only option for the older pet in pain or discomfort. Therapeutic laser, chiropractic care, acupuncture, massage and stem cell therapy are all options accessible to the general practitioner. Simply taking the time to talk to the owner about their pet’s nutrition and weight can help, though such discussions must be handled delicately. www.vet-advantage.com • Veterinary advantage «« July/August 2014 61 »» Trends Older Pet Care Considerations Area of concern Description Increased veterinary care Geriatric pets should have semi-annual veterinary visits instead of annual visits so signs of illness or other problems can be detected early and treated. Senior pet exams are similar to those for younger pets, but are more in depth, and may include dental care, possible bloodwork, and specific checks for physical signs of diseases that are more likely in older pets. Diet and nutrition Geriatric pets often need foods that are more readily digested, and have different calorie levels and ingredients, and anti-aging nutrients. Weight control Weight gain in geriatric dogs increases the risk of health problems, whereas weight loss is a bigger concern for geriatric cats. Parasite control Older pets’ immune systems are not as healthy as those of younger animals; as a result, they can’t fight off diseases or heal as fast as younger pets. Maintaining mobility As with older people, keeping older pets mobile through appropriate exercise helps keep them healthier and more mobile. Vaccination Your pet’s vaccination needs may change with age. Talk to your veterinarian about a vaccination program for your geriatric pet. Mental health Pets can show signs of senility. Stimulating them through interactions can help keep them mentally active. If any changes in your pet’s behavior are noticed, please consult your veterinarian. Environmental considerations Older pets may need changes in their lifestyle, such as sleeping areas to avoid stairs, more time indoors, etc. Disabled pets have special needs which can be discussed with your veterinarian. Reproductive diseases Non-neutered/non-spayed geriatric pets are at higher risk of mammary, testicular, and prostate cancers. Source: American Veterinary Medical Association, https://www.avma.org/public/petcare/pages/caring-for-an-older-pet-FAQs.aspx 62 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Arthritis pain questionnaire: Does your pet have signs of arthritis? Editor’s note: Clients of Twin Cities Animal Rehabilitation and Sports Medicine Clinic, Burnsville, Minn., are asked to print off the following questionnaire from the website and bring it to the clinic at the consultation, so the doctor can better understand the pet’s needs and disabilities. Thanks to Julia Tomlinson BVSc, MS, PhD, DACVS, CCRP, CVSMT, for allowing Veterinary Advantage to reprint the questionnaire. In general, how do you rate your pet’s health? ___Excellent. ___Very good. ___Good. ___Fair. ___Poor. Has your pet ever seen a veterinarian because of joint pain, stiffness or limping? ___Yes. Details________________________ ___No. Living with pain can lead to changes in behavior. This can be hard to read in a pet. On average, would you say your pet is (choose one): ___Completely uninterested in their surroundings, sleeps all the time. ___Will show interest, but no longer comes to greet you. ___Mostly interested in life and food, but reluctant to play. ___Plays only when encouraged, and not for long. ___Has had no change in personality. Does your pet have pain, swelling, warmth or stiffness in one or more legs? ___Yes, in one joint. ___Yes, in a few joints. ___Yes, in many joints. ___No. Has your pet had a joint or bone injury or a surgery? ___Yes. (Describe) ____________________ ___No. ___Unsure (e.g., adopted). Did your pet’s signs begin slowly or suddenly? ___Slowly, over the course of months. ___Suddenly, within days or a few weeks. In the morning, are the affected areas stiff for more than half an hour? ___Yes. ___No. ___There’s no morning stiffness. On any given day, how long does the joint stiffness usually last? ___Less than 30 minutes. ___30 minutes to 1 hour. ___More than 1 hour. Has the joint pain suddenly gotten worse within the past few weeks or days? ___Yes. ___No. Which of the following methods do you use to manage the pain, swelling or stiffness? (Check all that apply.) ___Physical activity/exercise. ___Nutritional supplements (fish oils, vitamins). ___Weight management. ___Physical therapy/chiropractic/massage ___Cold or hot treatment. ___Prescription medication. ___Over-the-counter joint supplements. ___Other (please specify): _________________ ___None of the above. Which over-the-counter medication and/or joint supplements do you currently use? (Check all that apply.) ___Aspirin. ___Glucosamine human medication (brand)________________ ___Veterinary joint supplement (brand)_______________ ___Herbal supplement (brand) ____________________ ___Other ______________________ ___None of the above Does your pet have any of the following conditions? (Check all that apply.) ___Kidney disease. ___Liver disease. ___Lung disease. ___Cardiovascular disease. ___Skin disease. ___Active infection. ___Bladder problems. ___Other. ___None of the above. www.vet-advantage.com • Veterinary advantage «« July/August 2014 63 »» Trends Heartworm diagnosed by 75 percent of veterinarians Preventives identified as key to stemming incidence Three out of four veterinarians in the Trends and factors United States diagnosed patients with heartworm in 2013, and heartworm-positive pets were reported in every state in the country, according to the latest Heartworm Incidence Survey conducted by the American Heartworm Society. And while weather conditions favorable to mosquito proliferation and transport of infected dogs were viewed as contributing factors, client compliance in giving heartworm preventives was identified as key in reducing incidence. Veterinarians from the Gulf and Mississippi Delta states reported the highest incidence rates of heartworm disease in dogs in the country, but relatively high rates were also noted in areas less well known for heartworm risk. These included the Upper Midwest (especially Michigan, Illinois, Indiana and Ohio), and the western states of Arizona and California. Sixty percent of veterinarians said that the incidence of heartworm disease in their practice areas had held steady since the last AHS survey was conducted three years ago. A roughly equal proportion of veterinarians said that incidence was up (19 percent) and down (21 percent) in their practice areas. One-third of veterinarians stated that heartworm is either a significant disease problem (18 percent) or one of the most serious diseases affecting their patients (15 percent). Just over half reported they see heartworm cases “occasionally,” while only 13 percent said they never see heartworm-positive patients. Top ten states The top ten states in average rate of heartwormpositive cases/clinic in 2013 were: 1. Alabama. 2. Louisiana. 3. Mississippi. 4. Texas. 5. Arkansas. 6. South Carolina. 7. North Carolina. 8-9. Tennessee and Georgia (tie). 10. Florida. The AHS survey has been conducted every three years since 2001 in order to track trends in heartworm incidence and inform the veterinary profession and public about the need for heartworm prevention. The latest survey, which was fielded in March 2014, represented 2013 testing data from 3.5 million patients from more than 4,300 veterinary clinics and shelters. “Our survey determined that heartworm disease continues to be widespread in many parts of the country,” said AHS president Stephen Jones, DVM, in a statement. “The silver lining to this unwelcome news is that a simple solution is in the hands of veterinarians and pet owners: getting more pet owners to give their pets heartworm preventives year-round.” The Society recommends heartworm prevention 12 months a year and heartworm testing once a year. Seventy-two percent of veterinarians surveyed said they follow the AHS guidelines for prevention, testing and treatment. 64 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Veterinarians who witnessed an upward or downward trend in heartworm disease reported on multiple factors related to those trends: • Poor compliance by clients, defined as not administering preventives year-round or skipping doses, was the most common factor (61 percent) cited by veterinarians who witnessed an upward trend. An influx of infected rescue dogs to local areas was also noted by approximately 40 percent of veterinarians in this group. • Heartworm preventive lack of efficacy was not considered a major factor. Among the 19 percent of veterinarians who reported that heartworm incidence was up, less than 6 percent of these cited lack of efficiency as a factor. • Among veterinarians who noted a downward trend in heartworm incidence, the leading reason given was more pet owners administering preventives (74 percent), followed by improved compliance (63 percent). EVERY DOG, EVERYWHERE, deserves affordable heartworm protection. IVERHART MAX® (ivermectin/pyrantel pamoate/praziquantel) Chewable Tablets help your clients keep more dogs protected. Share the benefits of IVERHART MAX Chewable Tablets with your clients. • Proven active ingredients used by veterinarians for years • A more cost-effective option than comparable heartworm preventives that do not control tapeworms1 • Four convenient tablet sizes including an option for toy breeds • A satisfaction guarantee that veterinarians and their clients can be confident in TALK TO VETERINARIANS about IVERHART MAX Chewable Tablets and help protect more dogs today. All dogs should be tested for heartworm infection before starting a preventive program with IVERHART MAX Chewable Tablets. Use with caution in sick, debilitated, or underweight animals and dogs weighing less than 10 lbs. For oral use in dogs only. The safe use of this drug has not been evaluated in pregnant or lactating bitches. Self-limiting adverse reactions including lethargy, limpness, salivation, shaking, diarrhea, decreased appetite, licking lips, and belching were reported between 20 minutes and 72 hours following treatment. 91 of this publication. For full product See brief summary of safety and effectiveness on page XX insert, call 800-338-3659 or go to virbacvet.com. Reference: 1. Brakke Consulting, Inc. Market Research Survey, December 2013. © 2014 Virbac Corporation. All Rights Reserved. IVERHART MAX is a registered trademark of Virbac Corporation in the US. 7/14 14846 »» Trends Managing Expectations Practice managers discuss the future of veterinary medicine What are newly certified veterinary practice managers thinking about their future and that of veterinary medicine? Veterinary Advantage asked that question of several managers who recently earned the Certified Veterinary Practice Manager (CVPM) designation through the Veterinary Hospital Managers Association. Following are edited responses from four. Trisha Jones, CVPM, hospital administrator, Raintree Veterinary Center and Olympia Pet Emergency, Hoquiam, Wash. Veterinary Advantage: How long have you been in veterinary medicine? Trisha Jones: Since June 1999. Veterinary Advantage: What are the greatest challenge(s) facing you and the veterinary profession in the years ahead? Jones: My greatest challenge will be to continue to grow with the industry and help my team understand the changes we need to make to practice better medicine, increase client service compliance, and keep the business healthy. These are particular challenges that all hospital managers face as we want our hospitals to grow and provide the best care to our patients. A challenge for the profession is to help clients better understand why higher quality medicine is best for their pets. Often our recommendations are more than the pet owner would like to spend in a visit. We are continually looking for new ways to make great pet healthcare affordable to our clients and hospital. It is challenging to offer top-of-the-line medicine and keep the hospital profitable to industry standards. Veterinary Advantage: What are the greatest opportunities for you and the veterinary profession? Jones: There are opportunities to help my team grow with so much education available. I think organizations such as AAHA, VHMA and IDEXX (and there are many more) are extremely beneficial to the hospital’s growth. They provide 66 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com us with many tools. The challenges we face with pet owner compliance are constantly being researched, and the industry provides us with tools to try to make the situation better. I think new programs like “Fear Free” and becoming a Cat Friendly Practice are big opportunities too. The more we show pet owners we truly care, the more compliance we will gain. Veterinary Advantage: What are the practice manager’s expectations of veterinary distribution reps? How can reps be of value to practice managers and veterinary hospitals? Jones: I have some fantastic reps that we work with at both hospitals. I think it is very beneficial when the vendors listen to our needs to make ordering streamlined and more costeffective. I have a particular MWI rep that I can ask for help pricing, searching for equipment or any type of inventory our hospital needs; he is very quick to respond. That is huge time-saver for me as the manager. Also, the education they provide for products and services is enormously valuable. When we bring in a new product, or are looking at a new product or equipment, I want my entire team engaged, and team training is an important piece of that. Tiffany Colton CVT, BASVT, CVPM, operations manager, Oakhurst Veterinary Hospital, Seminole, Fla. Veterinary Advantage: How long have you been in veterinary medicine? Tiffany Colton: Fourteen years. Veterinary Advantage: Your responsibilities at Oakhurst? Colton: I oversee the “operations” side. I do inventory, staff scheduling, chart reviews, training protocols, marketing, social media, monthly promos, community involvement, mentor for interns and several other tasks. Veterinary Advantage: What are the greatest challenge(s) facing you and the veterinary profession in the years ahead? Colton: I think the biggest challenge is trying to keep services offered at an affordable rate for clients while still managing to grow profit for the hospital. We continue to provide the best and most current medicine that we can for our patients, but unfortunately, costs continue to grow as well. Personally, my biggest challenge is that I want to continue to learn new things in the business side of veterinary medicine. Veterinary Advantage: What are the greatest opportunities for you and the veterinary profession? Colton: There is always an opportunity to grow. There are always new services that can be added, new medications being introduced to the market, and new products that may benefit our patients. Veterinary medicine, like human medicine, is always changing and developing. Veterinary Advantage: What are the practice manager’s expectations “I personally appreciate it when a rep lets me know about a similar product that may be more costeffective than a product that I order frequently, or when they have ideas that may help lower our cost of sales. I like to feel that they are ‘connected’ with our practice instead of just seeing us as a ‘weekly order.’” – Tiffany Colton CVT, BASVT, CVPM, operations manager, Oakhurst Veterinary Hospital, Seminole, Fla. of veterinary distribution reps? How can reps be of value to practice managers and veterinary hospitals? Colton: We want the reps to be honest with us. We like to have information on the most current changes to medications, products, diets, etc. We appreciate being told ahead of time if a product will be on backorder, short supply or a price increase. We like the reps who want to help build staff morale and contribute things to our staff. I personally appreciate it when a rep lets me know about a similar product that may be more cost-effective than a product that I order frequently, or when they have ideas that may help lower our cost of sales. I like to feel that they are “connected” with our practice instead of just seeing us as a “weekly order.” www.vet-advantage.com • Veterinary advantage «« July/August 2014 67 »» Trends Eric Young, CVPM, practice manager, Minooka (Ill.) Animal Hospital Veterinary Advantage: How long have you been in veterinary medicine? Eric Young: Eight years as a manager. Before that, I worked at an animal shelter while in college for four years. Veterinary Advantage: What are the greatest challenge(s) facing you and the veterinary profession in the years ahead? “Our expectations of the reps are to keep us informed and educated on current and new products that are offered by their company, and be our advocates for the challenge of astronomical price increases that sometimes occur.” Veterinary Advantage: What are the greatest opportunities? Young: I think the greatest opportunities lie in the potential to take advantage of advances in technology, veterinary equipment, and medical abilities and techniques. Veterinary Advantage: What are the practice manager’s expectations of veterinary distribution reps? How can reps be of value to practice managers and veterinary hospitals? Young: Our expectations of the reps are to keep us informed and educated on current and new products that are offered by their company, and be our advocates for the challenge of astronomical price increases that sometimes occur. They can truly be of value by providing us with tools to educate and reward staff, and ensure competitive pricing. – Kipp Wingo, DVM, CVPM Young: The greatest challenge facing me is to keep up with the technological advances and improvements of the rapidly changing veterinary industry. I think the greatest challenge facing the veterinary profession as a whole is to keep the industry growth in line with increasing costs of pharmaceuticals, veterinary equipment, and rising inflation. Kipp Wingo, DVM, CVPM Veterinary Advantage: As a DVM, why did you decide to pursue certification in practice management? Kipp Wingo: I received excellent training in veterinary medicine and surgery from Texas A&M University. However, I was not prepared/trained to run a business. After 20+ years as a mediocre entrepreneur, the changing world rather forced me to study and, hopefully, improve. I came to believe that a veterinary entrepreneur has two equal job descriptions. The emphasis must be placed on “equal,” meaning that superior patient care is EQUAL to superior business practices management. In addition, the radical and ongoing changes in the world of business dictate either I learn to lead and manage effectively, or face potential failure. I will not accept failure. I also found the process of preparing for CVPM certification quite enjoyable. 68 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Veterinary Advantage: What are the greatest challenge(s) facing you and the veterinary profession in the years ahead? Wingo: In my opinion the veterinary entrepreneur faces several challenges: The income we’ve all enjoyed from our pharmacy is shrinking and will continue to do so. We face the “WalMart” bill, Internet pharmacies, low-cost generics from chain pharmacies, big-box retail outlets selling veterinary products, etc. Our clients now view veterinary products as a commodity, and therefore those products have nothing to do with loyalty. The veterinary entrepreneur must adjust strategies to deal with this loss. Increasing competition from the “not-for-profit” and “low-cost” spay and neuter clinics, parking lot vaccine clinics, practices in pet stores. Most clients equate all services as equal, therefore, they very often will utilize the lowest cost service. The challenging economy has also forced the low-cost spay/neuter clinics to start dispensing veterinary products. These not-for-profit and low-cost organizations are threatening income to privately owned, tax-paying, jobcreating veterinary practices. The biggest challenge faced by the veterinary entrepreneur is the slow recovery from the “Great Recession.” It is true that the average income of the middle class has decreased; therefore, there is less discretionary income to be spent on behalf of pets. We must face the fact that we are in competition for discretionary or disposable income. The availability of less discretionary income leads to fewer patient visits, sticker shock, and product and procedure price shopping. (This is a driving force for the competition mentioned above.) To meet this challenge, many practices have decreased fees or, more often, have delayed increasing fees; or the fee increases have not been sufficient to keep up with the ever-increasing expenses. Ultimately, the inevitable sequella is decreased profit. A decrease in profit leads to many, often insurmountable, challenges. Contrary to the belief of some, profit is not evil. Profit pays doctors and supports team salaries, continuing education expenses, equipment purchases, taxes, etc., etc. Veterinary Advantage: What are the greatest opportunities? Wingo: The challenges from the above have lead to many wonderful opportunities. To protect pharmacy-related income, the selection of FDA-approved veterinary drugs rather than human generic drugs should be considered. When appropriate, injectable medications should be offered. Often, even when considering an equivalent drug, one realizes superior results due to elimination of the need for client compliance. As a benefit, those products are not available on Internet sites. If the veterinary entrepreneur is to survive, then more advanced medical and surgical procedures must be added to our repertoire. Low-cost spay/neuter/vaccine clinics are very unlikely to offer cutting edge procedures such as advanced dental procedures, arthroscopic/laparoscopic surgery, advanced ultrasonography, alternative medicine, etc. One must choose a marketable advanced discipline(s), then train, train and then train more. The attitude should be, “We must be better (have better skill) than the typical parking lot practitioner.” The shrinking economy requires that the veterinary entrepreneur’s leadership and management abilities be intensively and continually finely tuned. When one focuses their studies on leadership and management, opportunities such as improved profit will lead to improved patient care, a happier client and a happier team – all of which is a win-win situation. Veterinary Advantage: What are the practice manager’s expectations of veterinary distribution reps? How can reps be of value to practice managers and veterinary hospitals? Wingo: Sales representatives can be of the most value to practices and practice managers by striving to achieve a “partnership” with the practice managers. The relationship should be more of a symbiotic relationship as opposed to a salesperson/customer relationship. By helping the practice be profitable, the sales rep and their company then becomes profitable. Sales reps should disseminate information (educate). Effective sales reps should know their practices well enough to inform them of programs/products that suit the particular and unique needs of said practice. Visits to the practice should be by appointment only; otherwise, an unacceptable disruption of flow will ensue. If the rep has a desire to meet with a/the doctor, then an appointment should be required. In other words, don’t simply show up unannounced and disrupt my work. www.vet-advantage.com • Veterinary advantage «« July/August 2014 69 »» Partners for Healthy Pets Words that Work The best messages about preventive care are simple and to-the-point, says Karyn Gavzer Karyn Gavzer believes in the power of consistent, simple messages. She believes that words work. Gavzer is a veterinary practice management consultant who has helped industry, associations, and veterinary practices develop marketing and training programs for more than 20 years. She is the former director of marketing for the American Veterinary Medical Association, where she worked with industry on behalf of the AVMA to bring the first campaigns on heartworm awareness and “Pets Need Dentistry, Too” to the public. She currently speaks around the country on behalf of Partners for Healthy Pets, a collaboration of the American Veterinary Medical Foundation, AVMA, American Animal Hospital Association and industry to ensure pets receive preventive healthcare through regular veterinary visits. 70 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Her interest in prevention dates back more than 10 years, when the American Animal Hospital Association released “The Path to High Quality Care,” or what came to be known as the compliance study. At that time, veterinary products manufacturers challenged practitioners to demonstrate that their clients were as compliant with preventive-health recommendations as practitioners thought they were. Funded by industry, the AAHA undertook a medical records study to find out. It was the first of its kind in veterinary medicine. Eye-opener The results were eye-opening for the veterinary community. “It said that we are wildly inconsistent in delivering preventive healthcare,” she says. While most veterinarians believed that a high percentage of their clients complied with their recommendations, in fact, the study showed many did not. It was an eye-opener for Gavzer. “That’s when I woke up and got really passionate about the possibilities of preventive care. There is nothing veterinarians will do to impact the health and well-being of pets more than provide preventive care.” She went on the road on AAHA’s behalf to talk to practices about compliance and to challenge them to audit their medical records to help them see – by the numbers – the difference between their recommendations about care, and what their clients were actually doing. “We talked about setting protocols for care, and suggested those protocols be set up around preventive measures,” she says. Those measures would include the number of pets on heartworm preventives and flea/tick preventives, the number of pets who receive core vaccines, the number of pets who receive regular dental check-ups, and more “Significant progress has been made,” says Gavzer. But the road hasn’t been smooth and the work is not done. Partners for Healthy Pets provides tools and resources for practitioners to use to communicate the value and benefit of preventive care, enhance the veterinary-client relationship, and improve the overall quality of preventive healthcare provided for patients. These tools include surveys to help practices gauge their level of client service and satisfaction; guidelines to implementing AAHA/AVMA canine and feline preventive healthcare guidelines; tools to create Internet and social media marketing programs; training videos and more. In December 2013, Partners for Healthy Pets launched a consumer advertising campaign promoting the importance of annual veterinary checkups. TV viewers, magazine readers, Facebook and Twitter users, and clients bringing “There is nothing veterinarians will do to impact the health and well-being of pets more than provide preventive care.” A vision of improved health “Things came undone in 2008, when the recession hit,” she says. Veterinarians were practicing excellent medicine, but client visits dropped. In response, the veterinary community asked their national associations – AAHA and AVMA – to develop a campaign to urge pet owners to bring their pets in for regular preventive care – something the dental community had done successfully three decades earlier. They did so, with the help of industry partners, and Partners for Healthy Pets was born. Led by the AVMA and the AAHA, with support from industry, Partners for Healthy Pets is a collaborative alliance of over 110 veterinary associations, colleges of veterinary medicine and animal health companies, all committed to a vision of improved overall health for pets. their pets in for veterinary care are now seeing photos of Henley and Oz – the dog and cat featured in the ads – with a simple tag: “Special Instructions. Feed daily. Yearly checkups. Love forever.” The message is simple and consistent: An annual visit to the family vet is as essential as food and love. Practices need to get involved Though it is essential that pet owners get the message, it won’t happen without the involvement of veterinarians and their practice teams, says Gavzer. Studies show that many veterinarians don’t fully buy into the importance of preventive medicine themselves, she says. They and their hospital team members fail to do the things for their own pets that they recommend their clients do. Many also feel guilty about how much money it costs to take care of a pet today. “Clients pick up on that lack of confidence,” she says. www.vet-advantage.com • Veterinary advantage «« July/August 2014 71 »» Partners for Healthy Pets Prepaid wellness plans Prepaid wellness plans offer clients an affordable way to make sure their pets get the preventive care they need, says veterinary practice management consultant Karyn Gavzer. Such plans spell out upfront the preventive care the pet will need for the next 12 months, and allow the client to pay for that care in affordable monthly payments. Most plans include unlimited office visits, which often is all it takes to get a hesitant owner, who may be fearful of high bills, to visit the office regularly. “It’s a plan that fits the times we live in,” she says. Even so, annual wellness plans haven’t worked well in some veterinary medicine. “Some were so complicated, that the clients didn’t understand them, and the staff couldn’t explain them. You have to make them simple, and train staff on how to talk to clients about them.” What’s more, some pet owners confuse wellness plans with insurance, she adds. Again, the onus is on the veterinary practice to educate owners. “They need to say, ‘Wellness plans are great, because you know you will use them; and insurance is good for those catastrophic events that you can’t predict.’” Gavzer has been a proponent of breedspecific wellness plans, that is, plans that take into account the unique needs of various breeds. Goldens, for example, are prone to cancer and dysplasia; other breeds to blindness or Cushing’s. Veterinarians can usually explain the unique wellness needs of young, adult and senior pets, but they have an opportunity to take it a step further and tailor wellness plans by breed. “Practices that do are giving pet owners something they can’t get anywhere else,” she says. 72 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Despite challenges, the message of prevention is taking hold. Roughly 5,000 practices are participating in the Partners for Healthy Pets campaign, and the number is growing. Some veterinary schools are opening wellness clinics. “Until recently, there were no big opportunities for students to acquire those skill sets,” she says. Distributor sales reps can play a role as well in carrying the message of prevention, says Gavzer. Some ideas: • Help practices “re-boot” on Partners for Healthy Pets. Reps did a good job encouraging practices to enroll in the earliest days of the campaign. Since then, the program has introduced its toolbox and promotional materials. It’s time to re-energize practices and start encouraging them to use these tools, says Gavzer. “Perhaps it’s [illustrating] an easy way to explain prevention to a client, or how to make the ‘call to action’ to take the next step in their pet’s preventive care plan.” – Karyn Gavzer •H elp practices set goals (assuming the rep has established the kind of relationship that can allow that to occur); offer training programs associated with products or equipment that address preventive care. • Help them find the “words that work” to talk about prevention at the front desk, exam room, and throughout the practice. “Perhaps it’s [illustrating] an easy way to explain prevention to a client, or how to make the ‘call to action’ to take the next step in their pet’s preventive care plan,” says Gavzer. SponSorS SponSorS platinum SponSorS SponSorS SponSorS SponSorS platinum PLATINUM platinum platinum GOld platinum platinum SponSorS Silver GOLD GOld GOld GOld platinum GOld platinum platinum Silver GOld Silver SponSorS SponSorS Silver Silver brOnze GOld GOld GOld Silver platinum Silver Silver brOnze Silver brOnze brOnze brOnze GOld brOnze brOnze brOnze brOnze Silver brOnze SILVER BRONZE »» Sales Meeting Anesthesia Equipment Veterinarians are looking to provide safe anesthesia at a reasonable cost. By understanding the needs of their clinics, sales reps can help them do so. Each veterinary clinic has a unique set of needs with respect to the layout and design of its surgical and treatment areas. The right configuration of anesthesia machines depends on a clinic’s workflow. By knowing the types of procedures performed, how oxygen will be supplied, how waste gas will be disposed of, and what monitoring and other peripheral equipment (e.g., dental carts) will be used in the care zone, reps can help their customers evaluate their options. So, for instance, an anesthesia machine designated primarily for use in a treatment room may need to be used at several treatment tables. If the oxygen is centrally supplied through outlets, and hoses and floor space are at a premium, then a compact tabletop unit may best meet that clinic’s needs. Or, if oxygen is supplied by a small e-tank, a rolling stand with a single or double yoke block to hold the oxygen tanks may be the answer. Improvements in quality, enhanced patient safety Today’s anesthesia machines are better and safer than ever before. Enhancements in technology may include: • A negative pressure relieve valve, which provides room oxygen to the patient when, in rare cases, the oxygen source is completely depleted. • Occlusion valves, which have made it possible for veterinarians to close the APL valve (used to manage excess waste gas) with the touch of a button. In the past, they had to turn a dial to close the valve and then remember to open it to avoid over-pressurizing the machine and putting the patient at risk. There have been improvements in anesthetic protocol as well, and more veterinarians have come to realize the importance of monitoring capnography during a procedure to determine the level of carbon monoxide in the patient’s expired breath. Still, a number of factors, such as the condition of the anesthesia equipment, the staff’s expertise or the age and condition of the patient, can contribute to the degree of risk 74 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com ONE SMALL VIAL FOR ANESTHETIC INDUCTION. ONE GIANT LEAP FOR ANESTHESIA. SMOOTH INDUCTION PREDICTABLE TRANSITION EXCELLENT MUSCLE RELAXATION RAPID ELIMINATION RAPID ONSET WIDE SAFETY MARGIN MINIMAL SYSTEMIC EFFECTS CLEAR-HEADED RECOVERY Introducing Alfaxan (alfaxalone 10 mg/mL) ® A new choice in companion animal anesthetic has landed. Offering smooth, predictable results for all surgical interventions in your practice, Alfaxan® helps to support a stress-free anesthetic procedure for clinic staff as well as repeatable, reliable induction, transition, maintenance and recovery for their patients. That’s why it has become the induction agent of choice for many veterinarians around the world. It is one small step that you can take to introduce a new level of care into your anesthesia protocols. Contact your distributor sales representative or Jurox at 1-844-ALFAXAN to learn how your practice can benefit from this innovation in anesthesia. INDICATIONS: Alfaxan® is indicated for the induction and maintenance of anesthesia and for induction of anesthesia followed by maintenance with an inhalant anesthetic, in cats and dogs. Important Alfaxan® Risk Information: Warnings, Precautions and Contraindications: When using alfaxalone, patients should be continuously monitored, and facilities for the maintenance of a patent airway, artificial ventilation, and oxygen supplementation must be immediately available. Alfaxan® does not contain an antimicrobial preservative. Do not use if contamination is suspected. Strict aseptic techniques must be maintained because the vehicle is capable of supporting the rapid growth of microorganisms. Careful monitoring of the patient is necessary due to possibility of rapid arousal. Alfaxan® is contraindicated in cats and dogs with a known sensitivity to alfaxalone or its components, or when general anesthesia and/or sedation are contraindicated. Adverse Reactions: The most common side effects of alfaxalone include respiratory and cardiovascular derangements, such as apnea, hypotension and hypertension. Appropriate analgesia should be provided for painful procedures. Repeatable. Reliable. Relax. www.alfaxan.com (alfaxalone 10 mg/mL) »» Sales Meeting involved in sedating animals. Veterinarians can reduce the level of risk to the patient by developing a patientspecific anesthetic protocol, as well as providing appropriate vital signs monitoring. They can also minimize post-anesthetic risks by monitoring patients with a vital signs monitor designed to measure parameters such as blood pressure, temperature and oxygen saturation in the blood. Other products that can aid veterinarians in their patients’ recovery include fluid pumps and patient warming devices. medical tape is not sufficient to prevent waste gas expired by the patient from leaking into the clinic. A return on investment As important as it is to replace outdated anesthesia equipment, some veterinarians may be reluctant to make the investment. Sometimes, they may not recognize the increased risk the outdated equipment is placing on the patients and staff. In this case, sales reps can help the clinician identify unnecessary expenses his or her practice is incurring due to wasted oxygen or anesthetic agent, or some other factor. Reps can also focus on the return on investment associated with new anesthesia equipment. Similarly, when a veterinarian is considering expanding his or her clinic, sales reps can discuss the potential for increased revenue that a new anesthesia machine could bring. The ability to perform more procedures means additional revenue for the clinic. There have been improvements in anesthetic protocol as well, and more veterinarians have come to realize the importance of monitoring capnography during a procedure to determine the level of carbon monoxide in the patient’s expired breath. Although cost is almost always a factor for your customers, when it comes to selecting quality anesthesia equipment, veterinarians get what they pay for. Machines range in price from $2,100 to $6,800, depending on the types of accessories needed and the level of sophistication required for measuring oxygen and anesthetic agents. Higher priced units generally are constructed of high quality materials that last longer and are less likely to leak, according to experts. And, they often include safety features, technical support and compliance to International Organization for Standardization (ISO) manufacturing standards. Price aside, a well-maintained machine can last many years. Still, when veterinarians continue to use worn or outdated anesthesia equipment, they risk the safety of their patients and staff. It’s important for them to know that covering holes in breathing circuits with porous Some good probing questions reps may ask their veterinarian customers to initiate a discussion about anesthesia equipment include the following: • “Doctor, what types of procedures do you typically perform?” • “Do you find yourself doing more or less of these procedures? Why is that?” • “Have you noticed abnormally high oxygen or anesthetic agent use? If so, would you like me to perform a leak test on your anesthesia equipment?” Even if a leak test does not reveal issues with the veterinarian’s anesthesia equipment, the rep has proven himself or herself that much more valuable to the clinic. What better opportunity than to help customers improve the safety of their patients and staff, while generating additional revenue for their clinic? Editor’s note: Veterinary Advantage Magazine would like to thank Midmark Corp. for its assistance with this piece. 76 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com OUR SUTURES come in MANY BREEDS That’s why VPL Sutures are the reliable and affordable choice for every type of closure. From short-term to mid-term to long-term tissue healing requirements, veterinarians who use VPL Sutures know they can count on easy handling, excellent knotting performance, and outstanding wound support. In fact, for high quality versatile options at a fair price, VPL Sutures are simply a different breed. Monomend® ST Short-term synthetic absorbable monofilament. Made of glyconate for excellent pliability and easy tissue passage. Monomend® MT Mid-term absorbable monofilament for patients that have predictable wound healing. Made of glyconate for easy tissue passage and secure knotting. Monomend® MaX Long-term absorbable monofilament for patients with compromised wound healing. Supple for smooth tissue passage, and easy to knot. A SPECIAL OFFER FOR YOUR VETERINARY ACCOUNTS. April 1 through June 30, 2014. Veterinary clinics receive a FREE box of VPL Sutures for every 6 boxes purchased, mix-and-match, equal or lesser value. ©2014 Veterinary Products Laboratories 14-0060 Polymend® MT Mid-term synthetic absorbable braided suture. Holds through critical wound healing period, and then is rapidly absorbed. »» Equine By Jennifer Ryan Cell by Cell Recovery Equine veterinarians are increasingly using stem-cell therapy to help repair bone, ligament and tendon injuries Preston Hickman, DVM, has tried several different from the tail head area. The sample will be processed to concentrate the stem cell technologies in some of his performance horse patients from bone marregenerative cells. Then, the horse will row derived stem cells to various methods of processing adipose (fat) into stem be sedated again while the stem cells cells. However, he wasn’t overly impressed with the results. are administered to the affected areas. There are two avenues for veterinarians wanting to in“We thought it would open up new frontiers by utilizing clude stem-cell therapies in their equine practice: They can regenerative medicine, but after my first few stem cell treatinvest in the equipment and individual kits to harvest, isolate ments using available processes, I didn’t see the dramatic and activate the stem cells; or they can harvest adipose tisimprovement that I was expecting,” recalls Dr. Hickman, sue and send the samples to a central lab for stem cells to owner of Wichita Equine and Sports Medicine in Wichita, be isolated. Therapeutic doses are then mailed back. Kan. “I was a skeptic.” In either case, the horse’s Then, Dr. Hickman encountered Zoe, an advanced level own cells must be collected. dressage horse with a two-year history of lameness and Then, a patient-specific theraa fractured sesimoid. After many other conventional treatpy must be developed. The rements failed, he again turned to stem cells. This time he sulting therapy is best targeted tried a different method from MediVet-America that used for tendons, ligaments and adipose – or fat – adult stem cells collected from the patient. bone fractures. However, re“About 50 days later, she was sound and the owner was back search into laminitis treatment on the horse,” he says. “I thought, ‘this has got to be a fluke.’” is also being pursued and iniNearly two years later, Dr. Hickman has treated some 85 Jeremy Delk tially appears to be effective. horses with this type of activated stem-cell therapy and has Some horses receiving stem cell therapy are perforseen a positive response in every case. It’s been enough to mance horses. Unlike some drugs, there are no restrictions convince him of the value of the technology. by competitive organizations on using stem-cell therapy. It’s not considered a performance enhancement to repurpose The process the body’s own cells. Stem cells are essentially undifferentiated cells waiting to turn into specific cells such as skin, fat, muscle, bone or cartilage. Adult stem cells (such as from fat) can differentiate into most The investment cell lines with proper stimulation. Only adult stem cells from MediVet America, LLC, has developed a kit to allow veterithe horse being treated are used in equine stem cell therapies. narians to develop therapies in their own clinics. The comIt takes a large number of adult stem cells to help heal pany works with Henry Schein Inc. and Patterson Veterinary an injury, which is why fat cells are often used. Fat has sevSupply to distribute kits to veterinarians across the country. eral hundred times higher concentrations of stem cells than “We have developed the technology to allow the veteribone marrow or blood and is much less invasive than bone narian to harvest, isolate cells and activate these dormant marrow aspiration. cells so they can re-introduce back into the patient, in real To collect fat stem cells, the veterinarian will sedate the time promoting repair and healthier joint environments,” horse and collect approximately two to four tablespoons of says Jeremy Delk, CEO of MediVet, based in Nicholasville, fat (40 grams) using liposuction or surgical incision, usually Ky. “By isolating, activating and re-injecting the body’s own 78 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com The Vet-Advantage Price Index Helping Veterinarians Optimize Retail Pricing This app helps animal hospitals properly price their retail products and recapture important, high margin business that may have been lost to online retailers and big box stores. It allows users to: • Evaluate pricing strategy and find the optimum price points • Look at historical pricing data on the largest retail SKUs • Set margins or margin dollars with a built-in calculator • Improve retailing practices with weekly tips on best practices This app takes the guesswork out of the retail business so vets can stay in the game and better manage this part of their business. It can be found in the Apple App Store at a price of $25. Vet-Advantage takes no role in establishing any of these prices and the information is representative of the market only as a reflection of products that are available in publicly published Internet pricing. Volume discounts from certain sources may/may not be represented depending on how such discounts are presented to search engines used to gather consumer pricing. Now available at the app store »» Equine repair properties, we are just aiding in the fight of degeneration vs regeneration, by isolating these cells in high numbers and maintaining high viability.” Available since 2010, the MediVet kit includes enzymes and consumables. These kits allow an in-clinic solution for nearly half the cost of utilizing laboratory processing through the mail. The equipment offers a small footprint with minimal investment and on-site installation. “We wanted to be able to make this more effective, but more commercially viable and affordable,” Delk says. “What we try to do is take a conservative approach. Stem cells are not a panacea, although when good case selection is practiced they can offer a truly revolutionary tool in the veterinary tool box. The future is very bright, and we continue to draw from the research.” The future Current commercial equine therapies rely on adult stem cells derived from either bone marrow or adipose tissue. Sarah Reed, Ph.D., assistant professor of equine science at the University of Connecticut, is researching how umbilical cord stem cells may work in future therapies. Research shows umbilical cord stem cells are more like embryonic stem cells, which indicates their uses for equine therapies can be broader than adult stem cells. Specifically, future therapies might be able to recreate tendon cells and even produce collagen. “That’s one of the limitations with repairing tendon injuries,” Reed says. “When it repairs, it doesn’t repair like new. We did some comparisons and found umbilical cord stem cells really do differentiate more rapidly and tend Key points Robert J. Harman, DVM • Adult stem cells can differentiate into many cell lines. • Only adult stem cells are used safely in equine therapies. • The horse’s own cells must be collected for a patient-specific therapy. • Commercial therapy options rely on stem cells from adipose, or fat, tissue. • Stem cell therapy is best targeted for tendons, ligaments and bone fractures. • Research is progressing for the use of adult stem cells into many other equine diseases and injuries. Vet-Stem, Inc. also relies on adipose tissue to collect stem cells. In this model, the veterinarian collects the fat sample and then sends it to a central laboratory. The company returns therapeutic doses via FedEx within 48 hours of sample collection. There is less investment in equipment and training in this method, says Robert J. Harman, DVM, founder and CEO of the company, which is based in Poway, Calif. Vet-Stem also stores extra doses in case additional treatments are needed in the future. “It’s an exciting area that started 10 years ago, and it will be exciting to see where it will go in five more years,” Dr. Harman says. “I started in horses and at that time you couldn’t repair these injuries. You just kept getting scar tissue. When I saw the research on stem cells on the human side, it made sense to me as a natural healing mode.” Vet-Stem works with Animal Health International, Inc., to reach equine veterinarians. Distributors knowledgeable about the technology will be better positioned to grow as the technology is adopted, Dr. Harman says. 80 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com to produce higher amounts of collagen, suggesting they might be a better option.” However, drawbacks to using umbilical cord stem cells include access to the source material. The horse’s own umbilical cord must be collected during foaling, which would be years in advance of when an injury might occur. Despite research and commercial adoption, the specific mechanism by which adult or embryonic stem cells work still isn’t known. “We do know that the presence of these cells causes a slight immune response that attracts and secretes growth factors to the area, which tends to promote healing and increase cellular activity,” says Reed. “We don’t know what those growth factors are. What we do know is that when we inject the stem cell into the area, regeneration is improved, but it’s a big black box. We don’t have a good idea what actually these cells are doing and how they do it.” COMMUNITY People A passion followed Karen McGarrah uses the skills – and passion – she learned as a healthcare supply chain executive to help rescue horses Supply chain management is in her blood. So are horses. That could explain why, following a 32-year career in healthcare supply chain management, Karen McGarrah now spends most days working with rescue horses in southern California. Born in Columbus, Ga., McGarrah’s father was a purchasing agent for a large construction company that built dams in the Southeast. The family moved regularly until Karen reached the fourth grade, when they settled down in Alabama. She got her first full-time job at age 12 in order to pay for the upkeep of her horse. “My dad borrowed my first horse to see if I would take care of it,” she says. “He ended up buying it for me six months later. The rest is history.” Healthcare career McGarrah joined Baptist Health System in Birmingham in May 1981, as director of materials management for the hospital system’s Montclair facility. “Montclair was one of only four facilities in Baptist Health System at the time, and none of them had an internal materials management system,” Karen McGarrah and Marigold. she says. “I was the first person hired in the Baptist system. It was my role to provide internal structure and establish the foundation of materials management for Baptist to build the future internal materials system. This included creating an infrastructure of communications and a systemic structure of internal partnerships within the corporate headquarters.” Over the years, Baptist expanded in size, encompassing many more hospitals. McGarrah grew with the organization as well, ultimately becoming vice president of shared services. “We had a great time at Baptist,” she says today. “We were cutting edge, doing things others weren’t doing,” including innovative work with consultants medical/surgical distributors, and group purchasing organizations. “I am most proud of being the leader of a seasoned team of veterans who were recognized nationally for their innovation,” she says. “We had the full support of our CEO and senior vice president, and all of our accomplishments were as a team. We were the industry leaders of surgical innovations in addition to materials creation and functional areas. We established a company doing business locally for sterilized packs. www.vet-advantage.com • Veterinary advantage «« July/August 2014 81 COMMUNITY People Our laundry accommodated laundry for other facilities. We had an integumentary nurse for all our facilities. We had a PhD-prepared nurse who conducted all our clinical studies. We had a five-year strategic plan that was reviewed annually. We had so many things to be proud of as a team.” Supplier side of healthcare In January 1997, McGarrah jumped from the provider to the supplier side of the industry, joining IntePlex, a consulting company for Bergen Brunswig Corp., a national pharmaceutical and medical distributor. (The company’s medical unit was acquired by Cardinal Health in 2000. One year later, Bergen Brunswig Corp., the pharmaceutical wholesaler, merged with AmeriSource Health Corp. to form AmerisourceBergen Corp.) Preparing red meal buckets. IntePlex’s mission was to create a “one-stop shop” for hospitals, that is, a vendor that could bring both pharmaceuticals and medical supplies and equipment (product lines which, in the hospital supply chain, are traditionally carried by separate distributors). In 2000, McGarrah made another big career move, joining Broadlane, a healthcare group purchasing organization (acquired by MedAssets Inc. in 2010). “Group purchasing was something I had not done in the past and was the missing link in my resume. I felt it would be a great opportunity for me to learn the last piece of my total trade of supply chain.” In 2009, she became senior regional director for MedAssets Inc., a national group purchasing organization. 82 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com As such, she worked with senior vice presidents, regional directors of materials management and buyers, C-level executives, physician executives and others to promote use of the group purchasing contract portfolio and to drive savings for hospital participants. Then in September 2013, she switched gears. The switch While working for MedAssets (and living in Long Beach, Calif.), McGarrah began volunteering at Red Bucket Equine Rescue, which at the time was located in Huntington Beach. A 501(c) 3 corporation, Red Bucket was founded in 2009, one year after founder Susan Peirce rescued a starving thoroughbred filly from a run-down stable, whose manager stopped feeding her since he wasn’t being paid. Peirce bought 50 pounds of carrots and a red bucket, and fed the filly – whom she named Harlow – to health. In January 2009, she went to the same stable and found nine additional abandoned horses, one of whom subsequently died. Soon thereafter, she formed the non-profit organization. By May 2009, the rescue had grown from 9 horses to 71. As of May 2014, Red Bucket’s volunteer team had saved 249 horses and placed 131 of them in new homes. In September 2013, McGarrah made one more major life/career decision. “I left healthcare because I decided it was time for me to spend my life serving our Red Bucket horses, which has become my passion,” she says. “Volunteering is very rewarding, and I wanted to spend more time with the horses that I love so much.” (Roughly two years ago, Red Bucket moved to Chino Hills. McGarrah followed, and now lives about five minutes from the rescue.) Though she had left Alabama, years earlier, she never really left horses. In fact, she still owns a 60-acre farm in her home state, with 10 horses on it. “I have never been without a horse since I was a kid,” she says. She still gets back to the ranch three or four times a year. “Although I am in a volunteer position, I spend more time at the ranch than I spent on the job, and I spent a great deal more than 40 hours a week working,” she says. “I am at the ranch seven days a week working with the horses and volunteers. I am probably in the best health of my life. The ranch is 4.3 acres, and I walk it from end to end many times per day. “The horses we serve come to us abused by humans and have no reason to ever trust humans again. The mission of Red Bucket is ‘To save and rehabilitate horses, restore their trust in humankind, and find them safe, loving, permanent, adoptive homes.’ This is what we do every day. What is more worthy of my time and talent than this mission in life?” As volunteer ranch coordinator, McGarrah manages all ranch maintenance and projects, including: • Managing the volunteers for special ranch projects, stable service day, ranch care, cleaning of feed buckets, polo wraps, stall pipes, Sunday stall cleaning, water buckets, store rooms, painting, and overall ranch repair. • Managing vendors and volunteer specialists, such as electricians, plumbers and ranch care donations. • Helping keep the ranch clean. • Helping repair items for horses. • Supporting the overall maintenance, bedding, water bowls, and safety of the Red Bucket horse stalls. • Overseeing removal of manure in an environmentally friendly way. • Bringing the barn up to fire safety codes. Volunteers groom and turn out each horse every day, says McGarrah. The horses are fed according to their individual health plans, each out of his or her own red bucket, with his or her name on it. Some volunteers ride the horses, others simply choose to clean buckets, prepare hay or prepare meals. And everyone works to keep Red Bucket clean. “All you have to do is walk on our ranch to see how healthy our horses are,” she says. “The first thing people who come here say is, ‘This is the cleanest place I’ve ever seen.’” COMMUNITY Learning to trust Three-part model of rescue Rescuing slaughter-bound, starving and abused horses is just Part 1 of the mission of Chino Hills, Calif.-based Red Bucket Equine Rescue. “The second part of our mission is where the real work occurs,” says Karen McGarrah, volunteer ranch coordinator. “Our horses are carefully assessed, rehabilitated, and trained. They have been victims of unspeakable abuse, and at Red Bucket, they receive the time they need to recover and regain confidence in mankind, and in themselves.” The average weight gain for a Red Bucket rescued horse is 300 pounds, she adds. And Part 3? “When they are ready, the horses are matched with a suitable adopter, and the horse and adopter continue to receive field support after the horse goes home. We continue to support our adopters and provide ongoing training and counsel, removing any barriers to the horse staying in their new home. “Because of the strength of our program, and our commitment, we have a very low return rate, and are developing a strong reputation in the equine and animal welfare communities.” Most important, each volunteer is trained in the Red Bucket Way, which stresses consistency in how people interact with the horses. “A horse who has been abused has to be treated and touched the same way every day,” she says. “Every time a volunteer walks in, the horse anticipates how it will be touched, because of the abuse factor. The animal has expectations that aren’t good, so we want to be sure they’re treated the same way every time we walk into the stall.” Supply chain skills And yes, McGarrah is able to call upon the skills she picked up during her healthcare supply chain career. “The art of negotiation, skills of communication, leadership, integrity www.vet-advantage.com • Veterinary advantage «« July/August 2014 83 COMMUNITY in dealing with employees and vendors are all skills I have brought with me to Red Bucket,” she says. “Being a 501(c)3 is extremely difficult in hard economic times, such as we are having today. I am using all of my skills to help the horses I love to recover from abuse through better health, better veterinary care, and healthier lives for the future. “I have become engaged more and more with the purchasing of equipment and supplies,” she continues. “We are doing everything within our power to be prudent stewards of the funds being donated to Red Bucket.” More than 98 percent of all donations are used to take care of Red Bucket horses. The remainder is salary for Red Bucket’s lone full-time employee – the trainer. One thing that Red Bucket lacks is a full-time veterinarian. “One of our priorities is to raise the proper funding to have an in-house veterinarian,” she says. That said, several veterinarians volunteer their time, talent and supplies to the rescue. “We are so very thankful for this. We know we can call and discuss issues as they arise. They are available to us at moment’s notice. We are blessed with our veterinarians, who believe in what we are doing and help us help the horses.” “Nearly every five minutes, an American horse in good condition is brutally slaughtered for human consumption,” says McGarrah. “If they’re not slaughtered, the horses are abandoned, starved, savagely abused or are left to die painful deaths. “This is why we work so hard in using every penny of our money wisely.” Red Bucket Equine Rescue gladly seeks donations to continue its work. Visit its website at www. redbucketrescue.org. Volunteering at Red Bucket There’s plenty of work to do at Red Bucket Equine Rescue. “Red Bucket has something for everyone, and we need many special talents and skills to help the horses,” says volunteer ranch coordinator Karen McGarrah. Examples of volunteer responsibilities: • Feed crew: Feeds daily and removes blankets in the winter. The horse receives their bucket as a supplemental feeding during nighttime wellness checks. Diets are prepared based on a horse’s individual needs and are assessed and adjusted throughout their stay at Red Bucket. • Horse care: A dedicated team of veterinarians, farriers, horse transport and equine specialists donate their time, skills, expertise, and trade to address the unique needs of abused and abandoned horses. In addition volunteers groom the horses daily and ensure they get exercise, and make sure their individual health care and daily enrichment needs are met. • Apparel: Volunteers organize, sell, and promote Red Bucket apparel. • Fundraising. • Stall and ranch care: The stall care team manages the overall cleaning, maintenance, bedding, water bowls, and safety of the Red Bucket horses. • Newsletter: A team of volunteers write, edit, coordinate, and publish the monthly newsletter. • Marketing: This team protects and promotes the Red Bucket brand. • Communication: Internal and external communication including writing, finding sources to share horse’s stories, editing, and fundraising. • Finance: This team protects ensures that Red Bucket has the funds to care for the horses and the ranch. • Event coordination. • Recycling. • Visitor center and tours. • Photographers: Horses are videoed and photographed for the Red Bucket calendar, website, media events, promotional materials, “Because of You campaign,” etc. 84 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com AAFP video series intended to enhance feline quality-of-care The American Association of Feline Practitioners has launched an eight-part video series offering a glimpse into Cat Friendly Practices, and more specifically, how such practices are able to provide the highest quality of care while showing owners a commitment to address the distinct health needs and special considerations of feline patients. According to the Bayer Veterinary Care Usage Study III, 83 percent of cats are taken to the veterinarian in the first year of ownership, yet over half of them don’t return, according to the association. Currently, more than 1,400 practices have started AAFP’s Cat Friendly Practice program, and more than 600 have been designated. The videos are intended to educate veterinary teams on becoming cat-friendly, better understanding cats, tips to incorporate into your feline appointments, and how to educate cat owners on the importance of routine veterinary care. The series begins with a brief overview, and specific techniques and recommendations are detailed in the remainder of the videos: Part 1 — How to Make Feline Friendly Changes. Part 2 — Understanding Feline Behavior. Part 3 — Understanding & Preparing for the Feline Veterinary Visit. Part 4 — Being Flexible During Feline Examination. Part 5 — Enhancing the Feline Examination. Part 6 — Feline Friendly Handling during Veterinary Visits. Part 7 — Doing Procedures in the Examination Room. Part 8 — Now You Can Begin to Make Changes in Your Practice. Find more information at www.catvets.com Pet owners confuse flea/tick protection methods Sixty-three percent of people who purchased flea control products or flea control/heartworm preventive combo products that are not effective against ticks, actually believe that the products do kill ticks, according to the results of a pet owner survey from Merial. Thirty percent of people who say they would only purchase a product that kills ticks actually purchased products that are not effective against ticks. “Fleas and ticks are two very different parasites,” said Dr. Michael Murray, DVM, Merial, was quoted as saying. “Products that kill fleas don’t automatically kill COMMUNITY News disease-carrying ticks too. You have to read the label to see what parasites a product is effective against.” Experts of the Companion Animal Parasite Council (CAPC) note that a number of tick species are commonly identified in areas where they have not been present historically, reports Merial. As these tick species move into new areas, they will bring the diseases that they transmit with them, including canine ehrlichiosis, anaplasmosis, Lyme disease, Rocky Mountain spotted fever, hepatozoonosis and babesiosis. According to a national survey of veterinary clinics, dogs have tested positive for Lyme disease, ehrlichiosis, and/or anaplasmosis in most states. The survey questioned 1,000 U.S. residents – 21 percent from the Northeast, 22 percent from the Midwest, 34 percent from the South and 23 percent from the West – and featured responses from people of all ages, 68 percent of whom said they had used a flea or flea/tick control product in the past year. Bayer Animal Health names Scott Ethridge the Brand Manager for Seresto Bayer Animal Health has announced that Scott Ethridge has accepted the position of Brand Manager for Seresto. Ethridge, his wife Amy, and their three children Sabrina, Brody and Fischer will be moving to the Kansas City area from Oklahoma City later this summer. Ethridge brings diverse career experience to his new role. He joins CAP Marketing from the CAP Strategic Accounts team where he has been working as a Key Account Manager calling on major distributor customers. He was previously a Territory Sales Manager for Bayer CAP calling on veterinary clinics, and was a Bayer Council award winner in 2010. Putney announces new appointments Putney, Inc., announced the addition of Kelley Shimansky to its senior leadership team. As Vice President of Human Resources, Shimansky will focus on organizational design and optimiKelley zation to ensure the team achieves Shimansky its growth goals. Shimansky comes to Putney from WEX, where she was Vice President of Organizational Development. In that role she created a www.vet-advantage.com • Veterinary advantage «« July/August 2014 85 COMMUNITY News consolidated corporate standard for talent assessment and management, implemented a global HR technology platform and designed the onboarding program to shorten time to effectiveness of new hires. Putney also announced recent changes to its commercial team. Shannon Lancaster has been promoted to Senior Director of New Business Development and Strategy. Putney has also hired Sam Spina as Director of National Channel Sales, responsible for leading the direct, distribution and customer service teams to build relationships that deepen market penetration of existing products and gain rapid market share for future product launches. Putney announced two additional promotions in conjunction with the sales team development. James Morin has been promoted to Sales Analyst and Chris Kelly has been promoted to Inside Sales Representative. via best practices that better protect pets from parasitic infections while reducing the risk of zoonotic parasite transmission. The organization produces a number of leading industry resources that are recognized by the veterinary profession. These include the CAPC guidelines for parasitic prevention and control measures for ectoparasites, heartworm and intestinal parasites, and the CAPC parasite prevalence maps, which monitors vector-born and heartworm disease activity at the local and county levels across the United States. Virbac awards several distributor reps, veterinarians on “once-in-a-lifetime” sailing trip Virbac Corporation recently invited several distributor reps and select veterinarians to a once-in-a-lifetime opportunity to sail on the Virbac-Paprec 70’ tri-hulled catamaran in New York City Harbor, around the Statue of Putney CEO Jean Hoffman wins New England Ernst & Young Entrepreneur of the Year™ Award Jean Hoffman, president and CEO of Putney, Inc., was named the New England Ernst & Young (EY) Entrepreneur of the Year™ 2014 in the Life Sciences. Upon receiving the award at EY’s 28th annual Entrepreneur of the Year Awards Gala in New England, Hoffman credited her team who she said is “overcoming obstacles and accomplishing our goal of making pet healthcare more affordable.” As a New England award winner, Hoffman is nominated to EY’s national Entrepreneur of the Year 2014 program. Award winners in several national categories, as well as the Entrepreneur of the Year National Overall Award winner, will be announced at the annual awards gala in Palm Springs, California, on Nov. 15, 2014. VPL becomes a corporate sponsor of CAPC Veterinary Products Laboratories (VPL) announced it has become a corporate sponsor of the Companion Animal Parasite Council (CAPC). “We are proud to align ourselves with this organization in support of its overall mission, doing our part to help improve the health of our pets and further strengthen the bond between pets and pet owners.” Founded in 2002, CAPC was formed with the express purpose of changing the way veterinary professionals and pet owners approach parasite management, 86 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Liberty. Dr. Jean-Pierre Dick, son of Virbac’s founder, Dr. Richard-Pierre Dick, and skipper of the boat was in New York City with his crew for a week dedicated to exclusive sailing sessions with customers and also to receive one of the highest honors in sailing. He was recognized by the world renowned NYC Yacht Club for extraordinary courage at sea while competing in the Vendée Globe solo race around the world. Virbac’s invited guests sailed on the Virbac-Paprec 70’ MOD tri-hulled catamaran in NYC Harbor, around the Statue of Liberty, Ellis Island with unique view on lower Manhattan and the new Freedom Tower. One of Virbac’s guests, Henry Schein Animal Health Sales Representative Dennis Meyers, said “I’ve been in the industry for 32 years and this is by far the best experience among many award trips!” Virbac Corporation announced that Dr. Alan Taylor has been named Vice President of Business Development, effective July 14, 2014. In this role, Dr. Taylor will be responsible for generating external growth for Virbac North America and the Commonwealth Countries, through the acquisition or licensing-in of new products, and through the merger and acquisitions of third party companies. Additionally, he will support the R&D internal organization through the licensing-in of opportunities of selected new actives or new technologies that could be further developed internally. Before joining Virbac, Dr. Taylor held the position of head of Business Development North America and Global Pets for Merial Ltd. Veterinary Hospital of the Year winner features Midmark equipment Mueller Pet Medical Center was recently recognized with the 2014 Hospital of the Year Award for excellence in veterinary hospital design in the 49th annual Veterinary Economics Hospital Design Competition. Midmark worked with distribution partner, MWI Veterinary Supply, Inc., to provide a solution that would meet the needs of the veterinary hospital. The new design featured Midmark casework throughout the entire facility as well as Canis Major® Lift Tables in every canine exam room. Dechra Veterinary products expands to Canadian market Dechra Veterinary Products announced its entry into the Canadian Veterinary Animal Health Market. Its newly established subsidiary will be managed by Paul Ray, who brings over 20 years of sales and marketing experience in the Canadian animal health industry, according to Mike Eldred, President of North American Operations. “Additionally, we will be hiring key personnel to support our endocrinology and dermatology products who will be focused on providing the highest level of service and education to the veterinary profession,” Eldred said. COMMUNITY Virbac names Dr. Alan Taylor as VP of Business Development Henry Schein Animal Health’s Dawn Burdette to serve on AVMA’s Veterinary Economic Strategy Committee Henry Schein Animal Health announced the appointment of Dawn Burdette, Executive Director of Sales Leadership and Development at Henry Schein Animal Health, to the AmeriDawn Burdette can Veterinary Medical Association’s (AVMA) Veterinary Economics Strategy Committee as an At-Large Representative by the AVMA Executive Board. Burdette was appointed to the Committee at the April 10-12, 2014 AVMA Executive Board Meeting and will serve in this position from July 2014 to July 2017. The Committee is charged to advise the AVMA’s Executive Board on the broad scope of economic issues affecting veterinary medicine and make recommendations to develop strategies for addressing economic issues. Nominations were solicited from the general membership and other stakeholders, and all members of the Committee will be eligible to serve a second term of three years. Dechra expands Equine and Companion Animal division Dechra Veterinary Products announced it has expanded its Equine and Companion Animal divisions with the hiring of Dr. Marian Little, Greg Underwood and Denise Piekarski. Marian G. Little, DVM joins Dechra as the Equine Technical and Professional Services Manager. Dr. Little comes from Boehringer Ingelheim Vetmedica, Inc. where she held the position of Field Equine Professional Services Veterinarian since 2007. Greg Underwood has joined the Dechra Team as Director of Corporate Accounts and Distributor Relations. With over twenty years of experience in the animal health industry, Underwood will be responsible for corporate veterinary groups and distributor relations for Dechra. Piekarski joins Dechra as Marketing Manager and will be responsible for developing the recently acquired Phycox ® brand of joint supplements, as well as other key new products. www.vet-advantage.com • Veterinary advantage «« July/August 2014 87 COMMUNITY News Jurox selects Kansas City Animal Health Corridor for U.S. Headquarters DEA approves making tramadol a schedule IV controlled substance Jurox Pty Ltd, an Australian veterinary pharmaceutical company, announced that it has selected Kansas City, Mo., as in the KC Animal Health Corridor, for its U.S. headquarters. Bob Marcusse, president and CEO of the Kansas City Area Development Council, said, “The KC Animal Health Corridor’s high concentration of animal health entities paired with accessibility to distribution and service providers makes the Kansas City area an ideal location for Jurox to grow their presence and succeed in the U.S.” Jurox will create 13 jobs based in Kansas City and an additional 31 positions located throughout the U.S. The company selected the KC region due to its concentration of skilled workforce, intellectual capital and accessibility to service providers. The Drug Enforcement Administration (DEA) recently published its decision to schedule tramadol as a Schedule IV controlled substance, according to an AVDA email to members. The rule will become effective August 18 of this year. “The DEA’s action was fairly swift, having published its proposal to schedule tramadol just eight months ago,” the email said. AVDA indicated its support for DEA’s consideration to schedule tramadol, in part, because distributors will be able to operate more efficiently and consistently nationwide. Brakke Consulting and Trone Brand Energy to forecast pet pharmaceutical market Brakke Consulting, Inc., and Trone Brand Energy, announced they are joining forces to paint the picture of the future U.S. pet pharmaceutical marketplace. The first place pet owners go to purchase veterinarian-prescribed medicines is beginning to change as new distribution models and proposed legislative measures are evolving to give consumers more choice. New research by Brakke and Trone Brand Energy will define how this change of the pet pharmaceutical industry will affect manufacturers, distributors, retailers and veterinarians once a critical mass of consumers begin to adopt new models. “Changes to the pet pharmaceutical marketplace are going to present opportunities and challenges unlike any the industry has seen,” said Ron Brakke, president of Brakke Consulting. “We have partnered with Trone Brand Energy to help broaden the scope of the insights we gather. Companies that participate in the research will be offered a comprehensive body of implications on how they should change their business models to adapt to the new dynamics.” Companies wishing to participate in the study at a discounted rate can contact David Goodnight at 830285-1259 by July 31, 2014. 88 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Henry Schein Animal Health to host 2014 Veterinary Technology Summit in September Veterinarians and their staff seeking to gain valuable insights into state-of-the-art practice management, attend cutting-edge software training classes, and experience the latest veterinary technology solutions can attend the Henry Schein Veterinary Technology Summit, which takes place Sept. 3-5, 2014, at the Renaissance Schaumburg Convention Center Hotel in Chicago. Registration for this technologyfocused industry event remains open through August 31. Summit keynote speakers, including Andy Roark, DVM, MS; Mark Opperman, CVPM of VMC, Inc.; Wendy S. Meyers of Communication Solutions for Veterinarians Inc.; and Amanda L. Donnelly, DVM, MBA of ALD Veterinary Consulting, will cover topics including effective use of social media, blending old and new tactics for more effective practice marketing, boosting client communication and compliance, enhancing and promoting preventive care, and improving staff management and leadership. In addition, Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, Inc. and Kevin Vasquez, President and CEO of Henry Schein Animal Health, will discuss key trends impacting the animal health industry. To register or receive more information, visit www.VetSummit.com Product Announcements Jurox introduces Alfaxan® CIV (alfaxalone 10 mg/mL) intravenous injectable anesthetic for use in cats and dogs Alfaxan® is indicated for the induction and maintenance of anesthesia and for induction of anesthesia followed by maintenance with an inhalant anesthetic, in cats and dogs. Alfaxan® is a registered trademark of Jurox Pty. Limited, Fel-O-Vax® is manufactured with PureFil™ Technology, which includes improved purification processes and tighter manufacturing profiles, resulting in more serialto-serial consistency. PureFil™ Technology is designed to reduce vaccine reactions associated with extraneous proteins and cellular debris. IDEXX Laboratories introduces Whipworm Antigen Test Capable of Detecting Adult Parasite Australia and is a unique anesthetic molecule to the U.S. veterinary market. Jurox is an established family owned veterinary pharmaceutical company that manufactures and markets in excess of 120 proprietary animal health products in over 20 countries. With global headquarters in the Hunter Valley Australia, Jurox maintains commercial operations in New Zealand, United Kingdom and has recently established their U.S. headquarters in Kansas City, Missouri. For more information you can reach the Jurox team at 844-ALFAXAN.” IDEXX Laboratories, Inc. announced the introduction of a breakthrough technology to detect more whipworm infections in dogs earlier than current diagnostic methods. As the industry’s first enzyme-linked immunosorbent assay (ELISA) for whipworm antigen detection, it is the only test capable of directly detecting the presence of an adult whipworm parasite, according to a release. Until now, diagnostic tests could only detect whipworm infections by the presence of eggs in the feces. Since it can take up to three months for an adult whipworm to produce eggs, infected dogs may go untreated for months. Data collected through IDEXX Reference Laboratories shows that the Whipworm Antigen ELISA can detect more than double the number of infections in dogs when the ELISA is run with traditional ova and parasite testing, allowing for earlier diagnosis, management and treatment. To learn more about the IDEXX Comprehensive Fecal Panel and the Whipworm Antigen ELISA, call 877-278-1470 or visit www.idexx.com/whipworm Bayer is proud to introduce Boehringer Ingelheim Vetmedica, Inc. launches ULTRA™ Fel-O-Vax® Boehringer Ingelheim Vetmedica, Inc. (BIVI) announced the launch of ULTRA™ Fel-O-Vax®, the first ½ mL vaccine line for cats. ULTRA™ Fel-O-Vax ® joins its partner canine product line, ULTRA™ Duramune®, as the only pet vaccine lines on the market with 50 percent less volume per dose, according to a release. ULTRA™ See advertisement on page 99 www.vet-advantage.com • Veterinary advantage «« July/August 2014 89 Product Announcements Merck Animal Health announces FDA approval of BRAVECTO™ (fluralaner) Merial re-launches HEARTGARD® (ivermectin) tablets for dogs Merck Animal Health announced the U.S. Food and Drug Administration’s approval of BRAVECTO™ (fluralaner) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). BRAVECTO is the first and only treatment that has been shown to quickly and effectively kill fleas and multiple tick species for 12 weeks in a single dose. BRAVECTO also is effective for eight weeks against Amblyomma americanum ticks. Merial announced the re-launch of its HEARTGARD® (ivermectin) Tablets. Dogs with food allergies now have a monthly heartworm preventive that does not include any food ingredients that may trigger an allergic reaction. HEARTGARD Tablets help protect against heartworms that can lead to serious illness in dogs. Merial re-introduced these tablets to ensure that every dog has an option for heartworm disease prevention. “Many dogs suffer from food allergies and most oral heartworm preventives have meat components in their formulation,” said Dr. Michael Murray, Technical Marketing Director of U.S. Pets Parasiticides at Merial. “Merial is committed to providing dogs with food allergies an alternative that delivers the same heartworm disease prevention found in HEARTGARD Plus (ivermectin/pyrantel), which is a real beef chewable.” To learn more about HEARTGARD products and availability, visit http://www.heartgard.com. Kinetic Vet introduces EquiShield® IBH Spray Kinetic Vet branded products by Kinetic Technologies has released EquiShield® IBH Spray. EquiShield® IBH Spray is a soothing anesthetic spray with antiseptic and anti-inflammatory properties featuring the active ingredients Chlorhexidine Gluconate 2%, Pramoxine HCI 1%, Citronella Oil 1% and Hydrocortisone 0.5%. Call 877786-9882 or visit www.KineticVet.com for more information. Virbac Corporation announces the return of IVERHART PLUS® Virbac Corporation announced the return of IVERHART PLUS® (ivermectin/pyrantel) Flavored Chewables. IVERHART PLUS Tablets are effective in preventing heartworm infections in dogs and are available in a flavored chewable tablet. They provide a cost-effective alternative in an effort to make heartworm prevention available to more dogs and dog owners. IVERHART PLUS Tablets also provide protection against intestinal parasites. 90 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Midmark launches Canis Major® Lift Tables promotion Midmark Corporation introduced a new promotion within its animal health division that runs until Sept. 30, 2014. During the promotion, Midmark is offering a $750 rebate on both the Canis Major® Wet Dental/Treatment Lift Table and the Canis Major® Exam Lift Table. Important promotional dates include: • Promotion order period: July 1 – Sept. 30, 2014 • Veterinary facility invoice must be dated: July 1 – Oct.31, 2014 • Last date to take delivery of products: Oct. 31, 2014 • Last date to claim incentives: Nov. 30, 2014 For product inquiries, call the Midmark Animal Health Customer Experience Department at 1-800-MIDMARK or visit midmarkanimalhealth.com. For questions regarding the promotion, call ext. 7575. CAUTION: Federal (US) law restricts this drug to use by or on the order of a licensed veterinarian. BRIEF SUMMARY: Please consult package insert for complete product information. Indications: For use in dogs to prevent canine heartworm disease by eliminating the tissue stage of heartworm larvae (Dirofilaria immitis) for a month (30 days) after infection and for the treatment and control of roundworms (Toxocara canis, Toxascaris leonina), hookworms (Ancylostoma caninum, Uncinaria stenocephala, Ancylostoma braziliense), and tapeworms (Dipylidium caninum, Taenia pisiformis). WARNINGS: For use in dogs only. Keep this and all drugs out of reach of children. In safety studies, testicular hypoplasia was observed in some dogs receiving 3 and 5 times the maximum recommended dose monthly for 6 months (see Animal Safety). In case of ingestion by humans, clients should be advised to contact a physician immediately. Physicians may contact a Poison Control Center for advice concerning cases of ingestion by humans. PRECAUTIONS: Use with caution in sick, debilitated, or underweight animals and dogs weighing less than 10 lbs (see Animal Safety). The safe use of this drug has not been evaluated in pregnant or lactating bitches. All dogs should be tested for existing heartworm infection before starting treatment with IVERHART MAX Chewable Tablets, which are not effective against adult D. immitis. Infected dogs should be treated to remove adult heartworms and microfilariae before initiating a heartworm prevention program. While some microfilariae may be killed by the ivermectin in IVERHART MAX Chewable Tablets at the recommended dose level, IVERHART MAX Chewable Tablets are not effective for microfilariae clearance. A mild hypersensitivitytype reaction, presumably due to dead or dying microfilariae and particularly involving a transient diarrhea, has been observed in clinical trials with ivermectin alone after treatment of some dogs that have circulating microfilariae. ADVERSE REACTIONS: In clinical field trials with ivermectin/ pyrantel pamoate, vomiting or diarrhea within 24 hours of dosing was rarely observed (1.1% of administered doses). The following adverse reactions have been reported following the use of ivermectin: depression/lethargy, vomiting, anorexia, diarrhea, mydriasis, ataxia, staggering, convulsions and hypersalivation. ANIMAL SAFETY: Studies with ivermectin indicate that certain dogs of the Collie breed are more sensitive to the effects of ivermectin administered at elevated dose levels (more than 16 times the target use level of 6 mcg/kg) than dogs of other breeds. At elevated doses, sensitive dogs showed adverse reactions which included mydriasis, depression, ataxia, tremors, drooling, paresis, recumbency, excitability, stupor, coma and death. No signs of toxicity were seen at 10 times the recommended dose (27.2 mcg/lb) in sensitive Collies. Results of these studies and bioequivalence studies support the safety of ivermectin products in dogs, including Collies, when used as recommended by the label. In a laboratory safety study, 12-week-old Beagle puppies receiving 3 and 5 times the recommended dose once weekly for 13 weeks demonstrated a dose-related decrease in testicular maturation compared to untreated controls. HOW SUPPLIED: IVERHART MAX Chewable Tablets are available in four dosage strengths (see Dosage section) for dogs of different weights. Each strength comes in a box of 6 chewable tablets, packed 10 boxes per display box. STORAGE INFORMATION: Store at 20°C -25°C (68°F77°F), excursions permitted between 15°C-30°C (59°F86°F). Protect product from light. For technical assistance or to report adverse drug reactions, please call 1-800-338-3659. Manufactured by: Virbac AH, Inc. Fort Worth, TX 76137 NADA 141-257, Approved by FDA IVERHART MAX is a registered trademark of Virbac Corporation. © 2014 Virbac Corporation. All Rights Reserved. 7/14 14846 TRESADERM (thiabendazole-dexamethasone-neomycin sulfate solution) Dermatologic Solution CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION: Dermatologic Solution TRESADERM® (thiabendazole-dexamethasone-neomycin sulfate solution) contains the following active ingredients per ml: 40 mg thiabendazole, 1 mg dexamethasone, 3.2 mg neomycin (from neomycin sulfate). Inactive ingredients: glycerin, propylene glycol, purified water, hypophosphorous acid, calcium hypophosphite; about 8.5% ethyl alcohol and about 0.5% benzyl alcohol. INDICATIONS:Dermatologic solution TRESADERM is indicated as an aid in the treatment of certain bacterial, mycotic, and inflammatory dermatoses and otitis externa in dogs and cats. Both acute and chronic forms of these skin disorders respond to treatment with TRESADERM. Many forms of dermatosis are caused by bacteria (chiefly Staphylococcus aureus, Proteus vulgaris and Pseudomonas aeruginosa). Moreover, these organisms often act as opportunistic or concurrent pathogens that may complicate already established mycotic skin disorders, or otoacariasis caused by Otodectes cynotis. The principal etiologic agents of dermatomycoses in dogs and cats are species of the genera Microsporum and Trichophyton. The efficacy of neomycin as an antibacterial agent, with activity against both gramnegative and gram-positive pathogens, is well documented. Detailed studies in various laboratories have verified the significant activity thiabendazole displays against the important dermatophytes. Dexamethasone, a synthetic adrenocorticoid steroid, inhibits the reaction of connective tissue to injury and suppresses the classic inflammatory manifestations of skin disease. The formulation for TRESADERM combines these several activities in a complementary form for control of the discomfort and direct treatment of dermatitis and otitis externa produced by the above-mentioned infectious agents. DOSAGE AND ADMINISTRATION: Prior to the administration of Dermatologic Solution TRESADERM, remove the ceruminous, purulent or foreign materials from the ear canal, as well as the crust which may be associated with dermatoses affecting other parts of the body. The design of the container nozzle safely allows partial insertion into the ear canal for ease of administration. The amount to apply and the frequency of treatment are dependent upon the severity and extent of the lesions. Five to 15 drops should be instilled in the ear twice daily. In treating dermatoses affecting other than the ear the surface of the lesions should be well moistened (2 to 4 drops per square inch) with Dermatologic Solution TRESADERM twice daily. The volume required will be dependent upon the size of the lesion. Application of TRESADERM should be limited to a period of not longer than one week. PRECAUTIONS: On rare occasions dogs may be sensitive to neomycin. In these animals, application of the drug will result in erythema of the treated area, which may last for 24 to 48 hours. Also, evidence of transient discomfort has been noted in some dogs when the drug was applied to fissured or denuded areas. The expression of pain may last 2 to 5 minutes. Application of Dermatologic Solution TRESADERM should be limited to periods not longer than one week. While systemic side effects are not likely with topically applied corticosteroids, such a possibility should be considered if use of the solution is extensive and prolonged. If signs of salt and water retention or potassium excretion are noticed (increased thirst, weakness, lethargy, oliguria, gastrointestinal disturbances or tachycardia), treatment should be discontinued and appropriate measures taken to correct the electrolyte and fluid imbalance. Store in a refrigerator 36°-46°F (2°-8°C). WARNING: For topical use in dogs and cats. Avoid contact with eyes. Keep this and all drugs out of the reach of children. The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information. To report adverse effects in users, to obtain an MSDS, or for assistance call 1-888-637-4251. HOW SUPPLIED: Product 55871- Dermatologic Solution TRESADERM Veterinary is supplied in 7.5-ml and 15-ml dropper bottles, each in 12-bottle boxes. www.vet-advantage.com • Veterinary advantage VIRC-14846 IVMax Ad 1ThirdSumVetAdv PI prt.indd 1 7/9/14 5:48 PM «« July/August 2014 91 VETROPOLYCIN® (bacitracin-neomycin-polymyxin) Veterinary Ophthalmic Ointment TM (carprofen) WARNING: Do not use this product as a pre-surgical ocular lubricant. Adverse reactions of ocular irritation and corneal ulceration have been reported in association with such use. soft chewable tablets VETROPOLYCIN® HC Non-steroidal anti-inflammatory drug For oral use in dogs only BRIEF SUMMARY: Before using quellin soft chewable tablets, please consult the product insert, a summary of which follows: CAUTION: Federal Law restricts this drug to use by or on the order of a licensed veterinarian. PRODUCT DESCRIPTION: quellin (carprofen) is a non-steroidal anti-inflammatory drug (NSAID) of the propionic acid class that includes ibuprofen, naproxen, and ketoprofen. INDICATIONS: Carprofen is indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. CONTRAINDICATIONS: Carprofen should not be used in dogs exhibiting previous hypersensitivity to carprofen. WARNINGS: Keep out of reach of children. Not for human use. Consult a physician in cases of accidental ingestion by humans. For use in dogs only. Do not use in cats. All dogs should undergo a thorough history and physical examination before initiation of NSAID therapy. Appropriate laboratory tests to establish hematological and serum biochemical baseline data prior to, and periodically during, administration of any NSAID should be considered. PRECAUTIONS: As a class, NSAIDs may be associated with gastrointestinal, renal and hepatic toxicity. Effects may result from decreased prostaglandin production and inhibition of the enzyme cyclooxygenase which is responsible for the formation of prostaglandins from arachindonic acid. When NSAIDs inhibit prostaglandins that cause inflammation they may also inhibit those prostaglandins which maintain normal homeostatic function. These antiprostaglandin effects may result in clinically significant disease in patients with underlying or preexisting disease more often than in healthy patients. Carprofen is an NSAID, and as with others in that class, adverse reactions may occur with its use. The most frequently reported effects have been gastrointestinal signs. vents involving suspected renal, hematologic, and neurologic, dermatologic, and hepatic effects have also been reported. Concomitant use of carprofen with other anti-inflammatory drugs, such as other NSAIDs or corticosteroids, should be avoided because of the potential increase of adverse reactions, including gastrointestinal ulcerations and/or perforations. Carprofen is not recommended for use in dogs with bleeding disorders, as safety has not been established in dogs with these disorders. The safe use of carprofen in animals less than 6 weeks of age, pregnant dogs, dogs used for breeding purposes, or in lactating bitches has not been established. ADVERSE REACTIONS: During investigational studies for the caplet formulation with twice-daily administration of 1 mg/lb., no clinically significant adverse reactions were reported. Some clinical signs were observed during field studies which were similar for carprofen caplet and placebo treated dogs. Incidences were observed in both groups: vomiting (4%), diarrhea (4%), changes in appetite (3%), lethargy (1.4%), behavioral changes (1%), and constipation (0.3%). For a copy of the Material Safety Data Sheet (MSDS) or to report adverse reactions call Bayer Veterinary Services at 1-800-422-9874. For consumer questions call 1-800-255-6826. ANADA 200-555 Approved by FDA ©2014 Bayer HealthCare LLC. Bayer (reg’d), the Bayer Cross (reg’d), quellin™ are trademarks of Bayer. Bayer HealthCare LLC, Animal Health Division, PO Box 390, Shawnee Mission, KS 66201 GHG061914 January 2014 92 July/August 2014 NADA # 065-016. Approved by FDA. 18827 »» Veterinary adVantage • www.vet-advantage.com (bacitracin-neomycin-polymyxinhydrocortisone acetate 1%) Veterinary Ophthalmic Ointment NADA # 065-015. Approved by FDA. CONTRAINDICATIONS: Ophthalmic preparations containing corticosteroids are contraindicated in the treatment of those deep, ulcerative lesions of the cornea where the inner layer (endothelium) is involved, in fungal infections and in the presence of viral infections. WARNINGS: All topical ophthalmic preparations containing corticosteroids with or without an antimicrobial agent, are contraindicated in the initial treatment of corneal ulcers. They should not be used until the infection is under control and corneal regeneration is well under way. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits, and rodents during pregnancy have resulted in cleft palate in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies, including deformed forelegs, phocomelia, and anasarca. The INFORmATION belOW ApplIeS TO bOTh VeTROpOlYCIN AND VeTROpOlYCIN hC. STeRIle - ANTIbACTeRIAl CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. pReCAUTIONS: Sensitivity to these ophthalmic ointments is rare, however, if a reaction occurs, discontinue use of the preparation. The prolonged use of antibiotic-containing preparations may result in overgrowth of nonsusceptible organisms including fungi. Appropriate measures should be taken if this occurs. If infection does not respond to treatment in two or three days, the diagnosis and therapy should be reevaluated. Animals under treatment with VeTROpOlYCIN hC (bacitracin-neomycin-polymyxin with hydrocortisone acetate 1%) should be observed for usual signs of corticosteroid overdose which include polydipsia, polyuria and occasionally an increase in weight. Use of corticosteroids, depending on dose, duration, and specific steroid, may result in inhibition of endogenous steroid production following drug withdrawal. In patients presently receiving or recently withdrawn from systemic corticosteroid treatments, therapy with a rapidly acting corticosteroid should be considered in unusually stressful situations. Care should be taken not to contaminate the applicator tip during administration of the preparation. ADVeRSe ReACTIONS: Itching, burning or inflammation may occur in animals sensitive to the product. Discontinue use in such cases. SAp and SGpT (AlT) enzyme elevations, polydypsia and polyuria have occurred following parenteral or systemic use of synthetic corticosteroids in dogs. Vomiting and diarrhea (occasionally bloody) have been observed in dogs. Cushing’s syndrome in dogs has been reported in association with prolonged or repeated steroid therapy. manufactured for: Dechra Veterinary products 7015 College boulevard, Suite 525 Overland park, KS 66211 866-933-2472 NADA 141-426, Approved by FDA BRIEF SUMMARY (For full Prescribing Information, see package insert) Caution: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. Indications: Bravecto kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Ixodes scapularis (black-legged tick), Dermacentor variabilis (American dog tick), and Rhipicephalus sanguineus (brown dog tick)] for 12 weeks in dogs and puppies 6 months of age and older, and weighing 4.4 pounds or greater. Bravecto is also indicated for the treatment and control of Amblyomma americanum (lone star tick) infestations for 8 weeks in dogs and puppies 6 months of age and older, and weighing 4.4 pounds or greater. Contraindications: There are no known contraindications for the use of the product. Warnings: Not for human use. Keep this and all drugs out of the reach of children. Keep the product in the original packaging until use, in order to prevent children from getting direct access to the product. Do not eat, drink or smoke while handling the product. Wash hands thoroughly with soap and water immediately after use of the product. Precautions: Bravecto has not been shown to be effective for 12-weeks duration in puppies less than 6 months of age. Bravecto is not effective against Amblyomma americanum ticks beyond 8 weeks after dosing. Adverse Reactions: In a well-controlled U.S. field study, which included 294 dogs (224 dogs were administered Bravecto every 12 weeks and 70 dogs were administered an oral active control every 4 weeks and were provided with a tick collar); there were no serious adverse reactions. All potential adverse reactions were recorded in dogs treated with Bravecto over a 182-day period and in dogs treated with the active control over an 84-day period. The most frequently reported adverse reaction in dogs in the Bravecto and active control groups was vomiting. Percentage of Dogs with Adverse Reactions in the Field Study Adverse Reaction (AR) Bravecto Group: Percentage of Dogs with the AR During the 182-Day Study (n=224 dogs) Active Control Group: Percentage of Dogs with the AR During the 84-Day Study (n=70 dogs) Vomiting 7.1 14.3 Decreased Appetite 6.7 0.0 Diarrhea 4.9 2.9 Lethargy 5.4 7.1 Polydipsia 1.8 4.3 Flatulence 1.3 0.0 In a well-controlled laboratory dose confirmation study, one dog developed edema and hyperemia of the upper lips within one hour of receiving Bravecto. The edema improved progressively through the day and had resolved without medical intervention by the next morning. For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318. Additional information can be found at www.bravecto.com. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at http://www.fda.gov/AnimalVeterinary/ SafetyHealth. How Supplied: Bravecto is available in five strengths (112.5, 250, 500, 1000, and 1400 mg fluralaner per chew). Each chew is packaged individually into aluminum foil blister packs sealed with a peelable paper backed foil lid stock. Product may be packaged in 1, 2, or 4 chews per package. Distributed by: Intervet Inc (d/b/a Merck Animal Health) Summit, NJ 07901 Made in Austria Copyright © 2014 Intervet Inc, a subsidiary of Merck & Company Inc. All rights reserved 141487 R2 www.vet-advantage.com • Veterinary advantage «« July/August 2014 93 CHEWABLE TABLETS Brief Summary: Before using PREVICOX, please consult the product insert, a summary of which follows: Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Indications: PREVICOX (firocoxib) Chewable Tablets are indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with softtissue and orthopedic surgery in dogs. Contraindications: Dogs with known hypersensitivity to firocoxib should not receive PREVICOX. Warnings: Not for use in humans. Keep this and all medications out of the reach of children. Consult a physician in case of accidental ingestion by humans. For oral use in dogs only. Use of this product at doses above the recommended 2.27 mg/lb (5.0 mg/ kg) in puppies less than seven months of age has been associated with serious adverse reactions, including death (see Animal Safety). Due to tablet sizes and scoring, dogs weighing less than 12.5 lb (5.7 kg) cannot be accurately dosed. All dogs should undergo a thorough history and physical examination before the initiation of NSAID therapy. Appropriate laboratory testing to establish hematological and serum baseline data is recommended prior to and periodically during administration of any NSAID. Owners should be advised to observe for signs of potential drug toxicity (see Adverse Reactions and Animal Safety) and be given a Client Information Sheet about PREVICOX Chewable Tablets. For technical assistance or to report suspected adverse events, call 1-877-217-3543. Precautions: This product cannot be accurately dosed in dogs less than 12.5 pounds in body weight. Consider appropriate washout times when switching from one NSAID to another or when switching from corticosteroid use to NSAID use. As a class, cyclooxygenase inhibitory NSAIDs may be associated with renal, gastrointestinal and hepatic toxicity. Sensitivity to drug-associated adverse events varies with the individual patient. Dogs that have experienced adverse reactions from one NSAID may experience adverse reactions from another NSAID. Patients at greatest risk for adverse events are those that are dehydrated, on concomitant diuretic therapy, or those with existing renal, cardiovascular, and/or hepatic dysfunction. Concurrent administration of potentially nephrotoxic drugs should be carefully approached and monitored. NSAIDs may inhibit the prostaglandins that maintain normal homeostatic function. Such anti-prostaglandin effects may result in clinically significant disease in patients with underlying or pre-existing disease that has not been previously diagnosed. Since NSAIDs possess the potential to produce gastrointestinal ulceration and/or gastrointestinal perforation, concomitant use of PREVICOX Chewable Tablets with other anti-inflammatory drugs, such as NSAIDs or corticosteroids, should be avoided. The concomitant use of protein-bound drugs with PREVICOX Chewable Tablets has not been studied in dogs. Commonly used protein-bound drugs include cardiac, anticonvulsant, and behavioral medications. The influence of concomitant drugs that may inhibit the metabolism of PREVICOX Chewable Tablets has not been evaluated. Drug compatibility should be monitored in patients requiring adjunctive therapy. If additional pain medication is needed after the daily dose of PREVICOX, a non-NSAID class of analgesic may be necessary. Appropriate monitoring procedures should be employed during all surgical procedures. Anesthetic drugs may affect renal perfusion, approach concomitant use of anesthetics and NSAIDs cautiously. The use of parenteral fluids during surgery should be considered to decrease potential renal complications when using NSAIDs perioperatively. The safe use of PREVICOX Chewable Tablets in pregnant, lactating or breeding dogs has not been evaluated. Adverse Reactions: Osteoarthritis: In controlled field studies, 128 dogs (ages 11 months to 15 years) were evaluated for safety when given PREVICOX Chewable Tablets at a dose of 2.27mg/lb (5.0 mg/kg) orally once daily for 30 days. The following adverse reactions were observed. Dogs may have experienced more than one of the observed adverse reactions during the study. Adverse Reactions Seen in U. S. Field Studies Adverse Reactions Vomiting Diarrhea Decreased Appetite or Anorexia Lethargy Pain Somnolence Hyperactivity PREVICOX (n=128) 5 1 3 1 2 1 1 Active Control (n=121) 8 10 3 3 1 1 0 PREVICOX (firocoxib) Chewable Tablets were safely used during field studies concomitantly with other therapies, including vaccines, anthelmintics, and antibiotics. Soft-tissue Surgery: In controlled field studies evaluating soft-tissue postoperative pain and inflammation, 258 dogs (ages 10.5 weeks to 16 years) were evaluated for safety when given PREVICOX Chewable Tablets at a dose of 2.27 mg/ lb (5.0 mg/kg) orally approximately 2 hours prior to surgery and once daily thereafter for up to two days. The following adverse reactions were observed. Dogs may have experienced more than one of the observed reactions during the study. Adverse Reactions Seen in the Soft-tissue Surgery Postoperative Pain Field Studies Adverse Reactions Vomiting Diarrhea Bruising at Surgery Site Respiratory Arrest SQ Crepitus in Rear Leg and Flank Swollen Paw Firocoxib Group (n=127) 5 1 1 1 1 1 Control Group* (n=131) 6 1 1 0 0 0 *Sham-dosed (pilled) Orthopedic Surgery: In a controlled field study evaluating orthopedic postoperative pain and inflammation, 226 dogs of various breeds, ranging in age from 1 to 11.9 years in the PREVICOX-treated groups and 0.7 to 17 years in the control group were evaluated for safety. Of the 226 dogs, 118 were given PREVICOX Chewable Tablets at a dose of 2.27 mg/lb (5.0 mg/kg) orally approximately 2 hours prior to surgery and once daily thereafter for a total of three days. The following adverse reactions were observed. Dogs may have experienced more than one of the observed reactions during the study. Adverse Reactions Seen in the Orthopedic Surgery Postoperative Pain Field Study Adverse Reactions Vomiting Diarrhea Bruising at Surgery Site Inappetence/ Decreased Appetite Pyrexia Incision Swelling, Redness Oozing Incision Firocoxib Group (n=118) 1 2** 2 1 0 9 2 Control Group* (n=108) 0 1 3 2 1 5 0 A case may be represented in more than one category. *Sham-dosed (pilled). **One dog had hemorrhagic gastroenteritis. 94 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Post-Approval Experience (Rev. 2009): The following adverse reactions are based on post-approval adverse drug event reporting. The categories are listed in decreasing order of frequency by body system: Gastrointestinal: Vomiting, anorexia, diarrhea, melena, gastrointestinal perforation, hematemesis, hematachezia, weight loss, gastrointestinal ulceration, peritonitis, abdominal pain, hypersalivation, nausea Urinary: Elevated BUN, elevated creatinine, polydypsia, polyuria, hematuria, urinary incontinence, proteinuria, kidney failure, azotemia, urinary tract infection Neurological/Behavioral/Special Sense: Depression/lethargy, ataxia, seizures, nervousness, confusion, weakness, hyperactivity, tremor, paresis, head tilt, nystagmus, mydriasis, aggression, uveitis Hepatic: Elevated ALP, elevated ALT, elevated bilirubin, decreased albumin, elevated AST, icterus, decreased or increased total protein and globulin, pancreatitis, ascites, liver failure, decreased BUN Hematological: Anemia, neutrophilia, thrombocytopenia, neutropenia Cardiovascular/Respiratory: Tachypnea, dyspnea, tachycardia Dermatologic/Immunologic: Pruritis, fever, alopecia, moist dermatitis, autoimmune hemolytic anemia, facial/ muzzle edema, urticaria In some situations, death has been reported as an outcome of the adverse events listed above. For a complete listing of adverse reactions for firocoxib reported to the CVM see: http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/ucm055394.htm Information For Dog Owners: PREVICOX, like other drugs of its class, is not free from adverse reactions. Owners should be advised of the potential for adverse reactions and be informed of the clinical signs associated with drug intolerance. Adverse reactions may include vomiting, diarrhea, decreased appetite, dark or tarry stools, increased water consumption, increased urination, pale gums due to anemia, yellowing of gums, skin or white of the eye due to jaundice, lethargy, incoordination, seizure, or behavioral changes. Serious adverse reactions associated with this drug class can occur without warning and in rare situations result in death (see Adverse Reactions). Owners should be advised to discontinue PREVICOX therapy and contact their veterinarian immediately if signs of intolerance are observed. The vast majority of patients with drug-related adverse reactions have recovered when the signs are recognized, the drug is withdrawn, and veterinary care, if appropriate, is initiated. Owners should be advised of the importance of periodic follow up for all dogs during administration of any NSAID. Effectiveness: Two hundred and forty-nine dogs of various breeds, ranging in age from 11 months to 20 years, and weighing 13 to 175 lbs, were randomly administered PREVICOX or an active control drug in two field studies. Dogs were assessed for lameness, pain on manipulation, range of motion, joint swelling, and overall improvement in a non-inferiority evaluation of PREVICOX compared with the active control. At the study’s end, 87% of the owners rated PREVICOX-treated dogs as improved. Eighty-eight percent of dogs treated with PREVICOX were also judged improved by the veterinarians. Dogs treated with PREVICOX showed a level of improvement in veterinarianassessed lameness, pain on palpation, range of motion, and owner-assessed improvement that was comparable to the active control. The level of improvement in PREVICOX-treated dogs in limb weight bearing on the force plate gait analysis assessment was comparable to the active control. In a separate field study, two hundred fifty-eight client-owned dogs of various breeds, ranging in age from 10.5 weeks to 16 years and weighing from 7 to 168 lbs, were randomly administered PREVICOX or a control (sham-dosed-pilled) for the control of postoperative pain and inflammation associated with soft-tissue surgical procedures such as abdominal surgery (e.g., ovariohysterectomy, abdominal cryptorchidectomy, splenectomy, cystotomy) or major external surgeries (e.g., mastectomy, skin tumor removal ≤8 cm). The study demonstrated that PREVICOX-treated dogs had significantly lower need for rescue medication than the control (sham-dosed-pilled) in controlling postoperative pain and inflammation associated with soft-surgery. A multi-center field study with 226 client-owned dogs of various breeds, and ranging in age from 1 to 11.9 years in the PREVICOX-treated groups and 0.7 to 17 years in the control group was conducted. Dogs were randomly assigned to either the PREVICOX or the control (sham-dosed-pilled) group for the control of postoperative pain and inflammation associated with orthopedic surgery. Surgery to repair a ruptured cruciate ligament included the following stabilization procedures: fabellar suture and/or imbrication, fibular head transposition, tibial plateau leveling osteotomy (TPLO), and ‘over the top’ technique. The study (n = 220 for effectiveness) demonstrated that PREVICOX-treated dogs had significantly lower need for rescue medication than the control (sham-dosed-pilled) in controlling postoperative pain and inflammation associated with orthopedic surgery. Animal Safety: In a targeted animal safety study, firocoxib was administered orally to healthy adult Beagle dogs (eight dogs per group) at 5, 15, and 25 mg/kg (1, 3, and 5 times the recommended total daily dose) for 180 days. At the indicated dose of 5 mg/kg, there were no treatment-related adverse events. Decreased appetite, vomiting, and diarrhea were seen in dogs in all dose groups, including unmedicated controls, although vomiting and diarrhea were seen more often in dogs in the 5X dose group. One dog in the 3X dose group was diagnosed with juvenile polyarteritis of unknown etiology after exhibiting recurrent episodes of vomiting and diarrhea, lethargy, pain, anorexia, ataxia, proprioceptive deficits, decreased albumin levels, decreased and then elevated platelet counts, increased bleeding times, and elevated liver enzymes. On histopathologic examination, a mild ileal ulcer was found in one 5X dog. This dog also had a decreased serum albumin which returned to normal by study completion. One control and three 5X dogs had focal areas of inflammation in the pylorus or small intestine. Vacuolization without inflammatory cell infiltrates was noted in the thalamic region of the brain in three control, one 3X, and three 5X dogs. Mean ALP was within the normal range for all groups but was greater in the 3X and 5X dose groups than in the control group. Transient decreases in serum albumin were seen in multiple animals in the 3X and 5X dose groups, and in one control animal. In a separate safety study, firocoxib was administered orally to healthy juvenile (10-13 weeks of age) Beagle dogs at 5, 15, and 25 mg/kg (1, 3, and 5 times the recommended total daily dose) for 180 days. At the indicated (1X) dose of 5 mg/kg, on histopathologic examination, three out of six dogs had minimal periportal hepatic fatty change. On histopathologic examination, one control, one 1X, and two 5X dogs had diffuse slight hepatic fatty change. These animals showed no clinical signs and had no liver enzyme elevations. In the 3X dose group, one dog was euthanized because of poor clinical condition (Day 63). This dog also had a mildly decreased serum albumin. At study completion, out of five surviving and clinically normal 3X dogs, three had minimal periportal hepatic fatty change. Of twelve dogs in the 5X dose group, one died (Day 82) and three moribund dogs were euthanized (Days 38, 78, and 79) because of anorexia, poor weight gain, depression, and in one dog, vomiting. One of the euthanized dogs had ingested a rope toy. Two of these 5X dogs had mildly elevated liver enzymes. At necropsy all five of the dogs that died or were euthanized had moderate periportal or severe panzonal hepatic fatty change; two had duodenal ulceration; and two had pancreatic edema. Of two other clinically normal 5X dogs (out of four euthanized as comparators to the clinically affected dogs), one had slight and one had moderate periportal hepatic fatty change. Drug treatment was discontinued for four dogs in the 5X group. These dogs survived the remaining 14 weeks of the study. On average, the dogs in the 3X and 5X dose groups did not gain as much weight as control dogs. Rate of weight gain was measured (instead of weight loss) because these were young growing dogs. Thalamic vacuolation was seen in three of six dogs in the 3X dose group, five of twelve dogs in the 5X dose group, and to a lesser degree in two unmedicated controls. Diarrhea was seen in all dose groups, including unmedicated controls. In a separate dose tolerance safety study involving a total of six dogs (two control dogs and four treated dogs), firocoxib was administered to four healthy adult Beagle dogs at 50 mg/kg (ten times the recommended daily dose) for twenty-two days. All dogs survived to the end of the study. Three of the four treated dogs developed small intestinal erosion or ulceration. Treated dogs that developed small intestinal erosion or ulceration had a higher incidence of vomiting, diarrhea, and decreased food consumption than control dogs. One of these dogs had severe duodenal ulceration, with hepatic fatty change and associated vomiting, diarrhea, anorexia, weight loss, ketonuria, and mild elevations in AST and ALT. All four treated dogs exhibited progressively decreasing serum albumin that, with the exception of one dog that developed hypoalbuminemia, remained within normal range. Mild weight loss also occurred in the treated group. One of the two control dogs and three of the four treated dogs exhibited transient increases in ALP that remained within normal range. Made in France Marketed by: Merial Limited, Duluth, GA 30096-4640, U.S.A. 1-877-217-3543 NADA 141-230, Approved by FDA Rev. 07-2012 ®PREVICOX is a registered trademark of Merial. ©2014 Merial. All rights reserved. CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. Description: NEXGARD™ (afoxolaner) is available in four sizes of beef-flavored, soft chewables for oral administration to dogs and puppies according to their weight. Each chewable is formulated to provide a minimum afoxolaner dosage of 1.14 mg/ lb (2.5 mg/kg). Afoxolaner has the chemical composition 1-Naphthalenecarboxamide, 4-[5- [3-chloro-5-(trifluoromethyl)phenyl]-4, 5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl. Indications: NEXGARD kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis), and the treatment and control of Black-legged tick (Ixodes scapularis), American Dog tick (Dermacentor variabilis), and Lone Star tick (Amblyomma americanum) infestations in dogs and puppies 8 weeks of age and older, weighing 4 pounds of body weight or greater, for one month. Dosage and Administration: NEXGARD is given orally once a month, at the minimum dosage of 1.14 mg/lb (2.5 mg/kg). Dosing Schedule: Body Weight 4.0 to 10.0 lbs. 10.1 to 24.0 lbs. 24.1 to 60.0 lbs. 60.1 to 121.0 lbs. Over 121.0 lbs. Afoxolaner Per Chewables Chewable (mg) Administered 11.3 One 28.3 One 68 One 136 One Administer the appropriate combination of chewables NEXGARD can be administered with or without food. Care should be taken that the dog consumes the complete dose, and treated animals should be observed for a few minutes to ensure that part of the dose is not lost or refused. If it is suspected that any of the dose has been lost or if vomiting occurs within two hours of administration, redose with another full dose. If a dose is missed, administer NEXGARD and resume a monthly dosing schedule. Flea Treatment and Prevention: Treatment with NEXGARD may begin at any time of the year. In areas where fleas are common year-round, monthly treatment with NEXGARD should continue the entire year without interruption. To minimize the likelihood of flea reinfestation, it is important to treat all animals within a household with an approved flea control product. Tick Treatment and Control: Treatment with NEXGARD may begin at any time of the year (see Effectiveness). Contraindications: There are no known contraindications for the use of NEXGARD. Warnings: Not for use in humans. Keep this and all drugs out of the reach of children. In case of accidental ingestion, contact a physician immediately. Precautions: The safe use of NEXGARD in breeding, pregnant or lactating dogs has not been evaluated. Use with caution in dogs with a history of seizures (see Adverse Reactions). Adverse Reactions: In a well-controlled US field study, which included a total of 333 households and 615 treated dogs (415 administered afoxolaner; 200 administered active control), no serious adverse reactions were observed with NEXGARD. Over the 90-day study period, all observations of potential adverse reactions were recorded. The most frequent reactions reported at an incidence of > 1% within any of the three months of observations are presented in the following table. The most frequently reported adverse reaction was vomiting. The occurrence of vomiting was generally self-limiting and of short duration and tended to decrease with subsequent doses in both groups. Five treated dogs experienced anorexia during the study, and two of those dogs experienced anorexia with the first dose but not subsequent doses. Table 1: Dogs With Adverse Reactions. Treatment Group Afoxolaner Vomiting (with and without blood) Dry/Flaky Skin Diarrhea (with and without blood) Lethargy Anorexia N1 17 13 13 7 5 % (n=415) 4.1 3.1 3.1 1.7 1.2 Oral active control N2 25 2 7 4 9 % (n=200) 12.5 1.0 3.5 2.0 4.5 1 Number of dogs in the afoxolaner treatment group with the identified abnormality. 2 Number of dogs in the control group with the identified abnormality. In the US field study, one dog with a history of seizures experienced a seizure on the same day after receiving the first dose and on the same day after receiving the second dose of NEXGARD. This dog experienced a third seizure one week after receiving the third dose. The dog remained enrolled and completed the study. Another dog with a history of seizures had a seizure 19 days after the third dose of NEXGARD. The dog remained enrolled and completed the study. A third dog with a history of seizures received NEXGARD and experienced no seizures throughout the study. To report suspected adverse events, for technical assistance or to obtain a copy of the MSDS, contact Merial at 1-888637-4251 or www.merial.com/nexgard. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at http://www.fda.gov/AnimalVeterinary/SafetyHealth. Mode of Action: Afoxolaner is a member of the isoxazoline family, shown to bind at a binding site to inhibit insect and acarine ligand-gated chloride channels, in particular those gated by the neurotransmitter gamma-aminobutyric acid (GABA), thereby blocking pre- and post-synaptic transfer of chloride ions across cell membranes. Prolonged afoxolaner-induced hyperexcitation results in uncontrolled activity of the central nervous system and death of insects and acarines. The selective toxicity of afoxolaner between insects and acarines and mammals may be inferred by the differential sensitivity of the insects and acarines’ GABA receptors versus mammalian GABA receptors. Effectiveness: In a well-controlled laboratory study, NEXGARD began to kill fleas four hours after initial administration and demonstrated >99% effectiveness at eight hours. In a separate well-controlled laboratory study, NEXGARD demonstrated 100% effectiveness against adult fleas 24 hours post-infestation for 35 days, and was ≥ 93% effective at 12 hours post-infestation through Day 21, and on Day 35. On Day 28, NEXGARD was 81.1% effective 12 hours post-infestation. Dogs in both the treated and control groups that were infested with fleas on Day -1 generated flea eggs at 12- and 24-hours post-treatment (0-11 eggs and 1-17 eggs in the NEXGARD treated dogs, and 4-90 eggs and 0-118 eggs in the control dogs, at 12- and 24hours, respectively). At subsequent evaluations post-infestation, fleas from dogs in the treated group were essentially unable to produce any eggs (0-1 eggs) while fleas from dogs in the control group continued to produce eggs (1-141 eggs). In a 90-day US field study conducted in households with existing flea infestations of varying severity, the effectiveness of NEXGARD against fleas on the Day 30, 60 and 90 visits compared with baseline was 98.0%, 99.7%, and 99.9%, respectively. Collectively, the data from the three studies (two laboratory and one field) demonstrate that NEXGARD kills fleas before they can lay eggs, thus preventing subsequent flea infestations after the start of treatment of existing flea infestations. In well-controlled laboratory studies, NEXGARD demonstrated >94% effectiveness against Dermacentor variabilis and Ixodes scapularis, 48 hours post-infestation, and against Amblyomma americanum 72 hours post-infestation, for 30 days. Animal Safety: In a margin of safety study, NEXGARD was administered orally to 8- to 9-week-old Beagle puppies at 1, 3, and 5 times the maximum exposure dose (6.3 mg/kg) for three treatments every 28 days, followed by three treatments every 14 days, for a total of six treatments. Dogs in the control group were sham-dosed. There were no clinically-relevant effects related to treatment on physical examination, body weight, food consumption, clinical pathology (hematology, clinical chemistries, or coagulation tests), gross pathology, histopathology or organ weights. Vomiting occurred throughout the study, with a similar incidence in the treated and control groups, including one dog in the 5x group that vomited four hours after treatment. In a well-controlled field study, NEXGARD was used concomitantly with other medications, such as vaccines, anthelmintics, antibiotics (including topicals), steroids, NSAIDS, anesthetics, and antihistamines. No adverse reactions were observed from the concomitant use of NEXGARD with other medications. Storage Information: Store at or below 30°C (86°F) with excursions permitted up to 40°C (104°F). How Supplied: NEXGARD is available in four sizes of beef-flavored soft chewables: 11.3, 28.3, 68 or 136 mg afoxolaner. Each chewable size is available in color-coded packages of 1, 3 or 6 beef-flavored chewables. NADA 141-406, Approved by FDA Marketed by: Frontline Vet Labs™, a Division of Merial Limited. Duluth, GA 30096-4640 USA Made in Brazil. 1050-4493-02 Rev. 4/2014 ™NexGard and FRONTLINE VET LABS are trademarks of Merial. ©2014 Merial. All rights reserved. xng222320_LaunchTradeAd-VetAdvantage-PI-3.25x8.75_RSg.indd 1 6/9/14 4:54 PM www.vet-advantage.com • Veterinary advantage «« July/August 2014 95 96 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com For Animal Use Only 141-342 CIV (alfaxalone 10 mg/mL) Intravenous injectable anesthetic for use in cats and dogs. BRIEF SUMMARY OF PRESCRIBING INFORMATION This summary does not include all the information needed to use Alfaxan® safely and effectively. See full package insert for complete information. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. INDICATIONS: Alfaxan® is indicated for the induction and maintenance of anesthesia and for induction of anesthesia followed by maintenance with an inhalant anesthetic, in cats and dogs. DOSAGE AND ADMINISTRATION (highlights): Please refer to the complete package insert for full prescribing and administration information before use of this product. Administer by intravenous injection only. For induction, administer Alfaxan® over approximately 60 seconds or until clinical signs show the onset of anesthesia, titrating administration against the response of the patient. Rapid administration of Alfaxan® may be associated with an increased incidence of cardiorespiratory depression or apnea. Apnea can occur following induction or after the administration of maintenance boluses of Alfaxan®. The use of preanesthetics may reduce the Alfaxan® induction dose. The choice and the amount of phenothiazine, alpha2-adrenoreceptor agonist, benzodiazepine or opioid will influence the response of the patient to an induction dose of Alfaxan®. When using Alfaxan,® patients should be continuously monitored, and facilities for the maintenance of a patent airway, artificial ventilation, and oxygen supplementation must be immediately available. Alfaxan® does not contain an antimicrobial preservative. Do not use if contamination is suspected. Strict aseptic techniques must be maintained because the vehicle is capable of supporting the rapid growth of microorganisms. Failure to follow aseptic handling procedures may result in microbial contamination which may cause fever, infection/sepsis, and/or other life-threatening illness. Once Alfaxan® has been opened, vial contents should be drawn into sterile syringes; each syringe should be prepared for single patient use only. Unused product should be discarded within 6 hours. Alfaxan® should not be mixed with other therapeutic agents prior to administration. INDUCTION OF GENERAL ANESTHESIA: CATS: Induction dose guidelines range between 2.2 - 9.7 mg/kg for cats that did not receive a preanesthetic, and between 1.0 - 10.8 mg/kg for cats that received a preanesthetic. The Alfaxan® induction dose in the field study was reduced by 10 - 43%, depending on the combination of preanesthetics (dose sparing effect). To avoid anesthetic overdose, titrate the administration of Alfaxan® against the response of the patient. DOGS: Induction dose guidelines range between 1.5 - 4.5 mg/kg for dogs that did not receive a preanesthetic, and between 0.2 - 3.5 mg/kg for dogs that received a preanesthetic. The Alfaxan® induction dose in the field study was reduced by 23 - 50% depending on the combination of preanesthetics (dose sparing effect). To avoid anesthetic overdose, titrate the administration of Alfaxan® against the response of the patient. The average Alfaxan® induction dose rates for healthy cats and dogs given alfaxalone alone, or when alfaxalone is preceded by a preanesthetic, are indicated in species specific tables found in the full package insert. These tables are based on field study results and are for guidance only. The dose and rate for alfaxalone should be based upon patient response. MAINTENANCE OF GENERAL ANESTHESIA: CATS: Following induction of anesthesia with Alfaxan® and intubation, anesthesia may be maintained using intermittent Alfaxan® intravenous boluses or an inhalant anesthetic agent. Please review the full package insert for guidance on recommended intermittent doses of Alfaxan and their expected duration of effect. Clinical response may vary, and is determined by the dose, rate of administration, and frequency of maintenance injections. DOGS: Following induction of anesthesia with Alfaxan® and intubation, anesthesia may be main- tained using intermittent Alfaxan® intravenous boluses or an inhalant anesthetic agent. Please review the full package insert for guidance on recommended intermittent doses of Alfaxan and their expected duration of effect. Clinical response may vary, and is determined by the dose, rate of administration, and frequency of maintenance injections. Alfaxan® maintenance dose sparing is greater in cats and dogs that receive a preanesthetic. Maintenance dose and frequency should be based on the response of the individual patient. Inhalant anesthetic maintenance of general anesthesia in cats and dogs: Additional low doses of Alfaxan®, similar to a maintenance dose, may be required to facilitate the transition to inhalant maintenance anesthesia. WARNINGS: When anesthetized using Alfaxan®, patients should be continuously monitored, and facilities for the maintenance of a patent airway, artificial ventilation, and oxygen supplementation must be immediately available. Rapid bolus administration or anesthetic overdose may cause cardiorespiratory depression, including hypotension, apnea, hypoxia, or death. Arrhythmias may occur secondary to apnea and hypoxia. In cases of anesthetic overdose, stop Alfaxan® administration and administer treatment as indicated by the patient’s clinical signs. Cardiovascular depression should be treated with plasma expanders, pressor agents, anti-arrhythmic agents or other techniques as appropriate for the treatment of the clinical signs. HUMAN WARNINGS: Not for human use. Keep out of the reach of children. Exercise caution to avoid accidental self-injection. Overdose is likely to cause cardiorespiratory depression (such as hypotension, bradycardia and/or apnea). Remove the individual from the source of exposure and seek medical attention. Respiratory depression should be treated by artificial ventilation and oxygen. Avoid contact of this product with skin, eyes, and clothes. In case of contact, eyes and skin should be liberally flushed with water for 15 minutes. Consult a physician if irritation persists. In the case of accidental human ingestion, seek medical advice immediately and show the package insert or the label to the physician. The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information. To report adverse reactions in users or to obtain a copy of the MSDS for this product call 1-844-253-2926. DRUG ABUSE AND DEPENDENCE: Controlled Substance: Alfaxan® contains alfaxalone, a neurosteroid anesthetic and a class IV controlled substance. Abuse: Alfaxalone is a central nervous system depressant that acts on GABA receptor associated chloride channels, similar to the mechanism of action of Schedule IV sedatives such as benzodiazepines (diazepam and midazolam), barbiturates (phenobarbital and methohexital) and fospropofol. In a drug discrimination behavioral test in rats, the effects of alfaxalone were recognized as similar to those of midazolam. These biochemical and behavioral data suggest that alfaxalone has an abuse potential similar to other Schedule IV sedatives. Physical dependence: There are no data that assess the ability of alfaxalone to induce physical dependence. However, alfaxalone has a mechanism of action similar to the benzodiazepines and can block the behavioral responses associated with precipitated benzodiazepine withdrawal. Therefore, it is likely that alfaxalone can also produce physical dependence and withdrawal signs similar to that produced by the benzodiazepines. Psychological dependence: The ability of alfaxalone to produce psychological dependence is unknown because there are no data on the rewarding properties of the drug from animal self-administration studies or from human abuse potential studies. PRECAUTIONS: 1. Unpreserved formulation: Alfaxan® injection does not contain an antimicrobial preservative. Do not use if contamination is suspected. Strict aseptic techniques must be maintained because the vehicle is capable of supporting the rapid growth of microorganisms. Failure to follow aseptic handling procedures may result in microbial contamination which may cause fever, infection/sepsis, and/or other life-threatening illness. Any solution remaining in the vial following withdrawal of the required dose should be discarded. Once Alfaxan® has been opened, any unused product should be discarded within 6 hours. Alfaxan® should not be mixed with other therapeutic agents prior to administration. 2. Rapid arousal: Careful monitoring of the patient is necessary due to possibility of rapid arousal. 3. Preanesthesia: Benzodiazepines may be used safely prior to Alfaxan® in the presence of other preanesthetics. However, when a benzodiazepine was used as the sole preanesthetic, excitation occurred in some dogs and cats during Alfaxan® anesthesia and recovery. 4. Apnea: Apnea may occur following administration of an induction dose, a maintenance dose or a dose administered during the transition to inhalant maintenance anesthesia, especially with higher doses and rapid administration. Endotracheal intubation, oxygen supplementation, and intermittent positive pressure ventilation (IPPV) should be administered to treat apnea and associated hypoxemia. 5. Blood Pressure: The myocardial depressive effects of Alfaxan® combined with the vasodilatory effects of inhalant anesthetics can be additive, resulting in hypotension. Preanesthetics may increase the anesthesia effect of Alfaxan® and result in more pronounced changes in systolic, diastolic, and mean arterial blood pressures. Transient hypertension may occur, possibly due to elevated sympathetic activity. 6. Body Temperature: A decrease in body temperature occurs during Alfaxan® anesthesia unless an external heat source is provided. Supplemental heat should be provided to maintain acceptable core body temperature until full recovery. 7. Breeding Animals: Alfaxan® has not been evaluated in pregnant, lactating, and breeding cats. Alfaxalone crosses the placenta, and as with other general anesthetic agents, the administration of alfaxalone may be associated with neonatal depression. 8. Kittens and Puppies: Alfaxan® has not been evaluated in cats less than 4 weeks of age or in dogs less than 10 weeks of age. 9. Compromised or Debilitated Cats and Dogs: The administration of Alfaxan® to debilitated patients or patients with renal disease, hepatic disease, or cardiorespiratory disease has not been evaluated. Doses may need adjustment for geriatric or debilitated patients. Caution should be used in cats or dogs with cardiac, respiratory, renal or hepatic impairment, or in hypovolemic or debilitated cats and dogs, and geriatric animals. 10. Analgesia during anesthesia: Appropriate analgesia should be provided for painful procedures. ADVERSE REACTIONS: The primary side effects of alfaxalone are respiratory depression (apnea, bradypnea, hypoxia) and cardiovascular derangements (hypertension, hypotension, tachycardia, bradycardia). Other adverse reactions observed in clinical studies include hypothermia, emesis, unacceptable anesthesia quality, lack of effectiveness, vocalization, paddling, and muscle tremors. Adverse drug reactions may also be reported to the FDA/CVM at 1-888-FDA-VETS or http://www.fda.gov/AnimalVeterinary/SafetyHealth/ReportaProblem/ucm055305.htm OVERDOSE: Rapid administration, accidental overdose, or relative overdose due to inadequate dose sparing of Alfaxan® in the presence of preanesthetics may cause cardiopulmonary depression. Respiratory arrest (apnea) may be observed. In cases of respiratory depression, stop drug administration, establish a patent airway, and initiate assisted or controlled ventilation with pure oxygen. Cardiovascular depression should be treated with plasma expanders, pressor agents, antiarrhythmic agents or other techniques as appropriate for the observed abnormality. HOW SUPPLIED: Alfaxan® is supplied in 10 mL single-use vials containing 10 mg alfaxalone per mL. Manufactured for: Jurox Inc. 4520 Main Street, Kansas City, MO 64111, USA Alfaxan is a registered trademark of Jurox Pty Limited. US Patent # 7,897,586 www.vet-advantage.com • Veterinary advantage «« July/August 2014 97 »» Editor’s Note Senior pets demand our attention When Christopher Byers, DVM, worked as a technician in the mid-90s, “if an old dog or cat came into the office with his or her family, honestly, they were often treated just like any other patient – with care and compassion, yes, but they weren’t considered a special patient population with unique healthcare needs. Today, we recognize that geriatric patients do have unique health needs, and the sooner we identify them, the better they will likely be in both the short and long term.” in the discussion about the senior pet. “Animals are living closer to us, so we can see when they By Mark Thill don’t feel right,” Dr. Crumley tells us. “And people care intensely about making the quality of their pets’ lives better.” There’s another interesting dynamic, closely related: “The general population of pet owners is aging a bit, so people are sensitive to what’s ailing their pet,” says Dr. Crumley. “‘What I am experiencing, are my pets experiencing that as well?’” Many primary care hospitals have developed protocols specifically for geriatric care, and they have trained their nursing staffs and client services teams to educate pet owners and promote this specific aspect of preventive healthcare, Dr. Byers tells us. As a result, practices are educating their – Kate Crumley, DVM, president of the American Animal Hospital Association clients about the potential for osteoarthritis, heart disease, hyperthyroidism and 20 years ago, when I came out of school. It dechronic kidney disease in their senior pets. pends on breed and species, but gaining years Prior to bringing their older pets in to Twin on the pet’s life is pretty common. It’s expected Cities Animal Rehabilitation and Sports Medithese days.” cine Clinic, Burnsville, Minn., clients are asked Improved medical technology – surgical equipto fill out a mobility questionnaire related to their ment and supplies, pharmaceuticals, nutrition – is pets, explains Julia Tomlinson, BVSc. That’s beplaying a big role. What’s interesting is how the atcause arthritis and mobility issues are common titudes and actions of pet owners and their veteriamong senior pets, she tells us. narians are influencing the trend as well. The growth in the number of senior pets is In the past couple of issues of Vet-Advanongoing. With it come challenges and opportutage, we have reported on the significance of nities for Vet-Advantage readers. the human-animal bond. This bond plays a role In this month’s issue of Vet-Advantage, we draw attention to the care being provided to senior companion animals, and the role that distributors of veterinary products and equipment can play in that effort. Of course, any pet owner already knows that life expectancies are longer than ever. Says Kate Crumley, DVM, president of the American Animal Hospital Association, “Pets certainly are living longer than they did “Animals are living closer to us, so we can see when they don’t feel right. And people care intensely about making the quality of their pets’ lives better.” 98 July/August 2014 »» Veterinary adVantage • www.vet-advantage.com Whoa ! Did you say “touch screen” ® and “Cardell monitor” in the same sentence? Midmark has designed the precision and consistency you expect from the Cardell® name into a fast, light and intuitive touch screen vital signs monitor. Your clinics will appreciate the: 10.5" Touch Screen - for fast setup and ease of use Redesigned Menus - for intuitive navigation CO2 Available - upgrade at any time; mainstream or sidestream The Touch is the latest innovation from the most trusted name in veterinary vital signs monitoring. Contact your Midmark Animal Health Territory Manager to learn more or visit midmarkanimalhealth.com/VAJul2014.